id	sid	tid	token	lemma	pos
aiua-5029	1	1	stesura	stesura	PROPN
aiua-5029	1	2	seveso	seveso	PROPN
aiua-5029	1	3	archivio	archivio	PROPN
aiua-5029	1	4	italiano	italiano	X
aiua-5029	1	5	di	di	X
aiua-5029	1	6	urologia	urologia	PROPN
aiua-5029	1	7	e	e	PROPN
aiua-5029	1	8	andrologia	andrologia	NOUN
aiua-5029	1	9	2014	2014	NUM
aiua-5029	1	10	;	;	PUNCT
aiua-5029	1	11	86	86	NUM
aiua-5029	1	12	,	,	PUNCT
aiua-5029	1	13	4278	4278	NUM
aiua-5029	1	14	original	original	ADJ
aiua-5029	1	15	paper	paper	NOUN
aiua-5029	1	16	neoadjuvant	neoadjuvant	NOUN
aiua-5029	1	17	chemotherapy	chemotherapy	NOUN
aiua-5029	1	18	versus	versus	ADP
aiua-5029	1	19	cystectomy	cystectomy	NOUN
aiua-5029	1	20	in	in	ADP
aiua-5029	1	21	management	management	NOUN
aiua-5029	1	22	of	of	ADP
aiua-5029	1	23	stages	stage	NOUN
aiua-5029	1	24	ii	ii	NOUN
aiua-5029	1	25	,	,	PUNCT
aiua-5029	1	26	and	and	CCONJ
aiua-5029	1	27	iii	iii	NUM
aiua-5029	1	28	urinary	urinary	ADJ
aiua-5029	1	29	bladder	bladder	NOUN
aiua-5029	1	30	cancer	cancer	NOUN
aiua-5029	1	31	mohammed	mohammed	PROPN
aiua-5029	1	32	a.	a.	PROPN
aiua-5029	1	33	osman	osman	PROPN
aiua-5029	1	34	1	1	NUM
aiua-5029	1	35	,	,	PUNCT
aiua-5029	1	36	ayman	ayman	PROPN
aiua-5029	1	37	m.	m.	NOUN
aiua-5029	1	38	gabr	gabr	VERB
aiua-5029	1	39	2	2	NUM
aiua-5029	1	40	,	,	PUNCT
aiua-5029	1	41	mohammad	mohammad	PROPN
aiua-5029	1	42	s.	s.	PROPN
aiua-5029	1	43	elkady	elkady	PROPN
aiua-5029	1	44	3	3	NUM
aiua-5029	1	45	1	1	NUM
aiua-5029	1	46	general	general	ADJ
aiua-5029	1	47	organization	organization	NOUN
aiua-5029	1	48	for	for	ADP
aiua-5029	1	49	teaching	teaching	NOUN
aiua-5029	1	50	hospitals	hospital	NOUN
aiua-5029	1	51	institutes	institutes	PROPN
aiua-5029	1	52	,	,	PUNCT
aiua-5029	1	53	egypt	egypt	PROPN
aiua-5029	1	54	;	;	PUNCT
aiua-5029	1	55	2	2	NUM
aiua-5029	1	56	national	national	PROPN
aiua-5029	1	57	institute	institute	PROPN
aiua-5029	1	58	of	of	ADP
aiua-5029	1	59	urology	urology	PROPN
aiua-5029	1	60	&	&	CCONJ
aiua-5029	1	61	nephrology	nephrology	NOUN
aiua-5029	1	62	,	,	PUNCT
aiua-5029	1	63	egypt	egypt	PROPN
aiua-5029	1	64	;	;	PUNCT
aiua-5029	1	65	3	3	NUM
aiua-5029	1	66	ain	ain	NOUN
aiua-5029	1	67	shams	sham	NOUN
aiua-5029	1	68	university	university	PROPN
aiua-5029	1	69	,	,	PUNCT
aiua-5029	1	70	egypt	egypt	PROPN
aiua-5029	1	71	.	.	PUNCT
aiua-5029	2	1	purpose	purpose	NOUN
aiua-5029	2	2	:	:	PUNCT
aiua-5029	2	3	this	this	DET
aiua-5029	2	4	phase	phase	NOUN
aiua-5029	2	5	iii	iii	NOUN
aiua-5029	2	6	trial	trial	NOUN
aiua-5029	2	7	was	be	AUX
aiua-5029	2	8	de	de	ADV
aiua-5029	2	9	signed	sign	VERB
aiua-5029	2	10	to	to	PART
aiua-5029	2	11	compare	compare	VERB
aiua-5029	2	12	the	the	DET
aiua-5029	2	13	survival	survival	NOUN
aiua-5029	2	14	benefit	benefit	NOUN
aiua-5029	2	15	,	,	PUNCT
aiua-5029	2	16	surgical	surgical	ADJ
aiua-5029	2	17	respectability	respectability	NOUN
aiua-5029	2	18	,	,	PUNCT
aiua-5029	2	19	and	and	CCONJ
aiua-5029	2	20	toxicities	toxicity	NOUN
aiua-5029	2	21	among	among	ADP
aiua-5029	2	22	patients	patient	NOUN
aiua-5029	2	23	treated	treat	VERB
aiua-5029	2	24	by	by	ADP
aiua-5029	2	25	neoadjuvant	neoadjuvant	ADJ
aiua-5029	2	26	chemotherapy	chemotherapy	NOUN
aiua-5029	2	27	followed	follow	VERB
aiua-5029	2	28	by	by	ADP
aiua-5029	2	29	radical	radical	ADJ
aiua-5029	2	30	cystectomy	cystectomy	NOUN
aiua-5029	2	31	(	(	PUNCT
aiua-5029	2	32	arm	arm	VERB
aiua-5029	2	33	a	a	PRON
aiua-5029	2	34	)	)	PUNCT
aiua-5029	2	35	,	,	PUNCT
aiua-5029	2	36	with	with	ADP
aiua-5029	2	37	those	those	PRON
aiua-5029	2	38	treated	treat	VERB
aiua-5029	2	39	by	by	ADP
aiua-5029	2	40	radical	radical	ADJ
aiua-5029	2	41	cystectomy	cystectomy	NOUN
aiua-5029	2	42	(	(	PUNCT
aiua-5029	2	43	arm	arm	NOUN
aiua-5029	2	44	b	b	NOUN
aiua-5029	2	45	)	)	PUNCT
aiua-5029	2	46	in	in	ADP
aiua-5029	2	47	the	the	DET
aiua-5029	2	48	management	management	NOUN
aiua-5029	2	49	of	of	ADP
aiua-5029	2	50	stage	stage	PROPN
aiua-5029	2	51	ii	ii	PROPN
aiua-5029	2	52	,	,	PUNCT
aiua-5029	2	53	iii	iii	NUM
aiua-5029	2	54	urinary	urinary	ADJ
aiua-5029	2	55	bladder	bladder	NOUN
aiua-5029	2	56	cancer	cancer	NOUN
aiua-5029	2	57	.	.	PUNCT
aiua-5029	3	1	patients	patient	NOUN
aiua-5029	3	2	and	and	CCONJ
aiua-5029	3	3	methods	method	NOUN
aiua-5029	3	4	:	:	PUNCT
aiua-5029	3	5	for	for	ADP
aiua-5029	3	6	inclusion	inclusion	NOUN
aiua-5029	3	7	,	,	PUNCT
aiua-5029	3	8	patients	patient	NOUN
aiua-5029	3	9	should	should	AUX
aiua-5029	3	10	have	have	AUX
aiua-5029	3	11	pathologically	pathologically	ADV
aiua-5029	3	12	proven	prove	VERB
aiua-5029	3	13	urothelial	urothelial	ADJ
aiua-5029	3	14	carcinoma	carcinoma	NOUN
aiua-5029	3	15	in	in	ADP
aiua-5029	3	16	urinary	urinary	ADJ
aiua-5029	3	17	bladder	bladder	NOUN
aiua-5029	3	18	,	,	PUNCT
aiua-5029	3	19	clinical	clinical	ADJ
aiua-5029	3	20	stages	stage	NOUN
aiua-5029	3	21	from	from	ADP
aiua-5029	3	22	t2n0m0	t2n0m0	PROPN
aiua-5029	3	23	to	to	ADP
aiua-5029	3	24	t4an0m0	t4an0m0	PROPN
aiua-5029	3	25	,	,	PUNCT
aiua-5029	3	26	patient	patient	ADJ
aiua-5029	3	27	age	age	NOUN
aiua-5029	3	28	less	less	ADJ
aiua-5029	3	29	than	than	ADP
aiua-5029	3	30	65	65	NUM
aiua-5029	3	31	years	year	NOUN
aiua-5029	3	32	,	,	PUNCT
aiua-5029	3	33	and	and	CCONJ
aiua-5029	3	34	performance	performance	NOUN
aiua-5029	3	35	state	state	NOUN
aiua-5029	3	36	≤	≤	NOUN
aiua-5029	3	37	2	2	NUM
aiua-5029	3	38	.	.	PUNCT
aiua-5029	3	39	additionally	additionally	ADV
aiua-5029	3	40	,	,	PUNCT
aiua-5029	3	41	patients	patient	NOUN
aiua-5029	3	42	should	should	AUX
aiua-5029	3	43	have	have	VERB
aiua-5029	3	44	adequate	adequate	ADJ
aiua-5029	3	45	hematological	hematological	ADJ
aiua-5029	3	46	,	,	PUNCT
aiua-5029	3	47	renal	renal	ADJ
aiua-5029	3	48	,	,	PUNCT
aiua-5029	3	49	and	and	CCONJ
aiua-5029	3	50	liver	liver	NOUN
aiua-5029	3	51	functions	function	NOUN
aiua-5029	3	52	.	.	PUNCT
aiua-5029	4	1	arm	arm	VERB
aiua-5029	4	2	a	a	DET
aiua-5029	4	3	patients	patient	NOUN
aiua-5029	4	4	underwent	undergo	VERB
aiua-5029	4	5	3	3	NUM
aiua-5029	4	6	cycles	cycle	NOUN
aiua-5029	4	7	of	of	ADP
aiua-5029	4	8	neoadjuvant	neoadjuvant	ADJ
aiua-5029	4	9	cisplatin	cisplatin	NOUN
aiua-5029	4	10	and	and	CCONJ
aiua-5029	4	11	gemcitabine	gemcitabine	NOUN
aiua-5029	4	12	followed	follow	VERB
aiua-5029	4	13	by	by	ADP
aiua-5029	4	14	radical	radical	ADJ
aiua-5029	4	15	cystectomy	cystectomy	NOUN
aiua-5029	4	16	,	,	PUNCT
aiua-5029	4	17	while	while	SCONJ
aiua-5029	4	18	arm	arm	NOUN
aiua-5029	4	19	b	b	PROPN
aiua-5029	4	20	patients	patient	NOUN
aiua-5029	4	21	underwent	undergo	VERB
aiua-5029	4	22	radical	radical	ADJ
aiua-5029	4	23	cystectomy	cystectomy	NOUN
aiua-5029	4	24	directly	directly	ADV
aiua-5029	4	25	.	.	PUNCT
aiua-5029	5	1	results	result	NOUN
aiua-5029	5	2	:	:	PUNCT
aiua-5029	5	3	thirty	thirty	NUM
aiua-5029	5	4	patients	patient	NOUN
aiua-5029	5	5	had	have	AUX
aiua-5029	5	6	been	be	AUX
aiua-5029	5	7	enrolled	enrol	VERB
aiua-5029	5	8	in	in	ADP
aiua-5029	5	9	each	each	DET
aiua-5029	5	10	arm	arm	NOUN
aiua-5029	5	11	between	between	ADP
aiua-5029	5	12	september	september	PROPN
aiua-5029	5	13	2009	2009	NUM
aiua-5029	5	14	and	and	CCONJ
aiua-5029	5	15	april	april	PROPN
aiua-5029	5	16	2014	2014	NUM
aiua-5029	5	17	in	in	ADP
aiua-5029	5	18	3	3	NUM
aiua-5029	5	19	educational	educational	ADJ
aiua-5029	5	20	institutes	institute	NOUN
aiua-5029	5	21	in	in	ADP
aiua-5029	5	22	egypt	egypt	PROPN
aiua-5029	5	23	.	.	PUNCT
aiua-5029	6	1	the	the	DET
aiua-5029	6	2	3	3	NUM
aiua-5029	6	3	year	year	NOUN
aiua-5029	6	4	os	os	NOUN
aiua-5029	6	5	(	(	PUNCT
aiua-5029	6	6	overall	overall	ADJ
aiua-5029	6	7	survival	survival	NOUN
aiua-5029	6	8	)	)	PUNCT
aiua-5029	6	9	for	for	ADP
aiua-5029	6	10	arm	arm	NOUN
aiua-5029	6	11	a	a	PRON
aiua-5029	6	12	,	,	PUNCT
aiua-5029	6	13	and	and	CCONJ
aiua-5029	6	14	b	b	NOUN
aiua-5029	6	15	were	be	AUX
aiua-5029	6	16	60	60	NUM
aiua-5029	6	17	%	%	NOUN
aiua-5029	6	18	and	and	CCONJ
aiua-5029	6	19	50	50	NUM
aiua-5029	6	20	%	%	NOUN
aiua-5029	6	21	respectively	respectively	ADV
aiua-5029	6	22	.	.	PUNCT
aiua-5029	7	1	the	the	DET
aiua-5029	7	2	median	median	PROPN
aiua-5029	7	3	os	os	NOUN
aiua-5029	7	4	for	for	ADP
aiua-5029	7	5	arm	arm	NOUN
aiua-5029	7	6	a	a	PRON
aiua-5029	7	7	was	be	AUX
aiua-5029	7	8	36	36	NUM
aiua-5029	7	9	+	+	NUM
aiua-5029	7	10	months	month	NOUN
aiua-5029	7	11	and	and	CCONJ
aiua-5029	7	12	that	that	SCONJ
aiua-5029	7	13	for	for	ADP
aiua-5029	7	14	arm	arm	PROPN
aiua-5029	7	15	b	b	PROPN
aiua-5029	7	16	was	be	AUX
aiua-5029	7	17	32.5	32.5	NUM
aiua-5029	7	18	months	month	NOUN
aiua-5029	7	19	.	.	PUNCT
aiua-5029	8	1	the	the	DET
aiua-5029	8	2	3	3	NUM
aiua-5029	8	3	year	year	NOUN
aiua-5029	8	4	progression	progression	NOUN
aiua-5029	8	5	-	-	PUNCT
aiua-5029	8	6	free	free	ADJ
aiua-5029	8	7	survival	survival	NOUN
aiua-5029	8	8	(	(	PUNCT
aiua-5029	8	9	pfs	pfs	PROPN
aiua-5029	8	10	)	)	PUNCT
aiua-5029	8	11	for	for	ADP
aiua-5029	8	12	arm	arm	NOUN
aiua-5029	8	13	a	a	PRON
aiua-5029	8	14	,	,	PUNCT
aiua-5029	8	15	and	and	CCONJ
aiua-5029	8	16	b	b	NOUN
aiua-5029	8	17	were	be	AUX
aiua-5029	8	18	57	57	NUM
aiua-5029	8	19	%	%	NOUN
aiua-5029	8	20	and	and	CCONJ
aiua-5029	8	21	43	43	NUM
aiua-5029	8	22	%	%	NOUN
aiua-5029	8	23	respectively	respectively	ADV
aiua-5029	8	24	.	.	PUNCT
aiua-5029	9	1	the	the	DET
aiua-5029	9	2	median	median	PROPN
aiua-5029	9	3	pfs	pfs	PROPN
aiua-5029	9	4	for	for	ADP
aiua-5029	9	5	arm	arm	NOUN
aiua-5029	9	6	a	a	PRON
aiua-5029	9	7	was	be	AUX
aiua-5029	9	8	36	36	NUM
aiua-5029	9	9	+	+	NUM
aiua-5029	9	10	months	month	NOUN
aiua-5029	9	11	and	and	CCONJ
aiua-5029	9	12	for	for	ADP
aiua-5029	9	13	arm	arm	PROPN
aiua-5029	9	14	b	b	PROPN
aiua-5029	9	15	was	be	AUX
aiua-5029	9	16	28	28	NUM
aiua-5029	9	17	months	month	NOUN
aiua-5029	9	18	.	.	PUNCT
aiua-5029	10	1	a	a	DET
aiua-5029	10	2	subgroup	subgroup	NOUN
aiua-5029	10	3	analysis	analysis	NOUN
aiua-5029	10	4	was	be	AUX
aiua-5029	10	5	performed	perform	VERB
aiua-5029	10	6	to	to	PART
aiua-5029	10	7	correlate	correlate	VERB
aiua-5029	10	8	between	between	ADP
aiua-5029	10	9	3	3	NUM
aiua-5029	10	10	year	year	NOUN
aiua-5029	10	11	os	os	NOUN
aiua-5029	10	12	and	and	CCONJ
aiua-5029	10	13	predetermined	predetermine	VERB
aiua-5029	10	14	prognostic	prognostic	ADJ
aiua-5029	10	15	factors	factor	NOUN
aiua-5029	10	16	including	include	VERB
aiua-5029	10	17	age	age	NOUN
aiua-5029	10	18	,	,	PUNCT
aiua-5029	10	19	tumor	tumor	NOUN
aiua-5029	10	20	size	size	NOUN
aiua-5029	10	21	,	,	PUNCT
aiua-5029	10	22	pathological	pathological	ADJ
aiua-5029	10	23	stage	stage	NOUN
aiua-5029	10	24	,	,	PUNCT
aiua-5029	10	25	and	and	CCONJ
aiua-5029	10	26	the	the	DET
aiua-5029	10	27	response	response	NOUN
aiua-5029	10	28	to	to	ADP
aiua-5029	10	29	neoadjuvant	neoadjuvant	ADJ
aiua-5029	10	30	chemotherapy	chemotherapy	NOUN
aiua-5029	10	31	.	.	PUNCT
aiua-5029	11	1	the	the	DET
aiua-5029	11	2	later	later	ADV
aiua-5029	11	3	was	be	AUX
aiua-5029	11	4	performed	perform	VERB
aiua-5029	11	5	only	only	ADV
aiua-5029	11	6	in	in	ADP
aiua-5029	11	7	arm	arm	NOUN
aiua-5029	11	8	a.	a.	NOUN
aiua-5029	11	9	both	both	DET
aiua-5029	11	10	treatment	treatment	NOUN
aiua-5029	11	11	arms	arm	NOUN
aiua-5029	11	12	were	be	AUX
aiua-5029	11	13	tolerated	tolerate	VERB
aiua-5029	11	14	well	well	ADV
aiua-5029	11	15	with	with	ADP
aiua-5029	11	16	mild	mild	ADJ
aiua-5029	11	17	toxicities	toxicity	NOUN
aiua-5029	11	18	profiles	profile	NOUN
aiua-5029	11	19	.	.	PUNCT
aiua-5029	12	1	conclusion	conclusion	NOUN
aiua-5029	12	2	:	:	PUNCT
aiua-5029	12	3	neoadjuvant	neoadjuvant	ADJ
aiua-5029	12	4	chemotherapy	chemotherapy	NOUN
aiua-5029	12	5	achieved	achieve	VERB
aiua-5029	12	6	better	well	ADJ
aiua-5029	12	7	survival	survival	NOUN
aiua-5029	12	8	,	,	PUNCT
aiua-5029	12	9	surgical	surgical	ADJ
aiua-5029	12	10	respectability	respectability	NOUN
aiua-5029	12	11	,	,	PUNCT
aiua-5029	12	12	with	with	ADP
aiua-5029	12	13	nearly	nearly	ADV
aiua-5029	12	14	equivalent	equivalent	ADJ
aiua-5029	12	15	toxicities	toxicity	NOUN
aiua-5029	12	16	when	when	SCONJ
aiua-5029	12	17	compared	compare	VERB
aiua-5029	12	18	with	with	ADP
aiua-5029	12	19	radical	radical	ADJ
aiua-5029	12	20	cystectomy	cystectomy	NOUN
aiua-5029	12	21	.	.	PUNCT
aiua-5029	13	1	key	key	ADJ
aiua-5029	13	2	words	word	NOUN
aiua-5029	13	3	:	:	PUNCT
aiua-5029	13	4	neoadjuvant	neoadjuvant	ADJ
aiua-5029	13	5	;	;	PUNCT
aiua-5029	13	6	cisplatin	cisplatin	NOUN
aiua-5029	13	7	;	;	PUNCT
aiua-5029	13	8	cystectomy	cystectomy	NOUN
aiua-5029	13	9	;	;	PUNCT
aiua-5029	13	10	survival	survival	NOUN
aiua-5029	13	11	;	;	PUNCT
aiua-5029	13	12	3yos	3yos	NUM
aiua-5029	13	13	;	;	PUNCT
aiua-5029	13	14	arm	arm	NOUN
aiua-5029	13	15	a.	a.	NOUN
aiua-5029	13	16	submitted	submit	VERB
aiua-5029	13	17	14	14	NUM
aiua-5029	13	18	july	july	PROPN
aiua-5029	13	19	2014	2014	NUM
aiua-5029	13	20	;	;	PUNCT
aiua-5029	13	21	accepted	accept	VERB
aiua-5029	13	22	30	30	NUM
aiua-5029	13	23	september	september	PROPN
aiua-5029	13	24	2014	2014	NUM
aiua-5029	13	25	summary	summary	NOUN
aiua-5029	13	26	no	no	DET
aiua-5029	13	27	conflict	conflict	NOUN
aiua-5029	13	28	of	of	ADP
aiua-5029	13	29	interest	interest	NOUN
aiua-5029	13	30	declared	declare	VERB
aiua-5029	13	31	.	.	PUNCT
aiua-5029	14	1	incidence	incidence	NOUN
aiua-5029	14	2	of	of	ADP
aiua-5029	14	3	transitional	transitional	ADJ
aiua-5029	14	4	cell	cell	NOUN
aiua-5029	14	5	carcinoma	carcinoma	NOUN
aiua-5029	14	6	(	(	PUNCT
aiua-5029	14	7	tcc	tcc	NOUN
aiua-5029	14	8	)	)	PUNCT
aiua-5029	14	9	has	have	AUX
aiua-5029	14	10	been	be	AUX
aiua-5029	14	11	increasing	increase	VERB
aiua-5029	14	12	while	while	SCONJ
aiua-5029	14	13	squamous	squamous	ADJ
aiua-5029	14	14	cell	cell	NOUN
aiua-5029	14	15	carcinoma	carcinoma	NOUN
aiua-5029	14	16	(	(	PUNCT
aiua-5029	14	17	scc	scc	NOUN
aiua-5029	14	18	)	)	PUNCT
aiua-5029	14	19	has	have	AUX
aiua-5029	14	20	been	be	AUX
aiua-5029	14	21	decreasing	decrease	VERB
aiua-5029	14	22	.	.	PUNCT
aiua-5029	15	1	active	active	ADJ
aiua-5029	15	2	exposure	exposure	NOUN
aiua-5029	15	3	to	to	ADP
aiua-5029	15	4	tobacco	tobacco	NOUN
aiua-5029	15	5	smoke	smoke	NOUN
aiua-5029	15	6	has	have	VERB
aiua-5029	15	7	a	a	DET
aiua-5029	15	8	strong	strong	ADJ
aiua-5029	15	9	relationship	relationship	NOUN
aiua-5029	15	10	to	to	ADP
aiua-5029	15	11	tcc	tcc	PROPN
aiua-5029	15	12	.	.	PUNCT
aiua-5029	16	1	previous	previous	ADJ
aiua-5029	16	2	studies	study	NOUN
aiua-5029	16	3	have	have	AUX
aiua-5029	16	4	reported	report	VERB
aiua-5029	16	5	a	a	DET
aiua-5029	16	6	2.6	2.6	NUM
aiua-5029	16	7	fold	fold	ADJ
aiua-5029	16	8	risk	risk	NOUN
aiua-5029	16	9	of	of	ADP
aiua-5029	16	10	developing	develop	VERB
aiua-5029	16	11	bladder	bladder	NOUN
aiua-5029	16	12	cancer	cancer	NOUN
aiua-5029	16	13	in	in	ADP
aiua-5029	16	14	smokers	smoker	NOUN
aiua-5029	16	15	compared	compare	VERB
aiua-5029	16	16	to	to	ADP
aiua-5029	16	17	nonsmokers	nonsmoker	NOUN
aiua-5029	16	18	(	(	PUNCT
aiua-5029	16	19	1	1	NUM
aiua-5029	16	20	)	)	PUNCT
aiua-5029	16	21	.	.	PUNCT
aiua-5029	17	1	stage	stage	PROPN
aiua-5029	17	2	ii	ii	PROPN
aiua-5029	17	3	bladder	bladder	NOUN
aiua-5029	17	4	cancer	cancer	NOUN
aiua-5029	17	5	refers	refer	VERB
aiua-5029	17	6	to	to	ADP
aiua-5029	17	7	stages	stage	NOUN
aiua-5029	17	8	pt2an0m0	pt2an0m0	PROPN
aiua-5029	17	9	,	,	PUNCT
aiua-5029	17	10	where	where	SCONJ
aiua-5029	17	11	the	the	DET
aiua-5029	17	12	tumor	tumor	NOUN
aiua-5029	17	13	invades	invade	VERB
aiua-5029	17	14	superficial	superficial	ADJ
aiua-5029	17	15	muscularis	muscularis	PROPN
aiua-5029	17	16	propria	propria	PROPN
aiua-5029	17	17	,	,	PUNCT
aiua-5029	17	18	and	and	CCONJ
aiua-5029	17	19	pt2bn0m0	pt2bn0m0	PROPN
aiua-5029	17	20	,	,	PUNCT
aiua-5029	17	21	where	where	SCONJ
aiua-5029	17	22	it	it	PRON
aiua-5029	17	23	invades	invade	VERB
aiua-5029	17	24	deep	deep	ADJ
aiua-5029	17	25	muscularis	muscularis	PROPN
aiua-5029	17	26	propria	propria	PROPN
aiua-5029	17	27	.	.	PUNCT
aiua-5029	18	1	stage	stage	PROPN
aiua-5029	18	2	iii	iii	PROPN
aiua-5029	18	3	refers	refer	VERB
aiua-5029	18	4	to	to	ADP
aiua-5029	18	5	pt3n0m0	pt3n0m0	PROPN
aiua-5029	18	6	,	,	PUNCT
aiua-5029	18	7	where	where	SCONJ
aiua-5029	18	8	the	the	DET
aiua-5029	18	9	tumor	tumor	NOUN
aiua-5029	18	10	invades	invade	VERB
aiua-5029	18	11	perivesical	perivesical	ADJ
aiua-5029	18	12	tissue	tissue	NOUN
aiua-5029	18	13	,	,	PUNCT
aiua-5029	18	14	and	and	CCONJ
aiua-5029	18	15	pt4an0m0	pt4an0m0	PROPN
aiua-5029	18	16	,	,	PUNCT
aiua-5029	18	17	where	where	SCONJ
aiua-5029	18	18	it	it	PRON
aiua-5029	18	19	invades	invade	VERB
aiua-5029	18	20	prostatic	prostatic	ADJ
aiua-5029	18	21	stroma	stroma	NOUN
aiua-5029	18	22	,	,	PUNCT
aiua-5029	18	23	uterus	uterus	NOUN
aiua-5029	18	24	,	,	PUNCT
aiua-5029	18	25	vagina	vagina	ADJ
aiua-5029	18	26	(	(	PUNCT
aiua-5029	18	27	2	2	NUM
aiua-5029	18	28	)	)	PUNCT
aiua-5029	18	29	.	.	PUNCT
aiua-5029	19	1	according	accord	VERB
aiua-5029	19	2	to	to	ADP
aiua-5029	19	3	the	the	DET
aiua-5029	19	4	recent	recent	ADJ
aiua-5029	19	5	nccn	nccn	ADJ
aiua-5029	19	6	guidelines	guideline	NOUN
aiua-5029	19	7	,	,	PUNCT
aiua-5029	19	8	the	the	DET
aiua-5029	19	9	standard	standard	ADJ
aiua-5029	19	10	management	management	NOUN
aiua-5029	19	11	of	of	ADP
aiua-5029	19	12	stages	stage	NOUN
aiua-5029	19	13	ii	ii	NOUN
aiua-5029	19	14	,	,	PUNCT
aiua-5029	19	15	and	and	CCONJ
aiua-5029	19	16	iii	iii	X
aiua-5029	19	17	bladder	bladder	NOUN
aiua-5029	19	18	cancer	cancer	NOUN
aiua-5029	19	19	included	include	VERB
aiua-5029	19	20	radical	radical	ADJ
aiua-5029	19	21	cystectomy	cystectomy	NOUN
aiua-5029	19	22	,	,	PUNCT
aiua-5029	19	23	with	with	ADP
aiua-5029	19	24	strong	strong	ADJ
aiua-5029	19	25	consideration	consideration	NOUN
aiua-5029	19	26	of	of	ADP
aiua-5029	19	27	neoadjuvant	neoadjuvant	ADJ
aiua-5029	19	28	chemotherapy	chemotherapy	NOUN
aiua-5029	19	29	(	(	PUNCT
aiua-5029	19	30	3	3	NUM
aiua-5029	19	31	)	)	PUNCT
aiua-5029	19	32	.	.	PUNCT
aiua-5029	20	1	a	a	DET
aiua-5029	20	2	trial	trial	NOUN
aiua-5029	20	3	conducted	conduct	VERB
aiua-5029	20	4	by	by	ADP
aiua-5029	20	5	the	the	DET
aiua-5029	20	6	medical	medical	PROPN
aiua-5029	20	7	research	research	PROPN
aiua-5029	20	8	council	council	PROPN
aiua-5029	20	9	and	and	CCONJ
aiua-5029	20	10	the	the	DET
aiua-5029	20	11	european	european	PROPN
aiua-5029	20	12	organization	organization	PROPN
aiua-5029	20	13	for	for	ADP
aiua-5029	20	14	research	research	NOUN
aiua-5029	20	15	and	and	CCONJ
aiua-5029	20	16	treatment	treatment	NOUN
aiua-5029	20	17	of	of	ADP
aiua-5029	20	18	cancer	cancer	NOUN
aiua-5029	20	19	randomly	randomly	ADV
aiua-5029	20	20	assigned	assign	VERB
aiua-5029	20	21	976	976	NUM
aiua-5029	20	22	patients	patient	NOUN
aiua-5029	20	23	with	with	ADP
aiua-5029	20	24	locally	locally	ADV
aiua-5029	20	25	advanced	advanced	ADJ
aiua-5029	20	26	(	(	PUNCT
aiua-5029	20	27	t3	t3	NOUN
aiua-5029	20	28	or	or	CCONJ
aiua-5029	20	29	t4a	t4a	ADJ
aiua-5029	20	30	)	)	PUNCT
aiua-5029	20	31	or	or	CCONJ
aiua-5029	20	32	high	high	ADJ
aiua-5029	20	33	grade	grade	NOUN
aiua-5029	20	34	muscle	muscle	NOUN
aiua-5029	20	35	-	-	PUNCT
aiua-5029	20	36	invasive	invasive	ADJ
aiua-5029	20	37	(	(	PUNCT
aiua-5029	20	38	t2	t2	NOUN
aiua-5029	20	39	)	)	PUNCT
aiua-5029	20	40	bladder	bladder	NOUN
aiua-5029	20	41	cancer	cancer	NOUN
aiua-5029	20	42	to	to	PART
aiua-5029	20	43	undergo	undergo	VERB
aiua-5029	20	44	either	either	CCONJ
aiua-5029	20	45	definitive	definitive	ADJ
aiua-5029	20	46	treatment	treatment	NOUN
aiua-5029	20	47	immediately	immediately	ADV
aiua-5029	20	48	or	or	CCONJ
aiua-5029	20	49	definitive	definitive	ADJ
aiua-5029	20	50	treatment	treatment	NOUN
aiua-5029	20	51	(	(	PUNCT
aiua-5029	20	52	surgery	surgery	NOUN
aiua-5029	20	53	or	or	CCONJ
aiua-5029	20	54	radiotherapy	radiotherapy	NOUN
aiua-5029	20	55	)	)	PUNCT
aiua-5029	20	56	preceded	precede	VERB
aiua-5029	20	57	by	by	ADP
aiua-5029	20	58	three	three	NUM
aiua-5029	20	59	cycles	cycle	NOUN
aiua-5029	20	60	of	of	ADP
aiua-5029	20	61	neoadjuvant	neoadjuvant	ADJ
aiua-5029	20	62	cisplatin	cisplatin	NOUN
aiua-5029	20	63	,	,	PUNCT
aiua-5029	20	64	vinblastine	vinblastine	NOUN
aiua-5029	20	65	,	,	PUNCT
aiua-5029	20	66	and	and	CCONJ
aiua-5029	20	67	methotrexate	methotrexate	VERB
aiua-5029	20	68	.	.	PUNCT
aiua-5029	21	1	at	at	ADP
aiua-5029	21	2	a	a	DET
aiua-5029	21	3	median	median	ADJ
aiua-5029	21	4	follow	follow	NOUN
aiua-5029	21	5	-	-	PUNCT
aiua-5029	21	6	up	up	NOUN
aiua-5029	21	7	of	of	ADP
aiua-5029	21	8	8.0	8.0	NUM
aiua-5029	21	9	years	year	NOUN
aiua-5029	21	10	,	,	PUNCT
aiua-5029	21	11	os	os	PROPN
aiua-5029	21	12	was	be	AUX
aiua-5029	21	13	significantly	significantly	ADV
aiua-5029	21	14	greater	great	ADJ
aiua-5029	21	15	in	in	ADP
aiua-5029	21	16	the	the	DET
aiua-5029	21	17	arm	arm	NOUN
aiua-5029	21	18	randomly	randomly	ADV
aiua-5029	21	19	assigned	assign	VERB
aiua-5029	21	20	to	to	PART
aiua-5029	21	21	receive	receive	VERB
aiua-5029	21	22	neoadjuvant	neoadjuvant	ADJ
aiua-5029	21	23	chemotherapy	chemotherapy	NOUN
aiua-5029	21	24	.	.	PUNCT
aiua-5029	22	1	the	the	DET
aiua-5029	22	2	authors	author	NOUN
aiua-5029	22	3	concluded	conclude	VERB
aiua-5029	22	4	that	that	SCONJ
aiua-5029	22	5	,	,	PUNCT
aiua-5029	22	6	the	the	DET
aiua-5029	22	7	survival	survival	NOUN
aiua-5029	22	8	benefit	benefit	VERB
aiua-5029	22	9	from	from	ADP
aiua-5029	22	10	neoadjuvant	neoadjuvant	ADJ
aiua-5029	22	11	chemotherapy	chemotherapy	NOUN
aiua-5029	22	12	conferred	confer	VERB
aiua-5029	22	13	a	a	DET
aiua-5029	22	14	6	6	NUM
aiua-5029	22	15	%	%	NOUN
aiua-5029	22	16	absolute	absolute	ADJ
aiua-5029	22	17	increase	increase	NOUN
aiua-5029	22	18	in	in	ADP
aiua-5029	22	19	the	the	DET
aiua-5029	22	20	likelihood	likelihood	NOUN
aiua-5029	22	21	of	of	ADP
aiua-5029	22	22	being	be	AUX
aiua-5029	22	23	alive	alive	ADJ
aiua-5029	22	24	at	at	ADP
aiua-5029	22	25	3	3	NUM
aiua-5029	22	26	years	year	NOUN
aiua-5029	22	27	(	(	PUNCT
aiua-5029	22	28	56	56	NUM
aiua-5029	22	29	%	%	NOUN
aiua-5029	22	30	vs.	vs.	ADP
aiua-5029	22	31	50	50	NUM
aiua-5029	22	32	%	%	NOUN
aiua-5029	22	33	)	)	PUNCT
aiua-5029	22	34	,	,	PUNCT
aiua-5029	22	35	5	5	NUM
aiua-5029	22	36	years	year	NOUN
aiua-5029	22	37	(	(	PUNCT
aiua-5029	22	38	49	49	NUM
aiua-5029	22	39	%	%	NOUN
aiua-5029	22	40	vs.	vs.	ADP
aiua-5029	22	41	43	43	NUM
aiua-5029	22	42	%	%	NOUN
aiua-5029	22	43	)	)	PUNCT
aiua-5029	22	44	,	,	PUNCT
aiua-5029	22	45	and	and	CCONJ
aiua-5029	22	46	10	10	NUM
aiua-5029	22	47	years	year	NOUN
aiua-5029	22	48	(	(	PUNCT
aiua-5029	22	49	36	36	NUM
aiua-5029	22	50	%	%	NOUN
aiua-5029	22	51	vs.	vs.	ADP
aiua-5029	22	52	30	30	NUM
aiua-5029	22	53	%	%	NOUN
aiua-5029	22	54	)	)	PUNCT
aiua-5029	22	55	(	(	PUNCT
aiua-5029	22	56	p	p	NOUN
aiua-5029	22	57	0.037	0.037	NUM
aiua-5029	22	58	)	)	PUNCT
aiua-5029	22	59	(	(	PUNCT
aiua-5029	22	60	4	4	NUM
aiua-5029	22	61	)	)	PUNCT
aiua-5029	22	62	.	.	PUNCT
aiua-5029	23	1	a	a	DET
aiua-5029	23	2	meta	meta	ADJ
aiua-5029	23	3	-	-	PUNCT
aiua-5029	23	4	analysis	analysis	NOUN
aiua-5029	23	5	of	of	ADP
aiua-5029	23	6	ten	ten	NUM
aiua-5029	23	7	randomized	randomized	ADJ
aiua-5029	23	8	trials	trial	NOUN
aiua-5029	23	9	of	of	ADP
aiua-5029	23	10	neoadjuvant	neoadjuvant	ADJ
aiua-5029	23	11	chemotherapy	chemotherapy	NOUN
aiua-5029	23	12	,	,	PUNCT
aiua-5029	23	13	including	include	VERB
aiua-5029	23	14	updated	update	VERB
aiua-5029	23	15	data	datum	NOUN
aiua-5029	23	16	for	for	ADP
aiua-5029	23	17	2,688	2,688	NUM
aiua-5029	23	18	individual	individual	ADJ
aiua-5029	23	19	patients	patient	NOUN
aiua-5029	23	20	,	,	PUNCT
aiua-5029	23	21	showed	show	VERB
aiua-5029	23	22	that	that	SCONJ
aiua-5029	23	23	cisplatin	cisplatin	NOUN
aiua-5029	23	24	-	-	PUNCT
aiua-5029	23	25	based	base	VERB
aiua-5029	23	26	combination	combination	NOUN
aiua-5029	23	27	chemotherapy	chemotherapy	NOUN
aiua-5029	23	28	was	be	AUX
aiua-5029	23	29	associated	associate	VERB
aiua-5029	23	30	with	with	ADP
aiua-5029	23	31	a	a	DET
aiua-5029	23	32	significant	significant	ADJ
aiua-5029	23	33	13	13	NUM
aiua-5029	23	34	%	%	NOUN
aiua-5029	23	35	relative	relative	ADJ
aiua-5029	23	36	reduction	reduction	NOUN
aiua-5029	23	37	in	in	ADP
aiua-5029	23	38	the	the	DET
aiua-5029	23	39	risk	risk	NOUN
aiua-5029	23	40	of	of	ADP
aiua-5029	23	41	death	death	NOUN
aiua-5029	23	42	and	and	CCONJ
aiua-5029	23	43	resulted	result	VERB
aiua-5029	23	44	in	in	ADP
aiua-5029	23	45	5	5	NUM
aiua-5029	23	46	%	%	NOUN
aiua-5029	23	47	improvement	improvement	NOUN
aiua-5029	23	48	in	in	ADP
aiua-5029	23	49	5	5	NUM
aiua-5029	23	50	-	-	PUNCT
aiua-5029	23	51	year	year	NOUN
aiua-5029	23	52	survival	survival	NOUN
aiua-5029	23	53	from	from	ADP
aiua-5029	23	54	45	45	NUM
aiua-5029	23	55	%	%	NOUN
aiua-5029	23	56	to	to	ADP
aiua-5029	23	57	50	50	NUM
aiua-5029	23	58	%	%	NOUN
aiua-5029	23	59	(	(	PUNCT
aiua-5029	23	60	p	p	PROPN
aiua-5029	23	61	0.016	0.016	NUM
aiua-5029	23	62	)	)	PUNCT
aiua-5029	23	63	(	(	PUNCT
aiua-5029	23	64	5	5	NUM
aiua-5029	23	65	)	)	PUNCT
aiua-5029	23	66	.	.	PUNCT
aiua-5029	24	1	a	a	DET
aiua-5029	24	2	subsequent	subsequent	ADJ
aiua-5029	24	3	meta	meta	ADJ
aiua-5029	24	4	-	-	PUNCT
aiua-5029	24	5	analysis	analysis	NOUN
aiua-5029	24	6	of	of	ADP
aiua-5029	24	7	eight	eight	NUM
aiua-5029	24	8	trials	trial	NOUN
aiua-5029	24	9	used	use	VERB
aiua-5029	24	10	multiagent	multiagent	NOUN
aiua-5029	24	11	,	,	PUNCT
aiua-5029	24	12	cisplatin	cisplatin	NOUN
aiua-5029	24	13	-	-	PUNCT
aiua-5029	24	14	based	base	VERB
aiua-5029	24	15	chemotherapy	chemotherapy	NOUN
aiua-5029	24	16	,	,	PUNCT
aiua-5029	24	17	showed	show	VERB
aiua-5029	24	18	neoadjuvant	neoadjuvant	ADJ
aiua-5029	24	19	chemotherapy	chemotherapy	NOUN
aiua-5029	24	20	was	be	AUX
aiua-5029	24	21	associated	associate	VERB
aiua-5029	24	22	with	with	ADP
aiua-5029	24	23	a	a	DET
aiua-5029	24	24	6.5	6.5	NUM
aiua-5029	24	25	%	%	NOUN
aiua-5029	24	26	absolute	absolute	ADJ
aiua-5029	24	27	benefit	benefit	NOUN
aiua-5029	24	28	in	in	ADP
aiua-5029	24	29	5	5	NUM
aiua-5029	24	30	-	-	PUNCT
aiua-5029	24	31	year	year	NOUN
aiua-5029	24	32	os	os	NOUN
aiua-5029	24	33	(	(	PUNCT
aiua-5029	24	34	50	50	NUM
aiua-5029	24	35	%	%	NOUN
aiua-5029	24	36	vs.	vs.	ADP
aiua-5029	24	37	56.5	56.5	NUM
aiua-5029	24	38	%	%	NOUN
aiua-5029	24	39	)	)	PUNCT
aiua-5029	25	1	(	(	PUNCT
aiua-5029	25	2	p	p	NOUN
aiua-5029	25	3	0.006	0.006	NUM
aiua-5029	25	4	)	)	PUNCT
aiua-5029	25	5	(	(	PUNCT
aiua-5029	25	6	6	6	NUM
aiua-5029	25	7	)	)	PUNCT
aiua-5029	25	8	.	.	PUNCT
aiua-5029	26	1	study	study	NOUN
aiua-5029	26	2	objective	objective	NOUN
aiua-5029	26	3	was	be	AUX
aiua-5029	26	4	to	to	PART
aiua-5029	26	5	compare	compare	VERB
aiua-5029	26	6	the	the	DET
aiua-5029	26	7	survival	survival	NOUN
aiua-5029	26	8	benefit	benefit	NOUN
aiua-5029	26	9	,	,	PUNCT
aiua-5029	26	10	surdoi	surdoi	NOUN
aiua-5029	26	11	:	:	PUNCT
aiua-5029	26	12	10.4081	10.4081	NUM
aiua-5029	26	13	/	/	SYM
aiua-5029	26	14	aiua.2014.4.278	aiua.2014.4.278	NOUN
aiua-5029	26	15	background	background	NOUN
aiua-5029	26	16	bladder	bladder	NOUN
aiua-5029	26	17	cancer	cancer	NOUN
aiua-5029	26	18	is	be	AUX
aiua-5029	26	19	the	the	DET
aiua-5029	26	20	ninth	ninth	ADJ
aiua-5029	26	21	most	most	ADV
aiua-5029	26	22	common	common	ADJ
aiua-5029	26	23	cancer	cancer	NOUN
aiua-5029	26	24	throughout	throughout	ADP
aiua-5029	26	25	the	the	DET
aiua-5029	26	26	world	world	NOUN
aiua-5029	26	27	and	and	CCONJ
aiua-5029	26	28	is	be	AUX
aiua-5029	26	29	considerably	considerably	ADV
aiua-5029	26	30	more	more	ADV
aiua-5029	26	31	common	common	ADJ
aiua-5029	26	32	in	in	ADP
aiua-5029	26	33	developing	develop	VERB
aiua-5029	26	34	countries	country	NOUN
aiua-5029	26	35	.	.	PUNCT
aiua-5029	27	1	recently	recently	ADV
aiua-5029	27	2	,	,	PUNCT
aiua-5029	27	3	it	it	PRON
aiua-5029	27	4	was	be	AUX
aiua-5029	27	5	shown	show	VERB
aiua-5029	27	6	that	that	SCONJ
aiua-5029	27	7	,	,	PUNCT
aiua-5029	27	8	osman_stesura	osman_stesura	PRON
aiua-5029	27	9	seveso	seveso	VERB
aiua-5029	27	10	15/01/15	15/01/15	NUM
aiua-5029	27	11	13:09	13:09	NUM
aiua-5029	27	12	pagina	pagina	NOUN
aiua-5029	27	13	278	278	NUM
aiua-5029	27	14	279archivio	279archivio	PROPN
aiua-5029	27	15	italiano	italiano	NOUN
aiua-5029	27	16	di	di	NOUN
aiua-5029	27	17	urologia	urologia	PROPN
aiua-5029	27	18	e	e	PROPN
aiua-5029	27	19	andrologia	andrologia	NOUN
aiua-5029	27	20	2014	2014	NUM
aiua-5029	27	21	;	;	PUNCT
aiua-5029	27	22	86	86	NUM
aiua-5029	27	23	,	,	PUNCT
aiua-5029	27	24	4	4	NUM
aiua-5029	27	25	nact	nact	VERB
aiua-5029	27	26	versus	versus	ADP
aiua-5029	27	27	cystectomy	cystectomy	NOUN
aiua-5029	27	28	in	in	ADP
aiua-5029	27	29	bladder	bladder	NOUN
aiua-5029	27	30	cancer	cancer	NOUN
aiua-5029	27	31	gical	gical	ADJ
aiua-5029	27	32	resectability	resectability	NOUN
aiua-5029	27	33	,	,	PUNCT
aiua-5029	27	34	and	and	CCONJ
aiua-5029	27	35	toxicities	toxicity	NOUN
aiua-5029	27	36	among	among	ADP
aiua-5029	27	37	patients	patient	NOUN
aiua-5029	27	38	treated	treat	VERB
aiua-5029	27	39	by	by	ADP
aiua-5029	27	40	neoadjuvant	neoadjuvant	ADJ
aiua-5029	27	41	chemotherapy	chemotherapy	NOUN
aiua-5029	27	42	followed	follow	VERB
aiua-5029	27	43	by	by	ADP
aiua-5029	27	44	radical	radical	ADJ
aiua-5029	27	45	cystectomy	cystectomy	NOUN
aiua-5029	27	46	with	with	ADP
aiua-5029	27	47	those	those	DET
aiua-5029	27	48	underwent	underwent	ADJ
aiua-5029	27	49	radical	radical	ADJ
aiua-5029	27	50	cystectomy	cystectomy	NOUN
aiua-5029	27	51	in	in	ADP
aiua-5029	27	52	the	the	DET
aiua-5029	27	53	management	management	NOUN
aiua-5029	27	54	of	of	ADP
aiua-5029	27	55	stage	stage	NOUN
aiua-5029	27	56	t2n0	t2n0	VERB
aiua-5029	27	57	,	,	PUNCT
aiua-5029	27	58	t3n0	t3n0	NOUN
aiua-5029	27	59	,	,	PUNCT
aiua-5029	27	60	and	and	CCONJ
aiua-5029	27	61	t4an0	t4an0	VERB
aiua-5029	27	62	urinary	urinary	ADJ
aiua-5029	27	63	bladder	bladder	NOUN
aiua-5029	27	64	cancer	cancer	NOUN
aiua-5029	27	65	.	.	PUNCT
aiua-5029	28	1	the	the	DET
aiua-5029	28	2	primary	primary	ADJ
aiua-5029	28	3	end	end	NOUN
aiua-5029	28	4	point	point	NOUN
aiua-5029	28	5	was	be	AUX
aiua-5029	28	6	survival	survival	ADJ
aiua-5029	28	7	benefit	benefit	NOUN
aiua-5029	28	8	.	.	PUNCT
aiua-5029	29	1	patients	patient	NOUN
aiua-5029	29	2	and	and	CCONJ
aiua-5029	29	3	methods	method	NOUN
aiua-5029	29	4	patients	patient	NOUN
aiua-5029	29	5	were	be	AUX
aiua-5029	29	6	eligible	eligible	ADJ
aiua-5029	29	7	to	to	PART
aiua-5029	29	8	be	be	AUX
aiua-5029	29	9	enrolled	enrol	VERB
aiua-5029	29	10	in	in	ADP
aiua-5029	29	11	the	the	DET
aiua-5029	29	12	study	study	NOUN
aiua-5029	29	13	if	if	SCONJ
aiua-5029	29	14	they	they	PRON
aiua-5029	29	15	had	have	AUX
aiua-5029	29	16	pathologically	pathologically	ADV
aiua-5029	29	17	proven	prove	VERB
aiua-5029	29	18	urothelial	urothelial	ADJ
aiua-5029	29	19	carcinoma	carcinoma	NOUN
aiua-5029	29	20	in	in	ADP
aiua-5029	29	21	urinary	urinary	ADJ
aiua-5029	29	22	bladder	bladder	NOUN
aiua-5029	29	23	.	.	PUNCT
aiua-5029	30	1	patients	patient	NOUN
aiua-5029	30	2	should	should	AUX
aiua-5029	30	3	have	have	VERB
aiua-5029	30	4	clinical	clinical	ADJ
aiua-5029	30	5	stages	stage	NOUN
aiua-5029	30	6	from	from	ADP
aiua-5029	30	7	t2n0m0	t2n0m0	PROPN
aiua-5029	30	8	to	to	ADP
aiua-5029	30	9	t4an0m0	t4an0m0	PROPN
aiua-5029	30	10	(	(	PUNCT
aiua-5029	30	11	as	as	SCONJ
aiua-5029	30	12	defined	define	VERB
aiua-5029	30	13	by	by	ADP
aiua-5029	30	14	ct	ct	PROPN
aiua-5029	30	15	scan	scan	PROPN
aiua-5029	30	16	)	)	PUNCT
aiua-5029	30	17	(	(	PUNCT
aiua-5029	30	18	7	7	NUM
aiua-5029	30	19	)	)	PUNCT
aiua-5029	30	20	.	.	PUNCT
aiua-5029	31	1	patient	patient	ADJ
aiua-5029	31	2	age	age	NOUN
aiua-5029	31	3	had	have	VERB
aiua-5029	31	4	to	to	PART
aiua-5029	31	5	be	be	AUX
aiua-5029	31	6	less	less	ADJ
aiua-5029	31	7	than	than	ADP
aiua-5029	31	8	65	65	NUM
aiua-5029	31	9	years	year	NOUN
aiua-5029	31	10	and	and	CCONJ
aiua-5029	31	11	performance	performance	NOUN
aiua-5029	31	12	state	state	NOUN
aiua-5029	31	13	had	have	VERB
aiua-5029	31	14	to	to	PART
aiua-5029	31	15	be	be	AUX
aiua-5029	31	16	≤	≤	NUM
aiua-5029	31	17	2	2	NUM
aiua-5029	31	18	.	.	PUNCT
aiua-5029	32	1	patients	patient	NOUN
aiua-5029	32	2	should	should	AUX
aiua-5029	32	3	have	have	VERB
aiua-5029	32	4	adequate	adequate	ADJ
aiua-5029	32	5	hematological	hematological	ADJ
aiua-5029	32	6	,	,	PUNCT
aiua-5029	32	7	renal	renal	ADJ
aiua-5029	32	8	,	,	PUNCT
aiua-5029	32	9	and	and	CCONJ
aiua-5029	32	10	liver	liver	NOUN
aiua-5029	32	11	functions	function	NOUN
aiua-5029	32	12	.	.	PUNCT
aiua-5029	33	1	written	write	VERB
aiua-5029	33	2	informed	informed	ADJ
aiua-5029	33	3	consent	consent	NOUN
aiua-5029	33	4	was	be	AUX
aiua-5029	33	5	taken	take	VERB
aiua-5029	33	6	from	from	ADP
aiua-5029	33	7	patients	patient	NOUN
aiua-5029	33	8	before	before	ADP
aiua-5029	33	9	enrolment	enrolment	NOUN
aiua-5029	33	10	.	.	PUNCT
aiua-5029	34	1	female	female	ADJ
aiua-5029	34	2	patients	patient	NOUN
aiua-5029	34	3	in	in	ADP
aiua-5029	34	4	the	the	DET
aiua-5029	34	5	childbearing	childbearing	NOUN
aiua-5029	34	6	period	period	NOUN
aiua-5029	34	7	must	must	AUX
aiua-5029	34	8	had	have	VERB
aiua-5029	34	9	a	a	DET
aiua-5029	34	10	negative	negative	ADJ
aiua-5029	34	11	pregnancy	pregnancy	NOUN
aiua-5029	34	12	test	test	NOUN
aiua-5029	34	13	(	(	PUNCT
aiua-5029	34	14	serum	serum	NOUN
aiua-5029	34	15	β	β	PROPN
aiua-5029	34	16	-	-	NOUN
aiua-5029	34	17	hcg	hcg	NOUN
aiua-5029	34	18	)	)	PUNCT
aiua-5029	34	19	and	and	CCONJ
aiua-5029	34	20	both	both	CCONJ
aiua-5029	34	21	male	male	ADJ
aiua-5029	34	22	and	and	CCONJ
aiua-5029	34	23	female	female	ADJ
aiua-5029	34	24	patients	patient	NOUN
aiua-5029	34	25	must	must	AUX
aiua-5029	34	26	employ	employ	VERB
aiua-5029	34	27	effective	effective	ADJ
aiua-5029	34	28	contraceptive	contraceptive	ADJ
aiua-5029	34	29	measures	measure	NOUN
aiua-5029	34	30	prior	prior	ADV
aiua-5029	34	31	to	to	PART
aiua-5029	34	32	start	start	VERB
aiua-5029	34	33	of	of	ADP
aiua-5029	34	34	until	until	ADP
aiua-5029	34	35	four	four	NUM
aiua-5029	34	36	weeks	week	NOUN
aiua-5029	34	37	after	after	ADP
aiua-5029	34	38	the	the	DET
aiua-5029	34	39	last	last	ADJ
aiua-5029	34	40	dose	dose	NOUN
aiua-5029	34	41	of	of	ADP
aiua-5029	34	42	chemotherapy	chemotherapy	NOUN
aiua-5029	34	43	.	.	PUNCT
aiua-5029	35	1	additionally	additionally	ADV
aiua-5029	35	2	,	,	PUNCT
aiua-5029	35	3	patients	patient	NOUN
aiua-5029	35	4	must	must	AUX
aiua-5029	35	5	had	have	VERB
aiua-5029	35	6	no	no	DET
aiua-5029	35	7	concurrent	concurrent	ADJ
aiua-5029	35	8	malignancy	malignancy	NOUN
aiua-5029	35	9	.	.	PUNCT
aiua-5029	36	1	patients	patient	NOUN
aiua-5029	36	2	were	be	AUX
aiua-5029	36	3	allocated	allocate	VERB
aiua-5029	36	4	to	to	ADP
aiua-5029	36	5	either	either	DET
aiua-5029	36	6	arms	arm	NOUN
aiua-5029	36	7	;	;	PUNCT
aiua-5029	36	8	arm	arm	VERB
aiua-5029	36	9	a	a	DET
aiua-5029	36	10	consisted	consisted	NOUN
aiua-5029	36	11	of	of	ADP
aiua-5029	36	12	3	3	NUM
aiua-5029	36	13	cycles	cycle	NOUN
aiua-5029	36	14	of	of	ADP
aiua-5029	36	15	neoadjuvant	neoadjuvant	ADJ
aiua-5029	36	16	chemotherapy	chemotherapy	NOUN
aiua-5029	36	17	in	in	ADP
aiua-5029	36	18	the	the	DET
aiua-5029	36	19	form	form	NOUN
aiua-5029	36	20	of	of	ADP
aiua-5029	36	21	cisplatin	cisplatin	NOUN
aiua-5029	36	22	and	and	CCONJ
aiua-5029	36	23	gemcitabine	gemcitabine	NOUN
aiua-5029	36	24	followed	follow	VERB
aiua-5029	36	25	by	by	ADP
aiua-5029	36	26	radical	radical	ADJ
aiua-5029	36	27	cystectomy	cystectomy	NOUN
aiua-5029	36	28	,	,	PUNCT
aiua-5029	36	29	arm	arm	PROPN
aiua-5029	36	30	b	b	PROPN
aiua-5029	36	31	consisted	consist	VERB
aiua-5029	36	32	of	of	ADP
aiua-5029	36	33	radical	radical	ADJ
aiua-5029	36	34	cystectomy	cystectomy	NOUN
aiua-5029	36	35	.	.	PUNCT
aiua-5029	37	1	settings	setting	NOUN
aiua-5029	37	2	the	the	DET
aiua-5029	37	3	study	study	NOUN
aiua-5029	37	4	was	be	AUX
aiua-5029	37	5	conducted	conduct	VERB
aiua-5029	37	6	at	at	ADP
aiua-5029	37	7	the	the	DET
aiua-5029	37	8	oncology	oncology	NOUN
aiua-5029	37	9	unit	unit	NOUN
aiua-5029	37	10	,	,	PUNCT
aiua-5029	37	11	ain	ain	PROPN
aiua-5029	37	12	shams	sham	VERB
aiua-5029	37	13	university	university	NOUN
aiua-5029	37	14	hospitals	hospital	NOUN
aiua-5029	37	15	,	,	PUNCT
aiua-5029	37	16	ismailia	ismailia	ADJ
aiua-5029	37	17	oncology	oncology	NOUN
aiua-5029	37	18	teaching	teaching	NOUN
aiua-5029	37	19	hospital	hospital	NOUN
aiua-5029	37	20	,	,	PUNCT
aiua-5029	37	21	and	and	CCONJ
aiua-5029	37	22	national	national	PROPN
aiua-5029	37	23	institute	institute	PROPN
aiua-5029	37	24	of	of	ADP
aiua-5029	37	25	nephrology	nephrology	NOUN
aiua-5029	37	26	and	and	CCONJ
aiua-5029	37	27	urology	urology	NOUN
aiua-5029	37	28	.	.	PUNCT
aiua-5029	38	1	the	the	DET
aiua-5029	38	2	last	last	ADJ
aiua-5029	38	3	2	2	NUM
aiua-5029	38	4	hospitals	hospital	NOUN
aiua-5029	38	5	are	be	AUX
aiua-5029	38	6	run	run	VERB
aiua-5029	38	7	under	under	ADP
aiua-5029	38	8	the	the	DET
aiua-5029	38	9	general	general	ADJ
aiua-5029	38	10	organization	organization	NOUN
aiua-5029	38	11	for	for	ADP
aiua-5029	38	12	teaching	teaching	NOUN
aiua-5029	38	13	hospitals	hospital	NOUN
aiua-5029	38	14	institutes	institutes	PROPN
aiua-5029	38	15	,	,	PUNCT
aiua-5029	38	16	egypt	egypt	PROPN
aiua-5029	38	17	.	.	PUNCT
aiua-5029	39	1	study	study	NOUN
aiua-5029	39	2	design	design	VERB
aiua-5029	39	3	the	the	DET
aiua-5029	39	4	study	study	NOUN
aiua-5029	39	5	design	design	NOUN
aiua-5029	39	6	was	be	AUX
aiua-5029	39	7	shown	show	VERB
aiua-5029	39	8	in	in	ADP
aiua-5029	39	9	table	table	NOUN
aiua-5029	39	10	1	1	NUM
aiua-5029	39	11	.	.	PUNCT
aiua-5029	40	1	the	the	DET
aiua-5029	40	2	neoadjuvant	neoadjuvant	ADJ
aiua-5029	40	3	chemotherapy	chemotherapy	NOUN
aiua-5029	40	4	administration	administration	NOUN
aiua-5029	40	5	protocol	protocol	NOUN
aiua-5029	40	6	for	for	ADP
aiua-5029	40	7	arm	arm	NOUN
aiua-5029	40	8	1	1	NUM
aiua-5029	40	9	was	be	AUX
aiua-5029	40	10	as	as	SCONJ
aiua-5029	40	11	follows	follow	VERB
aiua-5029	40	12	:	:	PUNCT
aiua-5029	40	13	1	1	X
aiua-5029	40	14	.	.	PUNCT
aiua-5029	40	15	cisplatin	cisplatin	NOUN
aiua-5029	40	16	:	:	PUNCT
aiua-5029	40	17	pre	pre	ADJ
aiua-5029	40	18	-	-	NOUN
aiua-5029	40	19	chemotherapy	chemotherapy	ADJ
aiua-5029	40	20	,	,	PUNCT
aiua-5029	40	21	normal	normal	ADJ
aiua-5029	40	22	saline	saline	VERB
aiua-5029	40	23	0.9	0.9	NUM
aiua-5029	40	24	%	%	NOUN
aiua-5029	40	25	1	1	NUM
aiua-5029	40	26	litre	litre	NOUN
aiua-5029	40	27	over	over	ADP
aiua-5029	40	28	30	30	NUM
aiua-5029	40	29	-	-	SYM
aiua-5029	40	30	60	60	NUM
aiua-5029	40	31	minutes	minute	NOUN
aiua-5029	40	32	,	,	PUNCT
aiua-5029	40	33	followed	follow	VERB
aiua-5029	40	34	by	by	ADP
aiua-5029	40	35	cisplatin	cisplatin	NOUN
aiua-5029	40	36	iv	iv	NUM
aiua-5029	40	37	in	in	ADP
aiua-5029	40	38	normal	normal	ADJ
aiua-5029	40	39	saline	saline	NOUN
aiua-5029	40	40	0.9	0.9	NUM
aiua-5029	40	41	%	%	NOUN
aiua-5029	40	42	500	500	NUM
aiua-5029	40	43	ml	ml	NOUN
aiua-5029	40	44	over	over	ADP
aiua-5029	40	45	1	1	NUM
aiua-5029	40	46	hour	hour	NOUN
aiua-5029	40	47	.	.	PUNCT
aiua-5029	41	1	postchemotherapy	postchemotherapy	NOUN
aiua-5029	41	2	,	,	PUNCT
aiua-5029	41	3	normal	normal	ADJ
aiua-5029	41	4	saline	saline	NOUN
aiua-5029	41	5	0.9%1	0.9%1	NUM
aiua-5029	41	6	litre	litre	NOUN
aiua-5029	41	7	,	,	PUNCT
aiua-5029	41	8	with	with	ADP
aiua-5029	41	9	kcl	kcl	PROPN
aiua-5029	41	10	(	(	PUNCT
aiua-5029	41	11	potassium	potassium	NOUN
aiua-5029	41	12	chloride	chloride	NOUN
aiua-5029	41	13	)	)	PUNCT
aiua-5029	41	14	20meq	20meq	NOUN
aiua-5029	41	15	,	,	PUNCT
aiua-5029	41	16	mgso4	mgso4	PROPN
aiua-5029	41	17	(	(	PUNCT
aiua-5029	41	18	magnesium	magnesium	NOUN
aiua-5029	41	19	sulphate	sulphate	NOUN
aiua-5029	41	20	)	)	PUNCT
aiua-5029	41	21	1	1	NUM
aiua-5029	41	22	gm	gm	PROPN
aiua-5029	41	23	,	,	PUNCT
aiua-5029	41	24	and	and	CCONJ
aiua-5029	41	25	mannitol	mannitol	NOUN
aiua-5029	41	26	30	30	NUM
aiua-5029	41	27	gm	gm	NOUN
aiua-5029	41	28	over	over	ADP
aiua-5029	41	29	1	1	NUM
aiua-5029	41	30	hour	hour	NOUN
aiua-5029	41	31	.	.	NOUN
aiua-5029	42	1	2	2	X
aiua-5029	42	2	.	.	X
aiua-5029	42	3	gemcitabine	gemcitabine	NOUN
aiua-5029	42	4	iv	iv	NUM
aiua-5029	42	5	in	in	ADP
aiua-5029	42	6	normal	normal	ADJ
aiua-5029	42	7	saline	saline	NOUN
aiua-5029	42	8	0.9	0.9	NUM
aiua-5029	42	9	%	%	NOUN
aiua-5029	42	10	250	250	NUM
aiua-5029	42	11	ml	ml	NOUN
aiua-5029	42	12	over	over	ADP
aiua-5029	42	13	30	30	NUM
aiua-5029	42	14	minutes	minute	NOUN
aiua-5029	42	15	.	.	PUNCT
aiua-5029	43	1	cycles	cycle	NOUN
aiua-5029	43	2	of	of	ADP
aiua-5029	43	3	chemotherapy	chemotherapy	NOUN
aiua-5029	43	4	were	be	AUX
aiua-5029	43	5	administered	administer	VERB
aiua-5029	43	6	after	after	ADP
aiua-5029	43	7	checking	check	VERB
aiua-5029	43	8	cbc	cbc	NOUN
aiua-5029	43	9	,	,	PUNCT
aiua-5029	43	10	renal	renal	ADJ
aiua-5029	43	11	function	function	NOUN
aiua-5029	43	12	tests	test	NOUN
aiua-5029	43	13	,	,	PUNCT
aiua-5029	43	14	gfr	gfr	NOUN
aiua-5029	43	15	,	,	PUNCT
aiua-5029	43	16	liver	liver	NOUN
aiua-5029	43	17	function	function	NOUN
aiua-5029	43	18	tests	test	NOUN
aiua-5029	43	19	,	,	PUNCT
aiua-5029	43	20	bilirubin	bilirubin	NOUN
aiua-5029	43	21	,	,	PUNCT
aiua-5029	43	22	before	before	ADP
aiua-5029	43	23	day	day	NOUN
aiua-5029	43	24	1	1	NUM
aiua-5029	43	25	,	,	PUNCT
aiua-5029	43	26	and	and	CCONJ
aiua-5029	43	27	8	8	NUM
aiua-5029	43	28	of	of	ADP
aiua-5029	43	29	each	each	DET
aiua-5029	43	30	cycle	cycle	NOUN
aiua-5029	43	31	,	,	PUNCT
aiua-5029	43	32	with	with	ADP
aiua-5029	43	33	subsequent	subsequent	ADJ
aiua-5029	43	34	dose	dose	NOUN
aiua-5029	43	35	modification	modification	NOUN
aiua-5029	43	36	based	base	VERB
aiua-5029	43	37	on	on	ADP
aiua-5029	43	38	the	the	DET
aiua-5029	43	39	following	follow	VERB
aiua-5029	43	40	table	table	NOUN
aiua-5029	43	41	2	2	NUM
aiua-5029	43	42	(	(	PUNCT
aiua-5029	43	43	7	7	NUM
aiua-5029	43	44	)	)	PUNCT
aiua-5029	43	45	.	.	PUNCT
aiua-5029	44	1	evaluation	evaluation	NOUN
aiua-5029	44	2	baseline	baseline	VERB
aiua-5029	44	3	ct	ct	NUM
aiua-5029	44	4	thoracic	thoracic	NOUN
aiua-5029	44	5	-	-	PUNCT
aiua-5029	44	6	abdominal	abdominal	ADJ
aiua-5029	44	7	-	-	PUNCT
aiua-5029	44	8	pelvic	pelvic	ADJ
aiua-5029	44	9	(	(	PUNCT
aiua-5029	44	10	tap	tap	NOUN
aiua-5029	44	11	)	)	PUNCT
aiua-5029	44	12	was	be	AUX
aiua-5029	44	13	performed	perform	VERB
aiua-5029	44	14	before	before	ADP
aiua-5029	44	15	treatment	treatment	NOUN
aiua-5029	44	16	protocol	protocol	NOUN
aiua-5029	44	17	at	at	ADP
aiua-5029	44	18	the	the	DET
aiua-5029	44	19	time	time	NOUN
aiua-5029	44	20	of	of	ADP
aiua-5029	44	21	diagnosis	diagnosis	NOUN
aiua-5029	44	22	.	.	PUNCT
aiua-5029	45	1	after	after	ADP
aiua-5029	45	2	the	the	DET
aiua-5029	45	3	end	end	NOUN
aiua-5029	45	4	of	of	ADP
aiua-5029	45	5	chemotherapy	chemotherapy	NOUN
aiua-5029	45	6	,	,	PUNCT
aiua-5029	45	7	patients	patient	NOUN
aiua-5029	45	8	underwent	undergo	VERB
aiua-5029	45	9	ct	ct	PROPN
aiua-5029	45	10	ap	ap	PROPN
aiua-5029	45	11	to	to	PART
aiua-5029	45	12	evaluate	evaluate	VERB
aiua-5029	45	13	chemotherapy	chemotherapy	NOUN
aiua-5029	45	14	response	response	NOUN
aiua-5029	45	15	(	(	PUNCT
aiua-5029	45	16	table	table	NOUN
aiua-5029	45	17	3	3	NUM
aiua-5029	45	18	)	)	PUNCT
aiua-5029	45	19	.	.	PUNCT
aiua-5029	46	1	two	two	NUM
aiua-5029	46	2	weeks	week	NOUN
aiua-5029	46	3	after	after	ADP
aiua-5029	46	4	cycle	cycle	NOUN
aiua-5029	46	5	3	3	NUM
aiua-5029	46	6	of	of	ADP
aiua-5029	46	7	chemotherapy	chemotherapy	NOUN
aiua-5029	46	8	,	,	PUNCT
aiua-5029	46	9	patients	patient	NOUN
aiua-5029	46	10	underwent	undergo	VERB
aiua-5029	46	11	radical	radical	ADJ
aiua-5029	46	12	cystectomy	cystectomy	NOUN
aiua-5029	46	13	,	,	PUNCT
aiua-5029	46	14	pelvic	pelvic	ADJ
aiua-5029	46	15	lymphadenectomy	lymphadenectomy	NOUN
aiua-5029	46	16	,	,	PUNCT
aiua-5029	46	17	and	and	CCONJ
aiua-5029	46	18	urinary	urinary	ADJ
aiua-5029	46	19	diversion	diversion	NOUN
aiua-5029	46	20	,	,	PUNCT
aiua-5029	46	21	with	with	ADP
aiua-5029	46	22	transurethral	transurethral	ADJ
aiua-5029	46	23	resection	resection	NOUN
aiua-5029	46	24	(	(	PUNCT
aiua-5029	46	25	tur	tur	INTJ
aiua-5029	46	26	)	)	PUNCT
aiua-5029	46	27	prior	prior	ADV
aiua-5029	46	28	to	to	ADP
aiua-5029	46	29	the	the	DET
aiua-5029	46	30	surgery	surgery	NOUN
aiua-5029	46	31	to	to	PART
aiua-5029	46	32	know	know	VERB
aiua-5029	46	33	the	the	DET
aiua-5029	46	34	disease	disease	NOUN
aiua-5029	46	35	extent	extent	NOUN
aiua-5029	46	36	.	.	PUNCT
aiua-5029	47	1	after	after	ADP
aiua-5029	47	2	surgery	surgery	NOUN
aiua-5029	47	3	,	,	PUNCT
aiua-5029	47	4	pathological	pathological	ADJ
aiua-5029	47	5	evaluation	evaluation	NOUN
aiua-5029	47	6	was	be	AUX
aiua-5029	47	7	performed	perform	VERB
aiua-5029	47	8	to	to	PART
aiua-5029	47	9	evaluate	evaluate	VERB
aiua-5029	47	10	the	the	DET
aiua-5029	47	11	chemotherapy	chemotherapy	NOUN
aiua-5029	47	12	response	response	NOUN
aiua-5029	47	13	in	in	ADP
aiua-5029	47	14	arm	arm	NOUN
aiua-5029	47	15	a	a	NOUN
aiua-5029	47	16	,	,	PUNCT
aiua-5029	47	17	and	and	CCONJ
aiua-5029	47	18	to	to	PART
aiua-5029	47	19	confirm	confirm	VERB
aiua-5029	47	20	pathological	pathological	ADJ
aiua-5029	47	21	staging	staging	NOUN
aiua-5029	47	22	in	in	ADP
aiua-5029	47	23	arm	arm	PROPN
aiua-5029	47	24	b.	b.	PROPN
aiua-5029	47	25	follow	follow	VERB
aiua-5029	47	26	-	-	PUNCT
aiua-5029	47	27	up	up	NOUN
aiua-5029	47	28	after	after	ADP
aiua-5029	47	29	the	the	DET
aiua-5029	47	30	end	end	NOUN
aiua-5029	47	31	of	of	ADP
aiua-5029	47	32	the	the	DET
aiua-5029	47	33	treatment	treatment	NOUN
aiua-5029	47	34	protocol	protocol	NOUN
aiua-5029	47	35	,	,	PUNCT
aiua-5029	47	36	patients	patient	NOUN
aiua-5029	47	37	were	be	AUX
aiua-5029	47	38	followed	follow	VERB
aiua-5029	47	39	according	accord	VERB
aiua-5029	47	40	to	to	ADP
aiua-5029	47	41	the	the	DET
aiua-5029	47	42	nccn	nccn	ADJ
aiua-5029	47	43	guideline	guideline	NOUN
aiua-5029	47	44	for	for	ADP
aiua-5029	47	45	follow	follow	VERB
aiua-5029	47	46	-	-	PUNCT
aiua-5029	47	47	up	up	NOUN
aiua-5029	47	48	after	after	ADP
aiua-5029	47	49	bladder	bladder	NOUN
aiua-5029	47	50	cancer	cancer	NOUN
aiua-5029	47	51	treatment	treatment	NOUN
aiua-5029	47	52	;	;	PUNCT
aiua-5029	47	53	by	by	ADP
aiua-5029	47	54	regular	regular	ADJ
aiua-5029	47	55	clinic	clinic	NOUN
aiua-5029	47	56	visits	visit	NOUN
aiua-5029	47	57	every	every	DET
aiua-5029	47	58	3	3	NUM
aiua-5029	47	59	months	month	NOUN
aiua-5029	47	60	for	for	ADP
aiua-5029	47	61	the	the	DET
aiua-5029	47	62	first	first	ADJ
aiua-5029	47	63	2	2	NUM
aiua-5029	47	64	years	year	NOUN
aiua-5029	47	65	,	,	PUNCT
aiua-5029	47	66	then	then	ADV
aiua-5029	47	67	every	every	DET
aiua-5029	47	68	6	6	NUM
aiua-5029	47	69	months	month	NOUN
aiua-5029	47	70	for	for	ADP
aiua-5029	47	71	the	the	DET
aiua-5029	47	72	following	follow	VERB
aiua-5029	47	73	3	3	NUM
aiua-5029	47	74	years	year	NOUN
aiua-5029	47	75	,	,	PUNCT
aiua-5029	47	76	then	then	ADV
aiua-5029	47	77	annually	annually	ADV
aiua-5029	47	78	thereafter	thereafter	ADV
aiua-5029	47	79	.	.	PUNCT
aiua-5029	48	1	in	in	ADP
aiua-5029	48	2	each	each	DET
aiua-5029	48	3	visit	visit	NOUN
aiua-5029	48	4	,	,	PUNCT
aiua-5029	48	5	patients	patient	NOUN
aiua-5029	48	6	were	be	AUX
aiua-5029	48	7	evaluated	evaluate	VERB
aiua-5029	48	8	by	by	ADP
aiua-5029	48	9	history	history	NOUN
aiua-5029	48	10	taking	taking	NOUN
aiua-5029	48	11	,	,	PUNCT
aiua-5029	48	12	physical	physical	ADJ
aiua-5029	48	13	examination	examination	NOUN
aiua-5029	48	14	,	,	PUNCT
aiua-5029	48	15	laboratory	laboratory	NOUN
aiua-5029	48	16	investigations	investigation	NOUN
aiua-5029	48	17	in	in	ADP
aiua-5029	48	18	the	the	DET
aiua-5029	48	19	form	form	NOUN
aiua-5029	48	20	of	of	ADP
aiua-5029	48	21	cbc	cbc	NOUN
aiua-5029	48	22	,	,	PUNCT
aiua-5029	48	23	liver	liver	NOUN
aiua-5029	48	24	,	,	PUNCT
aiua-5029	48	25	renal	renal	ADJ
aiua-5029	48	26	functions	function	NOUN
aiua-5029	48	27	every	every	DET
aiua-5029	48	28	3months	3months	NUM
aiua-5029	48	29	for	for	ADP
aiua-5029	48	30	the	the	DET
aiua-5029	48	31	first	first	ADJ
aiua-5029	48	32	2	2	NUM
aiua-5029	48	33	years	year	NOUN
aiua-5029	48	34	then	then	ADV
aiua-5029	48	35	as	as	SCONJ
aiua-5029	48	36	clinically	clinically	ADV
aiua-5029	48	37	indicated	indicate	VERB
aiua-5029	48	38	.	.	PUNCT
aiua-5029	49	1	ct	ct	NUM
aiua-5029	49	2	tap	tap	NOUN
aiua-5029	49	3	were	be	AUX
aiua-5029	49	4	done	do	VERB
aiua-5029	49	5	every	every	DET
aiua-5029	49	6	6	6	NUM
aiua-5029	49	7	months	month	NOUN
aiua-5029	49	8	in	in	ADP
aiua-5029	49	9	the	the	DET
aiua-5029	49	10	first	first	ADJ
aiua-5029	49	11	2	2	NUM
aiua-5029	49	12	years	year	NOUN
aiua-5029	49	13	,	,	PUNCT
aiua-5029	49	14	then	then	ADV
aiua-5029	49	15	as	as	SCONJ
aiua-5029	49	16	clinically	clinically	ADV
aiua-5029	49	17	indicated	indicate	VERB
aiua-5029	49	18	(	(	PUNCT
aiua-5029	49	19	3	3	NUM
aiua-5029	49	20	)	)	PUNCT
aiua-5029	49	21	.	.	PUNCT
aiua-5029	50	1	toxicity	toxicity	NOUN
aiua-5029	50	2	toxic	toxic	ADJ
aiua-5029	50	3	effects	effect	NOUN
aiua-5029	50	4	were	be	AUX
aiua-5029	50	5	graded	grade	VERB
aiua-5029	50	6	according	accord	VERB
aiua-5029	50	7	to	to	ADP
aiua-5029	50	8	the	the	DET
aiua-5029	50	9	national	national	PROPN
aiua-5029	50	10	cancer	cancer	PROPN
aiua-5029	50	11	institute	institute	PROPN
aiua-5029	50	12	common	common	ADJ
aiua-5029	50	13	toxicity	toxicity	NOUN
aiua-5029	50	14	criteria	criterion	NOUN
aiua-5029	50	15	,	,	PUNCT
aiua-5029	50	16	version	version	NOUN
aiua-5029	50	17	2.0	2.0	NUM
aiua-5029	50	18	(	(	PUNCT
aiua-5029	50	19	8)	8)	NUM
aiua-5029	50	20	.	.	PUNCT
aiua-5029	51	1	early	early	ADJ
aiua-5029	51	2	chemotherapy	chemotherapy	NOUN
aiua-5029	51	3	toxicities	toxicity	NOUN
aiua-5029	51	4	were	be	AUX
aiua-5029	51	5	defined	define	VERB
aiua-5029	51	6	as	as	ADP
aiua-5029	51	7	toxicities	toxicity	NOUN
aiua-5029	51	8	that	that	PRON
aiua-5029	51	9	occurred	occur	VERB
aiua-5029	51	10	during	during	ADP
aiua-5029	51	11	treatment	treatment	NOUN
aiua-5029	51	12	till	till	SCONJ
aiua-5029	51	13	8	8	NUM
aiua-5029	51	14	-	-	SYM
aiua-5029	51	15	10	10	NUM
aiua-5029	51	16	weeks	week	NOUN
aiua-5029	51	17	post	post	NOUN
aiua-5029	51	18	chemotherapy	chemotherapy	NOUN
aiua-5029	51	19	.	.	PUNCT
aiua-5029	52	1	surgical	surgical	ADJ
aiua-5029	52	2	early	early	ADJ
aiua-5029	52	3	morbidities	morbidity	NOUN
aiua-5029	52	4	were	be	AUX
aiua-5029	52	5	defined	define	VERB
aiua-5029	52	6	1	1	NUM
aiua-5029	52	7	.	.	PUNCT
aiua-5029	52	8	hematology	hematology	NOUN
aiua-5029	52	9	for	for	ADP
aiua-5029	52	10	day	day	NOUN
aiua-5029	52	11	1	1	NUM
aiua-5029	52	12	of	of	ADP
aiua-5029	52	13	each	each	DET
aiua-5029	52	14	cycle	cycle	NOUN
aiua-5029	52	15	:	:	PUNCT
aiua-5029	52	16	neutrophils	neutrophil	NOUN
aiua-5029	52	17	(	(	PUNCT
aiua-5029	52	18	10³/ml	10³/ml	NUM
aiua-5029	52	19	)	)	PUNCT
aiua-5029	52	20	platelets	platelet	NOUN
aiua-5029	52	21	(	(	PUNCT
aiua-5029	52	22	10³/ml	10³/ml	NOUN
aiua-5029	52	23	)	)	PUNCT
aiua-5029	52	24	dose	dose	NOUN
aiua-5029	52	25	≥	≥	NOUN
aiua-5029	52	26	1	1	NUM
aiua-5029	52	27	and	and	CCONJ
aiua-5029	52	28	>	>	SYM
aiua-5029	52	29	100	100	NUM
aiua-5029	52	30	100	100	NUM
aiua-5029	52	31	%	%	NOUN
aiua-5029	52	32	both	both	DET
aiua-5029	52	33	0.5	0.5	NUM
aiua-5029	52	34	to	to	ADP
aiua-5029	52	35	0.99	0.99	NUM
aiua-5029	52	36	or	or	CCONJ
aiua-5029	52	37	75	75	NUM
aiua-5029	52	38	to	to	PART
aiua-5029	52	39	100	100	NUM
aiua-5029	52	40	75	75	NUM
aiua-5029	52	41	%	%	NOUN
aiua-5029	52	42	of	of	ADP
aiua-5029	52	43	gemcitabine	gemcitabine	NOUN
aiua-5029	52	44	only	only	ADV
aiua-5029	52	45	<	<	X
aiua-5029	52	46	0.5	0.5	NUM
aiua-5029	52	47	or	or	CCONJ
aiua-5029	52	48	<	<	X
aiua-5029	52	49	75	75	NUM
aiua-5029	52	50	delay	delay	NOUN
aiua-5029	52	51	both	both	DET
aiua-5029	52	52	drugs	drug	NOUN
aiua-5029	52	53	for	for	ADP
aiua-5029	52	54	gemcitabine	gemcitabine	NOUN
aiua-5029	52	55	only	only	ADV
aiua-5029	52	56	day	day	NOUN
aiua-5029	52	57	8	8	NUM
aiua-5029	52	58	:	:	PUNCT
aiua-5029	52	59	≥	≥	NOUN
aiua-5029	52	60	1	1	NUM
aiua-5029	52	61	and	and	CCONJ
aiua-5029	52	62	>	>	X
aiua-5029	52	63	100	100	NUM
aiua-5029	52	64	100	100	NUM
aiua-5029	52	65	%	%	NOUN
aiua-5029	52	66	0.5	0.5	NUM
aiua-5029	52	67	to	to	ADP
aiua-5029	52	68	0.99	0.99	NUM
aiua-5029	52	69	or	or	CCONJ
aiua-5029	52	70	75	75	NUM
aiua-5029	52	71	to	to	PART
aiua-5029	52	72	100	100	NUM
aiua-5029	52	73	75	75	NUM
aiua-5029	52	74	%	%	NOUN
aiua-5029	52	75	<	<	X
aiua-5029	52	76	0.5	0.5	NUM
aiua-5029	52	77	or	or	CCONJ
aiua-5029	52	78	<	<	X
aiua-5029	52	79	75	75	NUM
aiua-5029	52	80	omit	omit	NOUN
aiua-5029	52	81	2	2	NUM
aiua-5029	52	82	.	.	PUNCT
aiua-5029	52	83	renal	renal	ADJ
aiua-5029	52	84	function	function	NOUN
aiua-5029	52	85	test	test	NOUN
aiua-5029	52	86	(	(	PUNCT
aiua-5029	52	87	gfr	gfr	NOUN
aiua-5029	52	88	)	)	PUNCT
aiua-5029	52	89	(	(	PUNCT
aiua-5029	52	90	ml	ml	PROPN
aiua-5029	52	91	/	/	SYM
aiua-5029	52	92	min	min	NOUN
aiua-5029	52	93	)	)	PUNCT
aiua-5029	52	94	gfr	gfr	NOUN
aiua-5029	52	95	cisplatin	cisplatin	PROPN
aiua-5029	52	96	dose	dose	PROPN
aiua-5029	52	97	gemcitabine	gemcitabine	PROPN
aiua-5029	52	98	dose	dose	VERB
aiua-5029	52	99	≥	≥	NOUN
aiua-5029	52	100	60	60	NUM
aiua-5029	52	101	100	100	NUM
aiua-5029	52	102	%	%	NOUN
aiua-5029	52	103	100	100	NUM
aiua-5029	52	104	%	%	NOUN
aiua-5029	52	105	45	45	NUM
aiua-5029	52	106	to	to	PART
aiua-5029	52	107	59	59	NUM
aiua-5029	52	108	35	35	NUM
aiua-5029	52	109	mg	mg	NUM
aiua-5029	52	110	/	/	SYM
aiua-5029	52	111	m2	m2	PROPN
aiua-5029	52	112	d1	d1	PROPN
aiua-5029	52	113	+	+	PROPN
aiua-5029	52	114	2	2	NUM
aiua-5029	52	115	100	100	NUM
aiua-5029	52	116	%	%	NOUN
aiua-5029	52	117	(	(	PUNCT
aiua-5029	52	118	same	same	ADJ
aiua-5029	52	119	pre	pre	NOUN
aiua-5029	52	120	-	-	NOUN
aiua-5029	52	121	hydration	hydration	NOUN
aiua-5029	52	122	as	as	ADP
aiua-5029	52	123	70	70	NUM
aiua-5029	52	124	mg	mg	NUM
aiua-5029	52	125	/	/	SYM
aiua-5029	52	126	m2	m2	PROPN
aiua-5029	52	127	dose	dose	PROPN
aiua-5029	52	128	)	)	PUNCT
aiua-5029	52	129	<	<	X
aiua-5029	52	130	45	45	NUM
aiua-5029	52	131	delay	delay	NOUN
aiua-5029	52	132	delay	delay	NOUN
aiua-5029	52	133	table	table	NOUN
aiua-5029	52	134	1	1	NUM
aiua-5029	52	135	.	.	PUNCT
aiua-5029	52	136	treatment	treatment	NOUN
aiua-5029	52	137	protocol	protocol	NOUN
aiua-5029	52	138	of	of	ADP
aiua-5029	52	139	the	the	DET
aiua-5029	52	140	current	current	ADJ
aiua-5029	52	141	trial	trial	NOUN
aiua-5029	52	142	.	.	PUNCT
aiua-5029	53	1	table	table	NOUN
aiua-5029	53	2	2	2	NUM
aiua-5029	53	3	.	.	PUNCT
aiua-5029	53	4	dose	dose	NOUN
aiua-5029	53	5	modification	modification	NOUN
aiua-5029	53	6	based	base	VERB
aiua-5029	53	7	on	on	ADP
aiua-5029	53	8	hematological	hematological	NOUN
aiua-5029	53	9	,	,	PUNCT
aiua-5029	53	10	and	and	CCONJ
aiua-5029	53	11	renal	renal	ADJ
aiua-5029	53	12	function	function	NOUN
aiua-5029	53	13	results	result	NOUN
aiua-5029	53	14	.	.	PUNCT
aiua-5029	54	1	treatment	treatment	NOUN
aiua-5029	54	2	protocol	protocol	NOUN
aiua-5029	54	3	arm	arm	NOUN
aiua-5029	54	4	1	1	NUM
aiua-5029	54	5	arm	arm	NOUN
aiua-5029	54	6	2	2	NUM
aiua-5029	54	7	neoadjuvant	neoadjuvant	ADJ
aiua-5029	54	8	chemotherapy	chemotherapy	NOUN
aiua-5029	54	9	;	;	PUNCT
aiua-5029	54	10	cisplatin	cisplatin	NOUN
aiua-5029	54	11	(	(	PUNCT
aiua-5029	54	12	70	70	NUM
aiua-5029	54	13	mg	mg	NUM
aiua-5029	54	14	/	/	SYM
aiua-5029	54	15	m2	m2	PROPN
aiua-5029	54	16	day	day	NOUN
aiua-5029	54	17	1	1	NUM
aiua-5029	54	18	)	)	PUNCT
aiua-5029	54	19	,	,	PUNCT
aiua-5029	54	20	gemcitabine	gemcitabine	NOUN
aiua-5029	54	21	(	(	PUNCT
aiua-5029	54	22	1250	1250	NUM
aiua-5029	54	23	mg	mg	PROPN
aiua-5029	54	24	/	/	SYM
aiua-5029	54	25	m2	m2	PROPN
aiua-5029	54	26	day	day	NOUN
aiua-5029	54	27	1,8	1,8	NUM
aiua-5029	54	28	)	)	PUNCT
aiua-5029	54	29	q	q	NOUN
aiua-5029	54	30	3	3	NUM
aiua-5029	54	31	weeks	week	NOUN
aiua-5029	54	32	for	for	ADP
aiua-5029	54	33	radical	radical	ADJ
aiua-5029	54	34	cystectomy	cystectomy	NOUN
aiua-5029	54	35	3	3	NUM
aiua-5029	54	36	cycles	cycle	NOUN
aiua-5029	54	37	radical	radical	ADJ
aiua-5029	54	38	cystectomy	cystectomy	NOUN
aiua-5029	55	1	osman_stesura	osman_stesura	NOUN
aiua-5029	55	2	seveso	seveso	NOUN
aiua-5029	55	3	15/01/15	15/01/15	PROPN
aiua-5029	55	4	13:09	13:09	NUM
aiua-5029	55	5	pagina	pagina	NOUN
aiua-5029	55	6	279	279	NUM
aiua-5029	55	7	archivio	archivio	NOUN
aiua-5029	55	8	italiano	italiano	X
aiua-5029	55	9	di	di	X
aiua-5029	55	10	urologia	urologia	PROPN
aiua-5029	55	11	e	e	PROPN
aiua-5029	55	12	andrologia	andrologia	NOUN
aiua-5029	55	13	2014	2014	NUM
aiua-5029	55	14	;	;	PUNCT
aiua-5029	55	15	86	86	NUM
aiua-5029	55	16	,	,	PUNCT
aiua-5029	55	17	4	4	NUM
aiua-5029	55	18	m.a	m.a	NOUN
aiua-5029	55	19	osman	osman	PROPN
aiua-5029	55	20	,	,	PUNCT
aiua-5029	55	21	a.m.	a.m.	PROPN
aiua-5029	55	22	gabr	gabr	NOUN
aiua-5029	55	23	,	,	PUNCT
aiua-5029	55	24	m.s	m.s	PROPN
aiua-5029	55	25	.	.	PROPN
aiua-5029	55	26	elkady	elkady	PROPN
aiua-5029	55	27	280	280	NUM
aiua-5029	55	28	as	as	ADP
aiua-5029	55	29	complications	complication	NOUN
aiua-5029	55	30	that	that	PRON
aiua-5029	55	31	occurred	occur	VERB
aiua-5029	55	32	from	from	ADP
aiua-5029	55	33	day	day	NOUN
aiua-5029	55	34	1	1	NUM
aiua-5029	55	35	postoperative	postoperative	ADJ
aiua-5029	55	36	till	till	SCONJ
aiua-5029	55	37	full	full	ADJ
aiua-5029	55	38	recovery	recovery	NOUN
aiua-5029	55	39	from	from	ADP
aiua-5029	55	40	the	the	DET
aiua-5029	55	41	surgery	surgery	NOUN
aiua-5029	55	42	usually	usually	ADV
aiua-5029	55	43	6	6	NUM
aiua-5029	55	44	-	-	SYM
aiua-5029	55	45	8	8	NUM
aiua-5029	55	46	weeks	week	NOUN
aiua-5029	55	47	postoperative	postoperative	ADJ
aiua-5029	55	48	.	.	PUNCT
aiua-5029	56	1	late	late	ADJ
aiua-5029	56	2	toxicities	toxicity	NOUN
aiua-5029	56	3	referred	refer	VERB
aiua-5029	56	4	to	to	ADP
aiua-5029	56	5	those	those	PRON
aiua-5029	56	6	occurred	occur	VERB
aiua-5029	56	7	>	>	X
aiua-5029	56	8	10	10	NUM
aiua-5029	56	9	weeks	week	NOUN
aiua-5029	56	10	after	after	ADP
aiua-5029	56	11	finish	finish	NOUN
aiua-5029	56	12	of	of	ADP
aiua-5029	56	13	treatment	treatment	NOUN
aiua-5029	56	14	protocol	protocol	NOUN
aiua-5029	56	15	.	.	PUNCT
aiua-5029	57	1	statistical	statistical	ADJ
aiua-5029	57	2	analysis	analysis	NOUN
aiua-5029	57	3	all	all	DET
aiua-5029	57	4	calculations	calculation	NOUN
aiua-5029	57	5	were	be	AUX
aiua-5029	57	6	carried	carry	VERB
aiua-5029	57	7	out	out	ADP
aiua-5029	57	8	using	use	VERB
aiua-5029	57	9	prism	prism	NOUN
aiua-5029	57	10	6	6	NUM
aiua-5029	57	11	software	software	NOUN
aiua-5029	57	12	for	for	ADP
aiua-5029	57	13	windows	window	NOUN
aiua-5029	57	14	.	.	PUNCT
aiua-5029	58	1	all	all	DET
aiua-5029	58	2	analyses	analysis	NOUN
aiua-5029	58	3	were	be	AUX
aiua-5029	58	4	carried	carry	VERB
aiua-5029	58	5	by	by	ADP
aiua-5029	58	6	intention	intention	NOUN
aiua-5029	58	7	to	to	PART
aiua-5029	58	8	treat	treat	VERB
aiua-5029	58	9	.	.	PUNCT
aiua-5029	59	1	mean	mean	VERB
aiua-5029	59	2	and	and	CCONJ
aiua-5029	59	3	median	median	ADJ
aiua-5029	59	4	values	value	NOUN
aiua-5029	59	5	were	be	AUX
aiua-5029	59	6	used	use	VERB
aiua-5029	59	7	for	for	ADP
aiua-5029	59	8	the	the	DET
aiua-5029	59	9	description	description	NOUN
aiua-5029	59	10	of	of	ADP
aiua-5029	59	11	continuous	continuous	ADJ
aiua-5029	59	12	data	datum	NOUN
aiua-5029	59	13	.	.	PUNCT
aiua-5029	60	1	for	for	ADP
aiua-5029	60	2	comparison	comparison	NOUN
aiua-5029	60	3	between	between	ADP
aiua-5029	60	4	the	the	DET
aiua-5029	60	5	2	2	NUM
aiua-5029	60	6	group	group	NOUN
aiua-5029	60	7	characteristics	characteristic	NOUN
aiua-5029	60	8	,	,	PUNCT
aiua-5029	60	9	t	t	PROPN
aiua-5029	60	10	test	test	NOUN
aiua-5029	60	11	,	,	PUNCT
aiua-5029	60	12	and	and	CCONJ
aiua-5029	60	13	p	p	NOUN
aiua-5029	60	14	value	value	NOUN
aiua-5029	60	15	were	be	AUX
aiua-5029	60	16	used	use	VERB
aiua-5029	60	17	.	.	PUNCT
aiua-5029	61	1	overall	overall	ADJ
aiua-5029	61	2	survival	survival	NOUN
aiua-5029	61	3	(	(	PUNCT
aiua-5029	61	4	os	os	NOUN
aiua-5029	61	5	)	)	PUNCT
aiua-5029	61	6	and	and	CCONJ
aiua-5029	61	7	progression	progression	NOUN
aiua-5029	61	8	-	-	PUNCT
aiua-5029	61	9	free	free	ADJ
aiua-5029	61	10	survival	survival	NOUN
aiua-5029	61	11	(	(	PUNCT
aiua-5029	61	12	pfs	pfs	PROPN
aiua-5029	61	13	)	)	PUNCT
aiua-5029	61	14	for	for	ADP
aiua-5029	61	15	each	each	DET
aiua-5029	61	16	arm	arm	NOUN
aiua-5029	61	17	were	be	AUX
aiua-5029	61	18	analyzed	analyze	VERB
aiua-5029	61	19	by	by	ADP
aiua-5029	61	20	the	the	DET
aiua-5029	61	21	kaplan	kaplan	PROPN
aiua-5029	61	22	-	-	PUNCT
aiua-5029	61	23	meier	meier	PROPN
aiua-5029	61	24	method	method	NOUN
aiua-5029	61	25	.	.	PUNCT
aiua-5029	62	1	further	far	ADV
aiua-5029	62	2	,	,	PUNCT
aiua-5029	62	3	they	they	PRON
aiua-5029	62	4	were	be	AUX
aiua-5029	62	5	compared	compare	VERB
aiua-5029	62	6	using	use	VERB
aiua-5029	62	7	the	the	DET
aiua-5029	62	8	log	log	NOUN
aiua-5029	62	9	rank	rank	NOUN
aiua-5029	62	10	and	and	CCONJ
aiua-5029	62	11	wilcoxon	wilcoxon	ADJ
aiua-5029	62	12	tests	test	NOUN
aiua-5029	62	13	.	.	PUNCT
aiua-5029	63	1	os	os	PROPN
aiua-5029	63	2	was	be	AUX
aiua-5029	63	3	measured	measure	VERB
aiua-5029	63	4	from	from	ADP
aiua-5029	63	5	the	the	DET
aiua-5029	63	6	time	time	NOUN
aiua-5029	63	7	of	of	ADP
aiua-5029	63	8	randomization	randomization	NOUN
aiua-5029	63	9	till	till	SCONJ
aiua-5029	63	10	death	death	NOUN
aiua-5029	63	11	from	from	ADP
aiua-5029	63	12	bladder	bladder	NOUN
aiua-5029	63	13	cancer	cancer	NOUN
aiua-5029	63	14	or	or	CCONJ
aiua-5029	63	15	the	the	DET
aiua-5029	63	16	last	last	ADJ
aiua-5029	63	17	follow	follow	NOUN
aiua-5029	63	18	-	-	PUNCT
aiua-5029	63	19	up	up	ADP
aiua-5029	63	20	visit	visit	NOUN
aiua-5029	63	21	.	.	PUNCT
aiua-5029	64	1	pfs	pfs	PROPN
aiua-5029	64	2	was	be	AUX
aiua-5029	64	3	measured	measure	VERB
aiua-5029	64	4	from	from	ADP
aiua-5029	64	5	the	the	DET
aiua-5029	64	6	time	time	NOUN
aiua-5029	64	7	of	of	ADP
aiua-5029	64	8	randomization	randomization	NOUN
aiua-5029	64	9	till	till	SCONJ
aiua-5029	64	10	relapse	relapse	NOUN
aiua-5029	64	11	,	,	PUNCT
aiua-5029	64	12	or	or	CCONJ
aiua-5029	64	13	the	the	DET
aiua-5029	64	14	last	last	ADJ
aiua-5029	64	15	follow	follow	NOUN
aiua-5029	64	16	-	-	PUNCT
aiua-5029	64	17	up	up	ADP
aiua-5029	64	18	visit	visit	NOUN
aiua-5029	64	19	.	.	PUNCT
aiua-5029	65	1	log	log	PROPN
aiua-5029	65	2	rank	rank	NOUN
aiua-5029	65	3	approach	approach	NOUN
aiua-5029	65	4	and	and	CCONJ
aiua-5029	65	5	hazard	hazard	NOUN
aiua-5029	65	6	ratio	ratio	NOUN
aiua-5029	65	7	were	be	AUX
aiua-5029	65	8	used	use	VERB
aiua-5029	65	9	to	to	PART
aiua-5029	65	10	examine	examine	VERB
aiua-5029	65	11	the	the	DET
aiua-5029	65	12	effects	effect	NOUN
aiua-5029	65	13	of	of	ADP
aiua-5029	65	14	pre	pre	ADJ
aiua-5029	65	15	-	-	ADJ
aiua-5029	65	16	specified	specified	ADJ
aiua-5029	65	17	prognostic	prognostic	ADJ
aiua-5029	65	18	factors	factor	NOUN
aiua-5029	65	19	including	include	VERB
aiua-5029	65	20	age	age	NOUN
aiua-5029	65	21	,	,	PUNCT
aiua-5029	65	22	tumor	tumor	NOUN
aiua-5029	65	23	size	size	NOUN
aiua-5029	65	24	,	,	PUNCT
aiua-5029	65	25	pathological	pathological	ADJ
aiua-5029	65	26	staging	staging	NOUN
aiua-5029	65	27	,	,	PUNCT
aiua-5029	65	28	and	and	CCONJ
aiua-5029	65	29	pathological	pathological	ADJ
aiua-5029	65	30	response	response	NOUN
aiua-5029	65	31	to	to	ADP
aiua-5029	65	32	neoadjuvant	neoadjuvant	ADJ
aiua-5029	65	33	chemotherapy	chemotherapy	NOUN
aiua-5029	65	34	on	on	ADP
aiua-5029	65	35	the	the	DET
aiua-5029	65	36	3	3	NUM
aiua-5029	65	37	year	year	NOUN
aiua-5029	65	38	os	os	NOUN
aiua-5029	65	39	.	.	PUNCT
aiua-5029	66	1	p	p	NOUN
aiua-5029	66	2	value	value	NOUN
aiua-5029	66	3	was	be	AUX
aiua-5029	66	4	significant	significant	ADJ
aiua-5029	66	5	at	at	ADP
aiua-5029	66	6	≤	≤	NUM
aiua-5029	66	7	0.05	0.05	NUM
aiua-5029	66	8	.	.	PUNCT
aiua-5029	67	1	results	result	NOUN
aiua-5029	67	2	between	between	ADP
aiua-5029	67	3	september	september	PROPN
aiua-5029	67	4	2009	2009	NUM
aiua-5029	67	5	and	and	CCONJ
aiua-5029	67	6	april	april	PROPN
aiua-5029	67	7	2014	2014	NUM
aiua-5029	67	8	,	,	PUNCT
aiua-5029	67	9	60	60	NUM
aiua-5029	67	10	patients	patient	NOUN
aiua-5029	67	11	were	be	AUX
aiua-5029	67	12	enrolled	enrol	VERB
aiua-5029	67	13	in	in	ADP
aiua-5029	67	14	the	the	DET
aiua-5029	67	15	current	current	ADJ
aiua-5029	67	16	study	study	NOUN
aiua-5029	67	17	.	.	PUNCT
aiua-5029	68	1	30	30	NUM
aiua-5029	68	2	patients	patient	NOUN
aiua-5029	68	3	were	be	AUX
aiua-5029	68	4	assigned	assign	VERB
aiua-5029	68	5	to	to	ADP
aiua-5029	68	6	each	each	DET
aiua-5029	68	7	treatment	treatment	NOUN
aiua-5029	68	8	arm	arm	NOUN
aiua-5029	68	9	.	.	PUNCT
aiua-5029	69	1	all	all	DET
aiua-5029	69	2	patients	patient	NOUN
aiua-5029	69	3	fulfilled	fulfil	VERB
aiua-5029	69	4	eligibility	eligibility	NOUN
aiua-5029	69	5	criteria	criterion	NOUN
aiua-5029	69	6	for	for	ADP
aiua-5029	69	7	enrolment	enrolment	NOUN
aiua-5029	69	8	in	in	ADP
aiua-5029	69	9	the	the	DET
aiua-5029	69	10	current	current	ADJ
aiua-5029	69	11	study	study	NOUN
aiua-5029	69	12	.	.	PUNCT
aiua-5029	70	1	the	the	DET
aiua-5029	70	2	mean	mean	ADJ
aiua-5029	70	3	age	age	NOUN
aiua-5029	70	4	was	be	AUX
aiua-5029	70	5	50.6	50.6	NUM
aiua-5029	70	6	years	year	NOUN
aiua-5029	70	7	(	(	PUNCT
aiua-5029	70	8	range	range	NOUN
aiua-5029	70	9	30	30	NUM
aiua-5029	70	10	-	-	SYM
aiua-5029	70	11	65	65	NUM
aiua-5029	70	12	years	year	NOUN
aiua-5029	70	13	)	)	PUNCT
aiua-5029	70	14	.	.	PUNCT
aiua-5029	71	1	56	56	NUM
aiua-5029	71	2	patients	patient	NOUN
aiua-5029	71	3	were	be	AUX
aiua-5029	71	4	males	male	NOUN
aiua-5029	71	5	,	,	PUNCT
aiua-5029	71	6	and	and	CCONJ
aiua-5029	71	7	4	4	NUM
aiua-5029	71	8	were	be	AUX
aiua-5029	71	9	females	female	NOUN
aiua-5029	71	10	(	(	PUNCT
aiua-5029	71	11	93.3	93.3	NUM
aiua-5029	71	12	%	%	NOUN
aiua-5029	71	13	,	,	PUNCT
aiua-5029	71	14	6.7	6.7	NUM
aiua-5029	71	15	%	%	NOUN
aiua-5029	71	16	respectively	respectively	ADV
aiua-5029	71	17	)	)	PUNCT
aiua-5029	71	18	.	.	PUNCT
aiua-5029	72	1	the	the	DET
aiua-5029	72	2	median	median	ADJ
aiua-5029	72	3	performance	performance	NOUN
aiua-5029	72	4	status	status	NOUN
aiua-5029	72	5	was	be	AUX
aiua-5029	72	6	1	1	NUM
aiua-5029	72	7	(	(	PUNCT
aiua-5029	72	8	range	range	NOUN
aiua-5029	72	9	0	0	NUM
aiua-5029	72	10	-	-	SYM
aiua-5029	72	11	2	2	NUM
aiua-5029	72	12	)	)	PUNCT
aiua-5029	72	13	.	.	PUNCT
aiua-5029	73	1	the	the	DET
aiua-5029	73	2	mean	mean	ADJ
aiua-5029	73	3	tumor	tumor	NOUN
aiua-5029	73	4	size	size	NOUN
aiua-5029	73	5	was	be	AUX
aiua-5029	73	6	3.75	3.75	NUM
aiua-5029	73	7	cm	cm	NOUN
aiua-5029	73	8	(	(	PUNCT
aiua-5029	73	9	range	range	NOUN
aiua-5029	73	10	1.8	1.8	NUM
aiua-5029	73	11	-	-	SYM
aiua-5029	73	12	5.5	5.5	NUM
aiua-5029	73	13	cm	cm	NOUN
aiua-5029	73	14	)	)	PUNCT
aiua-5029	73	15	.	.	PUNCT
aiua-5029	74	1	12	12	NUM
aiua-5029	74	2	patients	patient	NOUN
aiua-5029	74	3	had	have	VERB
aiua-5029	74	4	stage	stage	NOUN
aiua-5029	74	5	t2n0	t2n0	VERB
aiua-5029	74	6	,	,	PUNCT
aiua-5029	74	7	38	38	NUM
aiua-5029	74	8	had	have	VERB
aiua-5029	74	9	stage	stage	NOUN
aiua-5029	74	10	t3n0	t3n0	NOUN
aiua-5029	74	11	,	,	PUNCT
aiua-5029	74	12	and	and	CCONJ
aiua-5029	74	13	10	10	NUM
aiua-5029	74	14	had	have	VERB
aiua-5029	74	15	stage	stage	NOUN
aiua-5029	74	16	t4an0	t4an0	PROPN
aiua-5029	74	17	.	.	PUNCT
aiua-5029	75	1	(	(	PUNCT
aiua-5029	75	2	20	20	NUM
aiua-5029	75	3	%	%	NOUN
aiua-5029	75	4	,	,	PUNCT
aiua-5029	75	5	63.3	63.3	NUM
aiua-5029	75	6	%	%	NOUN
aiua-5029	75	7	,	,	PUNCT
aiua-5029	75	8	16.7	16.7	NUM
aiua-5029	75	9	%	%	NOUN
aiua-5029	75	10	respectively	respectively	ADV
aiua-5029	75	11	)	)	PUNCT
aiua-5029	75	12	(	(	PUNCT
aiua-5029	75	13	table	table	NOUN
aiua-5029	75	14	4	4	NUM
aiua-5029	75	15	)	)	PUNCT
aiua-5029	75	16	.	.	PUNCT
aiua-5029	76	1	treatment	treatment	NOUN
aiua-5029	76	2	protocol	protocol	NOUN
aiua-5029	76	3	for	for	ADP
aiua-5029	76	4	arm	arm	NOUN
aiua-5029	76	5	a	a	PRON
aiua-5029	76	6	:	:	PUNCT
aiua-5029	76	7	all	all	PRON
aiua-5029	76	8	arm	arm	VERB
aiua-5029	76	9	a	a	DET
aiua-5029	76	10	patients	patient	NOUN
aiua-5029	76	11	received	receive	VERB
aiua-5029	76	12	neoadjuvant	neoadjuvant	ADJ
aiua-5029	76	13	chemotherapy	chemotherapy	NOUN
aiua-5029	76	14	,	,	PUNCT
aiua-5029	76	15	and	and	CCONJ
aiua-5029	76	16	a	a	DET
aiua-5029	76	17	total	total	NOUN
aiua-5029	76	18	of	of	ADP
aiua-5029	76	19	89	89	NUM
aiua-5029	76	20	cycles	cycle	NOUN
aiua-5029	76	21	were	be	AUX
aiua-5029	76	22	performed	perform	VERB
aiua-5029	76	23	.	.	PUNCT
aiua-5029	77	1	mean	mean	VERB
aiua-5029	77	2	chemotherapy	chemotherapy	NOUN
aiua-5029	77	3	cycles	cycle	NOUN
aiua-5029	77	4	were	be	AUX
aiua-5029	77	5	3	3	NUM
aiua-5029	77	6	(	(	PUNCT
aiua-5029	77	7	range	range	NOUN
aiua-5029	77	8	2	2	NUM
aiua-5029	77	9	-	-	SYM
aiua-5029	77	10	3	3	NUM
aiua-5029	77	11	)	)	PUNCT
aiua-5029	77	12	.	.	PUNCT
aiua-5029	78	1	to	to	PART
aiua-5029	78	2	evaluate	evaluate	VERB
aiua-5029	78	3	treatment	treatment	NOUN
aiua-5029	78	4	response	response	NOUN
aiua-5029	78	5	,	,	PUNCT
aiua-5029	78	6	ct	ct	PROPN
aiua-5029	78	7	ap	ap	PROPN
aiua-5029	78	8	was	be	AUX
aiua-5029	78	9	checked	check	VERB
aiua-5029	78	10	at	at	ADP
aiua-5029	78	11	mean	mean	ADJ
aiua-5029	78	12	time	time	NOUN
aiua-5029	78	13	of	of	ADP
aiua-5029	78	14	2.2	2.2	NUM
aiua-5029	78	15	weeks	week	NOUN
aiua-5029	78	16	after	after	ADP
aiua-5029	78	17	cycle	cycle	NOUN
aiua-5029	78	18	3	3	NUM
aiua-5029	78	19	(	(	PUNCT
aiua-5029	78	20	range	range	NOUN
aiua-5029	78	21	1	1	NUM
aiua-5029	78	22	-	-	SYM
aiua-5029	78	23	3	3	NUM
aiua-5029	78	24	weeks	week	NOUN
aiua-5029	78	25	)	)	PUNCT
aiua-5029	78	26	.	.	PUNCT
aiua-5029	79	1	neoadjuvant	neoadjuvant	ADJ
aiua-5029	79	2	chemotherapy	chemotherapy	NOUN
aiua-5029	79	3	response	response	NOUN
aiua-5029	79	4	among	among	ADP
aiua-5029	79	5	the	the	DET
aiua-5029	79	6	30	30	NUM
aiua-5029	79	7	patients	patient	NOUN
aiua-5029	79	8	enrolled	enrol	VERB
aiua-5029	79	9	,	,	PUNCT
aiua-5029	79	10	cr	cr	NOUN
aiua-5029	79	11	was	be	AUX
aiua-5029	79	12	achieved	achieve	VERB
aiua-5029	79	13	in	in	ADP
aiua-5029	79	14	6	6	NUM
aiua-5029	79	15	patients	patient	NOUN
aiua-5029	79	16	(	(	PUNCT
aiua-5029	79	17	20	20	NUM
aiua-5029	79	18	%	%	NOUN
aiua-5029	79	19	)	)	PUNCT
aiua-5029	79	20	,	,	PUNCT
aiua-5029	79	21	pr	pr	PROPN
aiua-5029	79	22	was	be	AUX
aiua-5029	79	23	observed	observe	VERB
aiua-5029	79	24	in	in	ADP
aiua-5029	79	25	16	16	NUM
aiua-5029	79	26	patients	patient	NOUN
aiua-5029	79	27	(	(	PUNCT
aiua-5029	79	28	53.3	53.3	NUM
aiua-5029	79	29	%	%	NOUN
aiua-5029	79	30	)	)	PUNCT
aiua-5029	79	31	,	,	PUNCT
aiua-5029	79	32	and	and	CCONJ
aiua-5029	79	33	sd	sd	NOUN
aiua-5029	79	34	was	be	AUX
aiua-5029	79	35	in	in	ADP
aiua-5029	79	36	6	6	NUM
aiua-5029	79	37	patients	patient	NOUN
aiua-5029	79	38	(	(	PUNCT
aiua-5029	79	39	20	20	NUM
aiua-5029	79	40	%	%	NOUN
aiua-5029	79	41	)	)	PUNCT
aiua-5029	79	42	.	.	PUNCT
aiua-5029	80	1	the	the	DET
aiua-5029	80	2	remaining	remain	VERB
aiua-5029	80	3	2	2	NUM
aiua-5029	80	4	patients	patient	NOUN
aiua-5029	80	5	had	have	VERB
aiua-5029	80	6	dp	dp	NOUN
aiua-5029	80	7	(	(	PUNCT
aiua-5029	80	8	6.7	6.7	NUM
aiua-5029	80	9	%	%	NOUN
aiua-5029	80	10	)	)	PUNCT
aiua-5029	80	11	.	.	PUNCT
aiua-5029	81	1	surgery	surgery	NOUN
aiua-5029	81	2	radical	radical	ADJ
aiua-5029	81	3	cystectomy	cystectomy	NOUN
aiua-5029	81	4	,	,	PUNCT
aiua-5029	81	5	pelvic	pelvic	ADJ
aiua-5029	81	6	lymphadenectomy	lymphadenectomy	NOUN
aiua-5029	81	7	,	,	PUNCT
aiua-5029	81	8	and	and	CCONJ
aiua-5029	81	9	urinary	urinary	ADJ
aiua-5029	81	10	diversion	diversion	NOUN
aiua-5029	81	11	were	be	AUX
aiua-5029	81	12	performed	perform	VERB
aiua-5029	81	13	in	in	ADP
aiua-5029	81	14	58	58	NUM
aiua-5029	81	15	out	out	ADP
aiua-5029	81	16	of	of	ADP
aiua-5029	81	17	the	the	DET
aiua-5029	81	18	60	60	NUM
aiua-5029	81	19	patients	patient	NOUN
aiua-5029	81	20	.	.	PUNCT
aiua-5029	82	1	for	for	ADP
aiua-5029	82	2	arm	arm	NOUN
aiua-5029	82	3	a	a	DET
aiua-5029	82	4	patients	patient	NOUN
aiua-5029	82	5	,	,	PUNCT
aiua-5029	82	6	28	28	NUM
aiua-5029	82	7	underwent	underwent	NOUN
aiua-5029	82	8	cystectomy	cystectomy	NOUN
aiua-5029	82	9	,	,	PUNCT
aiua-5029	82	10	the	the	DET
aiua-5029	82	11	remaining	remain	VERB
aiua-5029	82	12	2	2	NUM
aiua-5029	82	13	refused	refuse	VERB
aiua-5029	82	14	surgery	surgery	NOUN
aiua-5029	82	15	and	and	CCONJ
aiua-5029	82	16	lost	lose	VERB
aiua-5029	82	17	follow	follow	NOUN
aiua-5029	82	18	-	-	PUNCT
aiua-5029	82	19	up	up	NOUN
aiua-5029	82	20	.	.	PUNCT
aiua-5029	83	1	of	of	ADP
aiua-5029	83	2	them	they	PRON
aiua-5029	83	3	,	,	PUNCT
aiua-5029	83	4	19	19	NUM
aiua-5029	83	5	had	have	VERB
aiua-5029	83	6	neobladder	neobladder	NOUN
aiua-5029	83	7	,	,	PUNCT
aiua-5029	83	8	7	7	NUM
aiua-5029	83	9	ileal	ileal	ADJ
aiua-5029	83	10	conduit	conduit	NOUN
aiua-5029	83	11	,	,	PUNCT
aiua-5029	83	12	and	and	CCONJ
aiua-5029	83	13	2	2	NUM
aiua-5029	83	14	underwent	underwent	NOUN
aiua-5029	83	15	cutaneous	cutaneous	ADJ
aiua-5029	83	16	urinary	urinary	ADJ
aiua-5029	83	17	diversion	diversion	NOUN
aiua-5029	83	18	.	.	PUNCT
aiua-5029	84	1	surgery	surgery	NOUN
aiua-5029	84	2	was	be	AUX
aiua-5029	84	3	done	do	VERB
aiua-5029	84	4	at	at	ADP
aiua-5029	84	5	a	a	DET
aiua-5029	84	6	mean	mean	NOUN
aiua-5029	84	7	of	of	ADP
aiua-5029	84	8	2	2	NUM
aiua-5029	84	9	weeks	week	NOUN
aiua-5029	84	10	after	after	ADP
aiua-5029	84	11	cycle	cycle	NOUN
aiua-5029	84	12	3	3	NUM
aiua-5029	84	13	chemotherapy	chemotherapy	NOUN
aiua-5029	84	14	(	(	PUNCT
aiua-5029	84	15	range	range	NOUN
aiua-5029	84	16	1021	1021	NUM
aiua-5029	84	17	days	day	NOUN
aiua-5029	84	18	)	)	PUNCT
aiua-5029	84	19	.	.	PUNCT
aiua-5029	85	1	the	the	DET
aiua-5029	85	2	mean	mean	ADJ
aiua-5029	85	3	admission	admission	NOUN
aiua-5029	85	4	time	time	NOUN
aiua-5029	85	5	for	for	ADP
aiua-5029	85	6	surgery	surgery	NOUN
aiua-5029	85	7	was	be	AUX
aiua-5029	85	8	8.3	8.3	NUM
aiua-5029	85	9	days	day	NOUN
aiua-5029	85	10	(	(	PUNCT
aiua-5029	85	11	range	range	NOUN
aiua-5029	85	12	7	7	NUM
aiua-5029	85	13	-	-	SYM
aiua-5029	85	14	14	14	NUM
aiua-5029	85	15	days	day	NOUN
aiua-5029	85	16	)	)	PUNCT
aiua-5029	85	17	.	.	PUNCT
aiua-5029	86	1	the	the	DET
aiua-5029	86	2	average	average	ADJ
aiua-5029	86	3	blood	blood	NOUN
aiua-5029	86	4	loss	loss	NOUN
aiua-5029	86	5	was	be	AUX
aiua-5029	86	6	900	900	NUM
aiua-5029	86	7	ml	ml	NOUN
aiua-5029	86	8	(	(	PUNCT
aiua-5029	86	9	range	range	NOUN
aiua-5029	86	10	500	500	NUM
aiua-5029	86	11	-	-	SYM
aiua-5029	86	12	2000	2000	NUM
aiua-5029	86	13	ml	ml	NOUN
aiua-5029	86	14	)	)	PUNCT
aiua-5029	86	15	.	.	PUNCT
aiua-5029	87	1	pathological	pathological	ADJ
aiua-5029	87	2	evaluation	evaluation	NOUN
aiua-5029	87	3	after	after	SCONJ
aiua-5029	87	4	cystectomy	cystectomy	NOUN
aiua-5029	87	5	was	be	AUX
aiua-5029	87	6	done	do	VERB
aiua-5029	87	7	in	in	ADP
aiua-5029	87	8	all	all	DET
aiua-5029	87	9	the	the	DET
aiua-5029	87	10	28	28	NUM
aiua-5029	87	11	patients	patient	NOUN
aiua-5029	87	12	.	.	PUNCT
aiua-5029	88	1	r0	r0	NOUN
aiua-5029	88	2	was	be	AUX
aiua-5029	88	3	achieved	achieve	VERB
aiua-5029	88	4	in	in	ADP
aiua-5029	88	5	all	all	DET
aiua-5029	88	6	except	except	SCONJ
aiua-5029	88	7	2	2	NUM
aiua-5029	88	8	patients	patient	NOUN
aiua-5029	88	9	who	who	PRON
aiua-5029	88	10	had	have	VERB
aiua-5029	88	11	r1	r1	NOUN
aiua-5029	88	12	disease	disease	NOUN
aiua-5029	88	13	.	.	PUNCT
aiua-5029	89	1	pcr	pcr	PROPN
aiua-5029	89	2	(	(	PUNCT
aiua-5029	89	3	pathological	pathological	ADJ
aiua-5029	89	4	complete	complete	ADJ
aiua-5029	89	5	remission	remission	NOUN
aiua-5029	89	6	)	)	PUNCT
aiua-5029	89	7	(	(	PUNCT
aiua-5029	89	8	pt0	pt0	NOUN
aiua-5029	89	9	)	)	PUNCT
aiua-5029	89	10	was	be	AUX
aiua-5029	89	11	achieved	achieve	VERB
aiua-5029	89	12	in	in	ADP
aiua-5029	89	13	10	10	NUM
aiua-5029	89	14	patients	patient	NOUN
aiua-5029	89	15	(	(	PUNCT
aiua-5029	89	16	35	35	NUM
aiua-5029	89	17	%	%	NOUN
aiua-5029	89	18	)	)	PUNCT
aiua-5029	89	19	,	,	PUNCT
aiua-5029	89	20	ppr	ppr	NOUN
aiua-5029	89	21	(	(	PUNCT
aiua-5029	89	22	pathological	pathological	ADJ
aiua-5029	89	23	partial	partial	ADJ
aiua-5029	89	24	remission	remission	NOUN
aiua-5029	89	25	)	)	PUNCT
aiua-5029	89	26	in	in	ADP
aiua-5029	89	27	12	12	NUM
aiua-5029	89	28	patients	patient	NOUN
aiua-5029	89	29	(	(	PUNCT
aiua-5029	89	30	43	43	NUM
aiua-5029	89	31	%	%	NOUN
aiua-5029	89	32	)	)	PUNCT
aiua-5029	89	33	(	(	PUNCT
aiua-5029	89	34	8	8	NUM
aiua-5029	89	35	pt1	pt1	PROPN
aiua-5029	89	36	,	,	PUNCT
aiua-5029	89	37	and	and	CCONJ
aiua-5029	89	38	4	4	NUM
aiua-5029	89	39	patients	patient	NOUN
aiua-5029	89	40	pt2	pt2	PROPN
aiua-5029	89	41	)	)	PUNCT
aiua-5029	89	42	.	.	PUNCT
aiua-5029	90	1	the	the	DET
aiua-5029	90	2	remaining	remain	VERB
aiua-5029	90	3	6	6	NUM
aiua-5029	90	4	had	have	VERB
aiua-5029	90	5	sd	sd	NOUN
aiua-5029	90	6	(	(	PUNCT
aiua-5029	90	7	stable	stable	ADJ
aiua-5029	90	8	disease	disease	NOUN
aiua-5029	90	9	)	)	PUNCT
aiua-5029	90	10	(	(	PUNCT
aiua-5029	90	11	22	22	NUM
aiua-5029	90	12	%	%	NOUN
aiua-5029	90	13	)	)	PUNCT
aiua-5029	90	14	(	(	PUNCT
aiua-5029	90	15	2	2	NUM
aiua-5029	90	16	pt2	pt2	NOUN
aiua-5029	90	17	,	,	PUNCT
aiua-5029	90	18	3	3	NUM
aiua-5029	90	19	pt3	pt3	NOUN
aiua-5029	90	20	,	,	PUNCT
aiua-5029	90	21	and	and	CCONJ
aiua-5029	90	22	1	1	NUM
aiua-5029	90	23	pt4	pt4	NOUN
aiua-5029	90	24	)	)	PUNCT
aiua-5029	90	25	.	.	PUNCT
aiua-5029	91	1	the	the	DET
aiua-5029	91	2	mean	mean	ADJ
aiua-5029	91	3	number	number	NOUN
aiua-5029	91	4	of	of	ADP
aiua-5029	91	5	dissected	dissect	VERB
aiua-5029	91	6	pelvic	pelvic	ADJ
aiua-5029	91	7	lymph	lymph	NOUN
aiua-5029	91	8	nodes	node	NOUN
aiua-5029	91	9	was	be	AUX
aiua-5029	91	10	15	15	NUM
aiua-5029	91	11	(	(	PUNCT
aiua-5029	91	12	range	range	NOUN
aiua-5029	91	13	7	7	NUM
aiua-5029	91	14	-	-	SYM
aiua-5029	91	15	20	20	NUM
aiua-5029	91	16	):	):	PUNCT
aiua-5029	91	17	4	4	NUM
aiua-5029	91	18	patients	patient	NOUN
aiua-5029	91	19	had	have	VERB
aiua-5029	91	20	positive	positive	ADJ
aiua-5029	91	21	lymph	lymph	NOUN
aiua-5029	91	22	node	node	NOUN
aiua-5029	91	23	biopsies	biopsy	NOUN
aiua-5029	91	24	.	.	PUNCT
aiua-5029	92	1	for	for	ADP
aiua-5029	92	2	arm	arm	NOUN
aiua-5029	92	3	b	b	PROPN
aiua-5029	92	4	,	,	PUNCT
aiua-5029	92	5	all	all	DET
aiua-5029	92	6	the	the	DET
aiua-5029	92	7	30	30	NUM
aiua-5029	92	8	patients	patient	NOUN
aiua-5029	92	9	underwent	undergo	VERB
aiua-5029	92	10	cystectomy	cystectomy	NOUN
aiua-5029	92	11	.	.	PUNCT
aiua-5029	93	1	of	of	ADP
aiua-5029	93	2	them	they	PRON
aiua-5029	93	3	,	,	PUNCT
aiua-5029	93	4	18	18	NUM
aiua-5029	93	5	underwent	underwent	NOUN
aiua-5029	93	6	neobladder	neobladder	NOUN
aiua-5029	93	7	,	,	PUNCT
aiua-5029	93	8	6	6	NUM
aiua-5029	93	9	ileal	ileal	ADJ
aiua-5029	93	10	conduit	conduit	NOUN
aiua-5029	93	11	,	,	PUNCT
aiua-5029	93	12	5	5	NUM
aiua-5029	93	13	cutaarm	cutaarm	NOUN
aiua-5029	93	14	a	a	DET
aiua-5029	93	15	arm	arm	NOUN
aiua-5029	93	16	b	b	PROPN
aiua-5029	93	17	characteristics	characteristic	NOUN
aiua-5029	93	18	number	number	NOUN
aiua-5029	93	19	%	%	NOUN
aiua-5029	93	20	number	number	NOUN
aiua-5029	93	21	%	%	NOUN
aiua-5029	93	22	p	p	NOUN
aiua-5029	93	23	value	value	NOUN
aiua-5029	93	24	age	age	NOUN
aiua-5029	93	25	35	35	NUM
aiua-5029	93	26	-	-	SYM
aiua-5029	93	27	40	40	NUM
aiua-5029	93	28	40	40	NUM
aiua-5029	93	29	-	-	SYM
aiua-5029	93	30	50	50	NUM
aiua-5029	93	31	50	50	NUM
aiua-5029	93	32	-	-	SYM
aiua-5029	93	33	60	60	NUM
aiua-5029	93	34	60	60	NUM
aiua-5029	93	35	-	-	SYM
aiua-5029	93	36	65	65	NUM
aiua-5029	93	37	mean	mean	NOUN
aiua-5029	93	38	age	age	NOUN
aiua-5029	93	39	48.9	48.9	NUM
aiua-5029	93	40	--52.3	--52.3	NUM
aiua-5029	93	41	--0.04	--0.04	NOUN
aiua-5029	93	42	sex	sex	NOUN
aiua-5029	93	43	male	male	ADJ
aiua-5029	93	44	female	female	ADJ
aiua-5029	93	45	performance	performance	NOUN
aiua-5029	93	46	status	status	NOUN
aiua-5029	93	47	0	0	NUM
aiua-5029	93	48	1	1	NUM
aiua-5029	93	49	2	2	NUM
aiua-5029	93	50	performance	performance	NOUN
aiua-5029	93	51	status	status	NOUN
aiua-5029	93	52	(	(	PUNCT
aiua-5029	93	53	mean	mean	ADJ
aiua-5029	93	54	,	,	PUNCT
aiua-5029	93	55	median	median	ADJ
aiua-5029	93	56	)	)	PUNCT
aiua-5029	93	57	0.7	0.7	NUM
aiua-5029	93	58	,	,	PUNCT
aiua-5029	93	59	1	1	NUM
aiua-5029	93	60	--0.9	--0.9	NUM
aiua-5029	93	61	,	,	PUNCT
aiua-5029	93	62	1	1	NUM
aiua-5029	93	63	--0.1	--0.1	NOUN
aiua-5029	93	64	tumor	tumor	NOUN
aiua-5029	93	65	size	size	NOUN
aiua-5029	93	66	12	12	NUM
aiua-5029	93	67	cm	cm	NUM
aiua-5029	93	68	2.1	2.1	NUM
aiua-5029	93	69	-	-	SYM
aiua-5029	93	70	4	4	NUM
aiua-5029	93	71	cm	cm	NOUN
aiua-5029	93	72	>	>	SYM
aiua-5029	93	73	4	4	NUM
aiua-5029	93	74	cm	cm	NOUN
aiua-5029	93	75	mean	mean	NOUN
aiua-5029	93	76	tumor	tumor	NOUN
aiua-5029	93	77	size	size	NOUN
aiua-5029	93	78	3.7	3.7	NUM
aiua-5029	93	79	--3.8	--3.8	NUM
aiua-5029	93	80	--0.1	--0.1	PROPN
aiua-5029	93	81	histopathological	histopathological	ADJ
aiua-5029	93	82	grade	grade	NOUN
aiua-5029	93	83	1	1	NUM
aiua-5029	93	84	2	2	NUM
aiua-5029	93	85	3	3	NUM
aiua-5029	93	86	grade	grade	NOUN
aiua-5029	93	87	mean	mean	NOUN
aiua-5029	93	88	,	,	PUNCT
aiua-5029	93	89	median	median	NOUN
aiua-5029	93	90	2.5	2.5	NUM
aiua-5029	93	91	,	,	PUNCT
aiua-5029	93	92	3	3	NUM
aiua-5029	93	93	--2.6	--2.6	PROPN
aiua-5029	93	94	,	,	PUNCT
aiua-5029	93	95	3	3	NUM
aiua-5029	93	96	--0.1	--0.1	NOUN
aiua-5029	93	97	tumor	tumor	NOUN
aiua-5029	93	98	stage	stage	NOUN
aiua-5029	93	99	pt2n0	pt2n0	PROPN
aiua-5029	93	100	pt3n0	pt3n0	PROPN
aiua-5029	93	101	pt4an0	pt4an0	VERB
aiua-5029	94	1	tumor	tumor	NOUN
aiua-5029	94	2	stage	stage	NOUN
aiua-5029	94	3	median	median	PROPN
aiua-5029	94	4	t3	t3	PROPN
aiua-5029	94	5	t3	t3	PROPN
aiua-5029	94	6	0.07	0.07	NUM
aiua-5029	94	7	table	table	NOUN
aiua-5029	94	8	3	3	NUM
aiua-5029	94	9	.	.	PUNCT
aiua-5029	95	1	response	response	NOUN
aiua-5029	95	2	definitions	definition	NOUN
aiua-5029	95	3	.	.	PUNCT
aiua-5029	96	1	table	table	NOUN
aiua-5029	96	2	4	4	NUM
aiua-5029	96	3	.	.	PUNCT
aiua-5029	97	1	patients	patient	NOUN
aiua-5029	97	2	and	and	CCONJ
aiua-5029	97	3	diseases	disease	NOUN
aiua-5029	97	4	characteristics	characteristic	NOUN
aiua-5029	97	5	of	of	ADP
aiua-5029	97	6	each	each	DET
aiua-5029	97	7	treatment	treatment	NOUN
aiua-5029	97	8	.	.	PUNCT
aiua-5029	98	1	complete	complete	ADJ
aiua-5029	98	2	response	response	NOUN
aiua-5029	98	3	(	(	PUNCT
aiua-5029	98	4	cr	cr	NOUN
aiua-5029	98	5	)	)	PUNCT
aiua-5029	98	6	complete	complete	ADJ
aiua-5029	98	7	disappearance	disappearance	NOUN
aiua-5029	98	8	of	of	ADP
aiua-5029	98	9	the	the	DET
aiua-5029	98	10	tumor	tumor	NOUN
aiua-5029	98	11	partial	partial	ADJ
aiua-5029	98	12	response	response	NOUN
aiua-5029	98	13	(	(	PUNCT
aiua-5029	98	14	pr	pr	NOUN
aiua-5029	98	15	)	)	PUNCT
aiua-5029	98	16	50	50	NUM
aiua-5029	98	17	%	%	NOUN
aiua-5029	98	18	or	or	CCONJ
aiua-5029	98	19	more	more	ADJ
aiua-5029	98	20	reduction	reduction	NOUN
aiua-5029	98	21	in	in	ADP
aiua-5029	98	22	the	the	DET
aiua-5029	98	23	size	size	NOUN
aiua-5029	98	24	of	of	ADP
aiua-5029	98	25	the	the	DET
aiua-5029	98	26	tumor	tumor	NOUN
aiua-5029	98	27	disease	disease	NOUN
aiua-5029	98	28	progression	progression	NOUN
aiua-5029	98	29	(	(	PUNCT
aiua-5029	98	30	dp	dp	NOUN
aiua-5029	98	31	)	)	PUNCT
aiua-5029	98	32	25	25	NUM
aiua-5029	98	33	%	%	NOUN
aiua-5029	98	34	or	or	CCONJ
aiua-5029	98	35	more	more	ADJ
aiua-5029	98	36	increase	increase	NOUN
aiua-5029	98	37	in	in	ADP
aiua-5029	98	38	the	the	DET
aiua-5029	98	39	size	size	NOUN
aiua-5029	98	40	of	of	ADP
aiua-5029	98	41	the	the	DET
aiua-5029	98	42	tumor	tumor	NOUN
aiua-5029	98	43	stable	stable	ADJ
aiua-5029	98	44	disease	disease	NOUN
aiua-5029	98	45	(	(	PUNCT
aiua-5029	98	46	sd	sd	NOUN
aiua-5029	98	47	)	)	PUNCT
aiua-5029	98	48	all	all	DET
aiua-5029	98	49	other	other	ADJ
aiua-5029	98	50	situations	situation	NOUN
aiua-5029	98	51	1	1	NUM
aiua-5029	98	52	20	20	NUM
aiua-5029	98	53	7	7	NUM
aiua-5029	98	54	2	2	NUM
aiua-5029	98	55	3.3	3.3	NUM
aiua-5029	98	56	%	%	NOUN
aiua-5029	98	57	67	67	NUM
aiua-5029	98	58	%	%	NOUN
aiua-5029	98	59	23	23	NUM
aiua-5029	98	60	%	%	NOUN
aiua-5029	98	61	6.7	6.7	NUM
aiua-5029	98	62	%	%	NOUN
aiua-5029	98	63	0	0	NUM
aiua-5029	98	64	14	14	NUM
aiua-5029	98	65	10	10	NUM
aiua-5029	98	66	6	6	NUM
aiua-5029	98	67	0	0	NUM
aiua-5029	98	68	%	%	NOUN
aiua-5029	98	69	47	47	NUM
aiua-5029	98	70	%	%	NOUN
aiua-5029	98	71	33	33	NUM
aiua-5029	98	72	%	%	NOUN
aiua-5029	98	73	20	20	NUM
aiua-5029	98	74	%	%	NOUN
aiua-5029	98	75	0.1	0.1	NUM
aiua-5029	98	76	0.1	0.1	NUM
aiua-5029	98	77	0.1	0.1	NUM
aiua-5029	98	78	0.03	0.03	NUM
aiua-5029	98	79	4	4	NUM
aiua-5029	98	80	17	17	NUM
aiua-5029	98	81	9	9	NUM
aiua-5029	98	82	13.3	13.3	NUM
aiua-5029	98	83	%	%	NOUN
aiua-5029	98	84	56.7	56.7	NUM
aiua-5029	98	85	%	%	NOUN
aiua-5029	98	86	30	30	NUM
aiua-5029	98	87	%	%	NOUN
aiua-5029	98	88	3	3	NUM
aiua-5029	98	89	15	15	NUM
aiua-5029	98	90	12	12	NUM
aiua-5029	98	91	10	10	NUM
aiua-5029	98	92	%	%	NOUN
aiua-5029	98	93	50	50	NUM
aiua-5029	98	94	%	%	NOUN
aiua-5029	98	95	40	40	NUM
aiua-5029	98	96	%	%	NOUN
aiua-5029	98	97	------3	------3	NOUN
aiua-5029	98	98	7	7	NUM
aiua-5029	98	99	20	20	NUM
aiua-5029	98	100	10	10	NUM
aiua-5029	98	101	%	%	NOUN
aiua-5029	98	102	23.3	23.3	NUM
aiua-5029	98	103	%	%	NOUN
aiua-5029	98	104	66.7	66.7	NUM
aiua-5029	98	105	%	%	NOUN
aiua-5029	98	106	2	2	NUM
aiua-5029	98	107	6	6	NUM
aiua-5029	98	108	22	22	NUM
aiua-5029	98	109	6.7	6.7	NUM
aiua-5029	98	110	%	%	NOUN
aiua-5029	98	111	20	20	NUM
aiua-5029	98	112	%	%	NOUN
aiua-5029	98	113	73.3	73.3	NUM
aiua-5029	98	114	%	%	NOUN
aiua-5029	98	115	------6	------6	NOUN
aiua-5029	98	116	18	18	NUM
aiua-5029	98	117	6	6	NUM
aiua-5029	98	118	20	20	NUM
aiua-5029	98	119	%	%	NOUN
aiua-5029	98	120	60	60	NUM
aiua-5029	98	121	%	%	NOUN
aiua-5029	98	122	20	20	NUM
aiua-5029	98	123	%	%	NOUN
aiua-5029	98	124	8	8	NUM
aiua-5029	98	125	18	18	NUM
aiua-5029	98	126	4	4	NUM
aiua-5029	98	127	26.7	26.7	NUM
aiua-5029	98	128	%	%	NOUN
aiua-5029	98	129	60	60	NUM
aiua-5029	98	130	%	%	NOUN
aiua-5029	98	131	13.3	13.3	NUM
aiua-5029	98	132	%	%	NOUN
aiua-5029	98	133	------28	------28	PROPN
aiua-5029	98	134	2	2	NUM
aiua-5029	98	135	93	93	NUM
aiua-5029	98	136	%	%	NOUN
aiua-5029	98	137	7	7	NUM
aiua-5029	98	138	%	%	NOUN
aiua-5029	98	139	29	29	NUM
aiua-5029	98	140	1	1	NUM
aiua-5029	98	141	96.7	96.7	NUM
aiua-5029	98	142	%	%	NOUN
aiua-5029	98	143	3.3	3.3	NUM
aiua-5029	98	144	%	%	NOUN
aiua-5029	98	145	----11	----11	PROPN
aiua-5029	98	146	17	17	NUM
aiua-5029	98	147	2	2	NUM
aiua-5029	98	148	36.3	36.3	NUM
aiua-5029	98	149	%	%	NOUN
aiua-5029	98	150	56.7	56.7	NUM
aiua-5029	98	151	%	%	NOUN
aiua-5029	98	152	7	7	NUM
aiua-5029	98	153	%	%	NOUN
aiua-5029	98	154	9	9	NUM
aiua-5029	98	155	16	16	NUM
aiua-5029	98	156	5	5	NUM
aiua-5029	98	157	30	30	NUM
aiua-5029	98	158	%	%	NOUN
aiua-5029	98	159	53.3	53.3	NUM
aiua-5029	98	160	%	%	NOUN
aiua-5029	98	161	16.7	16.7	NUM
aiua-5029	98	162	%	%	NOUN
aiua-5029	98	163	------osman_stesura	------osman_stesura	PRON
aiua-5029	98	164	seveso	seveso	VERB
aiua-5029	98	165	22/01/15	22/01/15	NUM
aiua-5029	98	166	10:20	10:20	NUM
aiua-5029	98	167	pagina	pagina	NOUN
aiua-5029	98	168	280	280	NUM
aiua-5029	98	169	281archivio	281archivio	PROPN
aiua-5029	98	170	italiano	italiano	NOUN
aiua-5029	98	171	di	di	NOUN
aiua-5029	98	172	urologia	urologia	PROPN
aiua-5029	98	173	e	e	PROPN
aiua-5029	98	174	andrologia	andrologia	NOUN
aiua-5029	98	175	2014	2014	NUM
aiua-5029	98	176	;	;	PUNCT
aiua-5029	98	177	86	86	NUM
aiua-5029	98	178	,	,	PUNCT
aiua-5029	98	179	4	4	NUM
aiua-5029	98	180	nact	nact	VERB
aiua-5029	98	181	versus	versus	ADP
aiua-5029	98	182	cystectomy	cystectomy	NOUN
aiua-5029	98	183	in	in	ADP
aiua-5029	98	184	bladder	bladder	NOUN
aiua-5029	98	185	cancer	cancer	NOUN
aiua-5029	98	186	neous	neous	PROPN
aiua-5029	98	187	reservoir	reservoir	NOUN
aiua-5029	98	188	,	,	PUNCT
aiua-5029	98	189	and	and	CCONJ
aiua-5029	98	190	1	1	NUM
aiua-5029	98	191	had	have	VERB
aiua-5029	98	192	cutaneous	cutaneous	ADJ
aiua-5029	98	193	urinary	urinary	ADJ
aiua-5029	98	194	diversion	diversion	NOUN
aiua-5029	98	195	.	.	PUNCT
aiua-5029	99	1	surgery	surgery	NOUN
aiua-5029	99	2	was	be	AUX
aiua-5029	99	3	done	do	VERB
aiua-5029	99	4	at	at	ADP
aiua-5029	99	5	mean	mean	NOUN
aiua-5029	99	6	of	of	ADP
aiua-5029	99	7	3	3	NUM
aiua-5029	99	8	weeks	week	NOUN
aiua-5029	99	9	after	after	ADP
aiua-5029	99	10	diagnosis	diagnosis	NOUN
aiua-5029	99	11	(	(	PUNCT
aiua-5029	99	12	range	range	NOUN
aiua-5029	99	13	17	17	NUM
aiua-5029	99	14	-	-	SYM
aiua-5029	99	15	30	30	NUM
aiua-5029	99	16	days	day	NOUN
aiua-5029	99	17	)	)	PUNCT
aiua-5029	99	18	.	.	PUNCT
aiua-5029	100	1	the	the	DET
aiua-5029	100	2	mean	mean	ADJ
aiua-5029	100	3	admission	admission	NOUN
aiua-5029	100	4	time	time	NOUN
aiua-5029	100	5	for	for	ADP
aiua-5029	100	6	surgery	surgery	NOUN
aiua-5029	100	7	was	be	AUX
aiua-5029	100	8	7	7	NUM
aiua-5029	100	9	days	day	NOUN
aiua-5029	100	10	(	(	PUNCT
aiua-5029	100	11	range	range	NOUN
aiua-5029	100	12	6	6	NUM
aiua-5029	100	13	-	-	SYM
aiua-5029	100	14	10	10	NUM
aiua-5029	100	15	days	day	NOUN
aiua-5029	100	16	)	)	PUNCT
aiua-5029	100	17	.	.	PUNCT
aiua-5029	101	1	the	the	DET
aiua-5029	101	2	average	average	ADJ
aiua-5029	101	3	blood	blood	NOUN
aiua-5029	101	4	loss	loss	NOUN
aiua-5029	101	5	was	be	AUX
aiua-5029	101	6	850	850	NUM
aiua-5029	101	7	ml	ml	NOUN
aiua-5029	101	8	(	(	PUNCT
aiua-5029	101	9	range	range	NOUN
aiua-5029	101	10	4502000	4502000	NUM
aiua-5029	101	11	ml	ml	NOUN
aiua-5029	101	12	)	)	PUNCT
aiua-5029	101	13	.	.	PUNCT
aiua-5029	102	1	pathological	pathological	ADJ
aiua-5029	102	2	evaluation	evaluation	NOUN
aiua-5029	102	3	was	be	AUX
aiua-5029	102	4	done	do	VERB
aiua-5029	102	5	in	in	ADP
aiua-5029	102	6	all	all	DET
aiua-5029	102	7	the	the	DET
aiua-5029	102	8	30	30	NUM
aiua-5029	102	9	patients	patient	NOUN
aiua-5029	102	10	.	.	PUNCT
aiua-5029	103	1	r0	r0	NOUN
aiua-5029	103	2	was	be	AUX
aiua-5029	103	3	achieved	achieve	VERB
aiua-5029	103	4	in	in	ADP
aiua-5029	103	5	26	26	NUM
aiua-5029	103	6	patients	patient	NOUN
aiua-5029	103	7	.	.	PUNCT
aiua-5029	104	1	the	the	DET
aiua-5029	104	2	remaining	remain	VERB
aiua-5029	104	3	4	4	NUM
aiua-5029	104	4	had	have	VERB
aiua-5029	104	5	r1	r1	NOUN
aiua-5029	104	6	disease	disease	NOUN
aiua-5029	104	7	.	.	PUNCT
aiua-5029	105	1	pathological	pathological	ADJ
aiua-5029	105	2	staging	staging	NOUN
aiua-5029	105	3	was	be	AUX
aiua-5029	105	4	pt2	pt2	NOUN
aiua-5029	105	5	,	,	PUNCT
aiua-5029	105	6	pt3	pt3	NOUN
aiua-5029	105	7	,	,	PUNCT
aiua-5029	105	8	and	and	CCONJ
aiua-5029	105	9	pt4a	pt4a	NOUN
aiua-5029	105	10	in	in	ADP
aiua-5029	105	11	7	7	NUM
aiua-5029	105	12	,	,	PUNCT
aiua-5029	105	13	18	18	NUM
aiua-5029	105	14	,	,	PUNCT
aiua-5029	105	15	and	and	CCONJ
aiua-5029	105	16	5	5	NUM
aiua-5029	105	17	patients	patient	NOUN
aiua-5029	105	18	respectively	respectively	ADV
aiua-5029	105	19	.	.	PUNCT
aiua-5029	106	1	the	the	DET
aiua-5029	106	2	mean	mean	ADJ
aiua-5029	106	3	number	number	NOUN
aiua-5029	106	4	of	of	ADP
aiua-5029	106	5	dissected	dissect	VERB
aiua-5029	106	6	pelvic	pelvic	ADJ
aiua-5029	106	7	lymph	lymph	NOUN
aiua-5029	106	8	nodes	node	NOUN
aiua-5029	106	9	was	be	AUX
aiua-5029	106	10	13	13	NUM
aiua-5029	106	11	and	and	CCONJ
aiua-5029	106	12	6	6	NUM
aiua-5029	106	13	patients	patient	NOUN
aiua-5029	106	14	had	have	VERB
aiua-5029	106	15	positive	positive	ADJ
aiua-5029	106	16	lymph	lymph	NOUN
aiua-5029	106	17	node	node	NOUN
aiua-5029	106	18	biopsies	biopsy	NOUN
aiua-5029	106	19	.	.	PUNCT
aiua-5029	107	1	adjuvant	adjuvant	ADJ
aiua-5029	107	2	chemotherapy	chemotherapy	NOUN
aiua-5029	107	3	was	be	AUX
aiua-5029	107	4	given	give	VERB
aiua-5029	107	5	to	to	ADP
aiua-5029	107	6	4	4	NUM
aiua-5029	107	7	patients	patient	NOUN
aiua-5029	107	8	from	from	ADP
aiua-5029	107	9	arm	arm	NOUN
aiua-5029	107	10	a	a	PRON
aiua-5029	107	11	for	for	ADP
aiua-5029	107	12	positive	positive	ADJ
aiua-5029	107	13	lymph	lymph	NOUN
aiua-5029	107	14	node	node	NOUN
aiua-5029	107	15	in	in	ADP
aiua-5029	107	16	the	the	DET
aiua-5029	107	17	form	form	NOUN
aiua-5029	107	18	of	of	ADP
aiua-5029	107	19	cisplatin	cisplatin	NOUN
aiua-5029	107	20	and	and	CCONJ
aiua-5029	107	21	gemcitabine	gemcitabine	NOUN
aiua-5029	107	22	for	for	ADP
aiua-5029	107	23	3	3	NUM
aiua-5029	107	24	cycles	cycle	NOUN
aiua-5029	107	25	.	.	PUNCT
aiua-5029	108	1	additionally	additionally	ADV
aiua-5029	108	2	,	,	PUNCT
aiua-5029	108	3	13	13	NUM
aiua-5029	108	4	patients	patient	NOUN
aiua-5029	108	5	from	from	ADP
aiua-5029	108	6	arm	arm	PROPN
aiua-5029	108	7	b	b	PROPN
aiua-5029	108	8	received	receive	VERB
aiua-5029	108	9	adjuvant	adjuvant	ADJ
aiua-5029	108	10	chemotherapy	chemotherapy	NOUN
aiua-5029	108	11	(	(	PUNCT
aiua-5029	108	12	6	6	NUM
aiua-5029	108	13	positive	positive	ADJ
aiua-5029	108	14	lymph	lymph	NOUN
aiua-5029	108	15	nodes	node	NOUN
aiua-5029	108	16	,	,	PUNCT
aiua-5029	108	17	2	2	NUM
aiua-5029	108	18	r1	r1	NOUN
aiua-5029	108	19	,	,	PUNCT
aiua-5029	108	20	and	and	CCONJ
aiua-5029	108	21	5	5	NUM
aiua-5029	108	22	pt4a	pt4a	NOUN
aiua-5029	108	23	)	)	PUNCT
aiua-5029	108	24	in	in	ADP
aiua-5029	108	25	the	the	DET
aiua-5029	108	26	form	form	NOUN
aiua-5029	108	27	of	of	ADP
aiua-5029	108	28	either	either	CCONJ
aiua-5029	108	29	cisplatin	cisplatin	NOUN
aiua-5029	108	30	and	and	CCONJ
aiua-5029	108	31	gemcitabine	gemcitabine	NOUN
aiua-5029	108	32	,	,	PUNCT
aiua-5029	108	33	or	or	CCONJ
aiua-5029	108	34	carboplatin	carboplatin	NOUN
aiua-5029	108	35	and	and	CCONJ
aiua-5029	108	36	gemcitabine	gemcitabine	NOUN
aiua-5029	108	37	.	.	PUNCT
aiua-5029	109	1	(	(	PUNCT
aiua-5029	109	2	6	6	NUM
aiua-5029	109	3	,	,	PUNCT
aiua-5029	109	4	and	and	CCONJ
aiua-5029	109	5	7	7	NUM
aiua-5029	109	6	patients	patient	NOUN
aiua-5029	109	7	respectively	respectively	ADV
aiua-5029	109	8	)	)	PUNCT
aiua-5029	109	9	,	,	PUNCT
aiua-5029	109	10	for	for	ADP
aiua-5029	109	11	a	a	DET
aiua-5029	109	12	mean	mean	NOUN
aiua-5029	109	13	of	of	ADP
aiua-5029	109	14	4	4	NUM
aiua-5029	109	15	cycles	cycle	NOUN
aiua-5029	109	16	(	(	PUNCT
aiua-5029	109	17	range	range	NOUN
aiua-5029	109	18	3	3	NUM
aiua-5029	109	19	-	-	SYM
aiua-5029	109	20	6	6	NUM
aiua-5029	109	21	)	)	PUNCT
aiua-5029	109	22	.	.	PUNCT
aiua-5029	110	1	survival	survival	PROPN
aiua-5029	110	2	data	data	VERB
aiua-5029	110	3	the	the	DET
aiua-5029	110	4	3	3	NUM
aiua-5029	110	5	year	year	NOUN
aiua-5029	110	6	os	os	NOUN
aiua-5029	110	7	for	for	ADP
aiua-5029	110	8	arm	arm	NOUN
aiua-5029	110	9	a	a	PRON
aiua-5029	110	10	,	,	PUNCT
aiua-5029	110	11	and	and	CCONJ
aiua-5029	110	12	arm	arm	PROPN
aiua-5029	110	13	b	b	PROPN
aiua-5029	110	14	were	be	AUX
aiua-5029	110	15	60	60	NUM
aiua-5029	110	16	%	%	NOUN
aiua-5029	110	17	,	,	PUNCT
aiua-5029	110	18	50	50	NUM
aiua-5029	110	19	%	%	NOUN
aiua-5029	110	20	respectively	respectively	ADV
aiua-5029	110	21	(	(	PUNCT
aiua-5029	110	22	figure	figure	NOUN
aiua-5029	110	23	1	1	NUM
aiua-5029	110	24	)	)	PUNCT
aiua-5029	110	25	.	.	PUNCT
aiua-5029	111	1	the	the	DET
aiua-5029	111	2	median	median	PROPN
aiua-5029	111	3	os	os	NOUN
aiua-5029	111	4	for	for	ADP
aiua-5029	111	5	arm	arm	NOUN
aiua-5029	111	6	a	a	PRON
aiua-5029	111	7	was	be	AUX
aiua-5029	111	8	36	36	NUM
aiua-5029	111	9	+	+	NUM
aiua-5029	111	10	months	month	NOUN
aiua-5029	111	11	and	and	CCONJ
aiua-5029	111	12	that	that	SCONJ
aiua-5029	111	13	for	for	ADP
aiua-5029	111	14	arm	arm	PROPN
aiua-5029	111	15	b	b	PROPN
aiua-5029	111	16	was	be	AUX
aiua-5029	111	17	32.5	32.5	NUM
aiua-5029	111	18	months	month	NOUN
aiua-5029	111	19	.	.	PUNCT
aiua-5029	112	1	the	the	DET
aiua-5029	112	2	3	3	NUM
aiua-5029	112	3	year	year	NOUN
aiua-5029	112	4	pfs	pfs	PROPN
aiua-5029	112	5	for	for	ADP
aiua-5029	112	6	arm	arm	NOUN
aiua-5029	112	7	a	a	PRON
aiua-5029	112	8	and	and	CCONJ
aiua-5029	112	9	b	b	NOUN
aiua-5029	112	10	were	be	AUX
aiua-5029	112	11	57	57	NUM
aiua-5029	112	12	%	%	NOUN
aiua-5029	112	13	and	and	CCONJ
aiua-5029	112	14	43	43	NUM
aiua-5029	112	15	%	%	NOUN
aiua-5029	112	16	respectively	respectively	ADV
aiua-5029	112	17	(	(	PUNCT
aiua-5029	112	18	figure	figure	NOUN
aiua-5029	112	19	2	2	NUM
aiua-5029	112	20	)	)	PUNCT
aiua-5029	112	21	.	.	PUNCT
aiua-5029	113	1	the	the	DET
aiua-5029	113	2	median	median	PROPN
aiua-5029	113	3	pfs	pfs	PROPN
aiua-5029	113	4	for	for	ADP
aiua-5029	113	5	arm	arm	NOUN
aiua-5029	113	6	a	a	PRON
aiua-5029	113	7	was	be	AUX
aiua-5029	113	8	36	36	NUM
aiua-5029	113	9	+	+	NUM
aiua-5029	113	10	months	month	NOUN
aiua-5029	113	11	and	and	CCONJ
aiua-5029	113	12	that	that	SCONJ
aiua-5029	113	13	for	for	ADP
aiua-5029	113	14	arm	arm	PROPN
aiua-5029	113	15	b	b	PROPN
aiua-5029	113	16	was	be	AUX
aiua-5029	113	17	28	28	NUM
aiua-5029	113	18	months	month	NOUN
aiua-5029	113	19	.	.	PUNCT
aiua-5029	114	1	during	during	ADP
aiua-5029	114	2	the	the	DET
aiua-5029	114	3	36	36	NUM
aiua-5029	114	4	months	month	NOUN
aiua-5029	114	5	follow	follow	VERB
aiua-5029	114	6	-	-	PUNCT
aiua-5029	114	7	up	up	NOUN
aiua-5029	114	8	period	period	NOUN
aiua-5029	114	9	,	,	PUNCT
aiua-5029	114	10	11	11	NUM
aiua-5029	114	11	patients	patient	NOUN
aiua-5029	114	12	died	die	VERB
aiua-5029	114	13	from	from	ADP
aiua-5029	114	14	arm	arm	NOUN
aiua-5029	114	15	a	a	DET
aiua-5029	114	16	(	(	PUNCT
aiua-5029	114	17	9	9	NUM
aiua-5029	114	18	bladder	bladder	NOUN
aiua-5029	114	19	cancer	cancer	NOUN
aiua-5029	114	20	relapses	relapse	NOUN
aiua-5029	114	21	,	,	PUNCT
aiua-5029	114	22	1	1	NUM
aiua-5029	114	23	cardiovascular	cardiovascular	ADJ
aiua-5029	114	24	cause	cause	NOUN
aiua-5029	114	25	,	,	PUNCT
aiua-5029	114	26	and	and	CCONJ
aiua-5029	114	27	1	1	NUM
aiua-5029	114	28	unknown	unknown	ADJ
aiua-5029	114	29	cause	cause	NOUN
aiua-5029	114	30	)	)	PUNCT
aiua-5029	114	31	.	.	PUNCT
aiua-5029	115	1	for	for	ADP
aiua-5029	115	2	arm	arm	NOUN
aiua-5029	115	3	b	b	PROPN
aiua-5029	115	4	,	,	PUNCT
aiua-5029	115	5	15	15	NUM
aiua-5029	115	6	patients	patient	NOUN
aiua-5029	115	7	died	die	VERB
aiua-5029	115	8	(	(	PUNCT
aiua-5029	115	9	12	12	NUM
aiua-5029	115	10	bladder	bladder	NOUN
aiua-5029	115	11	cancer	cancer	NOUN
aiua-5029	115	12	relapses	relapse	NOUN
aiua-5029	115	13	,	,	PUNCT
aiua-5029	115	14	2	2	NUM
aiua-5029	115	15	pulmonary	pulmonary	NOUN
aiua-5029	115	16	embolism	embolism	NOUN
aiua-5029	115	17	,	,	PUNCT
aiua-5029	115	18	and	and	CCONJ
aiua-5029	115	19	1	1	NUM
aiua-5029	115	20	unknown	unknown	ADJ
aiua-5029	115	21	cause	cause	NOUN
aiua-5029	115	22	)	)	PUNCT
aiua-5029	115	23	.	.	PUNCT
aiua-5029	116	1	during	during	ADP
aiua-5029	116	2	the	the	DET
aiua-5029	116	3	36	36	NUM
aiua-5029	116	4	months	month	NOUN
aiua-5029	116	5	follow	follow	VERB
aiua-5029	116	6	-	-	PUNCT
aiua-5029	116	7	up	up	NOUN
aiua-5029	116	8	period	period	NOUN
aiua-5029	116	9	,	,	PUNCT
aiua-5029	116	10	12	12	NUM
aiua-5029	116	11	patients	patient	NOUN
aiua-5029	116	12	from	from	ADP
aiua-5029	116	13	arm	arm	NOUN
aiua-5029	116	14	a	a	PRON
aiua-5029	116	15	relapsed	relapse	VERB
aiua-5029	116	16	,	,	PUNCT
aiua-5029	116	17	(	(	PUNCT
aiua-5029	116	18	9	9	NUM
aiua-5029	116	19	locoregional	locoregional	ADJ
aiua-5029	116	20	,	,	PUNCT
aiua-5029	116	21	and	and	CCONJ
aiua-5029	116	22	3	3	NUM
aiua-5029	116	23	metastatic	metastatic	NOUN
aiua-5029	116	24	)	)	PUNCT
aiua-5029	116	25	,	,	PUNCT
aiua-5029	116	26	and	and	CCONJ
aiua-5029	116	27	17	17	NUM
aiua-5029	116	28	relapsed	relapse	VERB
aiua-5029	116	29	from	from	ADP
aiua-5029	116	30	arm	arm	PROPN
aiua-5029	116	31	b	b	PROPN
aiua-5029	116	32	(	(	PUNCT
aiua-5029	116	33	11	11	NUM
aiua-5029	116	34	locoregional	locoregional	ADJ
aiua-5029	116	35	and	and	CCONJ
aiua-5029	116	36	6	6	NUM
aiua-5029	116	37	metastatic	metastatic	ADJ
aiua-5029	116	38	)	)	PUNCT
aiua-5029	116	39	.	.	PUNCT
aiua-5029	117	1	for	for	ADP
aiua-5029	117	2	subgroup	subgroup	NOUN
aiua-5029	117	3	analysis	analysis	NOUN
aiua-5029	117	4	,	,	PUNCT
aiua-5029	117	5	the	the	DET
aiua-5029	117	6	3	3	NUM
aiua-5029	117	7	year	year	NOUN
aiua-5029	117	8	os	os	NOUN
aiua-5029	117	9	for	for	ADP
aiua-5029	117	10	arm	arm	NOUN
aiua-5029	117	11	a	a	DET
aiua-5029	117	12	patients	patient	NOUN
aiua-5029	117	13	who	who	PRON
aiua-5029	117	14	were	be	AUX
aiua-5029	117	15	<	<	X
aiua-5029	117	16	60	60	NUM
aiua-5029	117	17	y.o	y.o	NOUN
aiua-5029	117	18	was	be	AUX
aiua-5029	117	19	64	64	NUM
aiua-5029	117	20	%	%	NOUN
aiua-5029	117	21	,	,	PUNCT
aiua-5029	117	22	and	and	CCONJ
aiua-5029	117	23	for	for	ADP
aiua-5029	117	24	those	those	DET
aiua-5029	117	25	>	>	SYM
aiua-5029	117	26	60	60	NUM
aiua-5029	117	27	years	year	NOUN
aiua-5029	117	28	was	be	AUX
aiua-5029	117	29	50	50	NUM
aiua-5029	117	30	%	%	NOUN
aiua-5029	117	31	.	.	PUNCT
aiua-5029	118	1	the	the	DET
aiua-5029	118	2	3	3	NUM
aiua-5029	118	3	year	year	NOUN
aiua-5029	118	4	os	os	NOUN
aiua-5029	118	5	for	for	ADP
aiua-5029	118	6	arm	arm	NOUN
aiua-5029	118	7	b	b	PROPN
aiua-5029	118	8	patients	patient	NOUN
aiua-5029	118	9	who	who	PRON
aiua-5029	118	10	were	be	AUX
aiua-5029	118	11	<	<	X
aiua-5029	118	12	60	60	NUM
aiua-5029	118	13	y.o	y.o	NOUN
aiua-5029	118	14	was	be	AUX
aiua-5029	118	15	54	54	NUM
aiua-5029	118	16	%	%	NOUN
aiua-5029	118	17	,	,	PUNCT
aiua-5029	118	18	and	and	CCONJ
aiua-5029	118	19	for	for	ADP
aiua-5029	118	20	those	those	DET
aiua-5029	118	21	>	>	SYM
aiua-5029	118	22	60	60	NUM
aiua-5029	118	23	years	year	NOUN
aiua-5029	118	24	was	be	AUX
aiua-5029	118	25	17	17	NUM
aiua-5029	118	26	%	%	NOUN
aiua-5029	118	27	.	.	PUNCT
aiua-5029	119	1	(	(	PUNCT
aiua-5029	119	2	p	p	NOUN
aiua-5029	119	3	value	value	NOUN
aiua-5029	119	4	0.02	0.02	NUM
aiua-5029	119	5	,	,	PUNCT
aiua-5029	119	6	chi	chi	PROPN
aiua-5029	119	7	square	square	ADJ
aiua-5029	119	8	5.5	5.5	NUM
aiua-5029	119	9	)	)	PUNCT
aiua-5029	119	10	.	.	PUNCT
aiua-5029	120	1	the	the	DET
aiua-5029	120	2	3	3	NUM
aiua-5029	120	3	year	year	NOUN
aiua-5029	120	4	os	os	NOUN
aiua-5029	120	5	for	for	ADP
aiua-5029	120	6	arm	arm	NOUN
aiua-5029	120	7	a	a	DET
aiua-5029	120	8	t2	t2	NOUN
aiua-5029	120	9	patients	patient	NOUN
aiua-5029	120	10	was	be	AUX
aiua-5029	120	11	83	83	NUM
aiua-5029	120	12	%	%	NOUN
aiua-5029	120	13	,	,	PUNCT
aiua-5029	120	14	and	and	CCONJ
aiua-5029	120	15	for	for	ADP
aiua-5029	120	16	t3	t3	PROPN
aiua-5029	120	17	-	-	PUNCT
aiua-5029	120	18	t4a	t4a	ADJ
aiua-5029	120	19	patients	patient	NOUN
aiua-5029	120	20	was	be	AUX
aiua-5029	120	21	54.5	54.5	NUM
aiua-5029	120	22	%	%	NOUN
aiua-5029	120	23	.	.	PUNCT
aiua-5029	121	1	the	the	DET
aiua-5029	121	2	3	3	NUM
aiua-5029	121	3	year	year	NOUN
aiua-5029	121	4	os	os	NOUN
aiua-5029	121	5	for	for	ADP
aiua-5029	121	6	arm	arm	PROPN
aiua-5029	121	7	b	b	PROPN
aiua-5029	121	8	t2	t2	NOUN
aiua-5029	121	9	patients	patient	NOUN
aiua-5029	121	10	was	be	AUX
aiua-5029	121	11	75	75	NUM
aiua-5029	121	12	%	%	NOUN
aiua-5029	121	13	,	,	PUNCT
aiua-5029	121	14	and	and	CCONJ
aiua-5029	121	15	those	those	PRON
aiua-5029	121	16	with	with	ADP
aiua-5029	121	17	t3	t3	NOUN
aiua-5029	121	18	-	-	PUNCT
aiua-5029	121	19	t4a	t4a	PROPN
aiua-5029	121	20	was	be	AUX
aiua-5029	121	21	41	41	NUM
aiua-5029	121	22	%	%	NOUN
aiua-5029	121	23	(	(	PUNCT
aiua-5029	121	24	p	p	NOUN
aiua-5029	121	25	value	value	NOUN
aiua-5029	121	26	0.01	0.01	NUM
aiua-5029	121	27	,	,	PUNCT
aiua-5029	121	28	chi	chi	PROPN
aiua-5029	121	29	square	square	PROPN
aiua-5029	121	30	5.7	5.7	NUM
aiua-5029	121	31	)	)	PUNCT
aiua-5029	121	32	.	.	PUNCT
aiua-5029	122	1	the	the	DET
aiua-5029	122	2	3	3	NUM
aiua-5029	122	3	year	year	NOUN
aiua-5029	122	4	os	os	NOUN
aiua-5029	122	5	for	for	ADP
aiua-5029	122	6	arm	arm	NOUN
aiua-5029	122	7	a	a	DET
aiua-5029	122	8	patients	patient	NOUN
aiua-5029	122	9	who	who	PRON
aiua-5029	122	10	have	have	VERB
aiua-5029	122	11	tumors	tumor	NOUN
aiua-5029	122	12	<	<	X
aiua-5029	122	13	4	4	NUM
aiua-5029	122	14	cm	cm	NOUN
aiua-5029	122	15	was	be	AUX
aiua-5029	122	16	70	70	NUM
aiua-5029	122	17	%	%	NOUN
aiua-5029	122	18	,	,	PUNCT
aiua-5029	122	19	and	and	CCONJ
aiua-5029	122	20	for	for	ADP
aiua-5029	122	21	those	those	PRON
aiua-5029	122	22	>	>	SYM
aiua-5029	122	23	4	4	NUM
aiua-5029	122	24	cm	cm	NOUN
aiua-5029	122	25	was	be	AUX
aiua-5029	122	26	37.5	37.5	NUM
aiua-5029	122	27	%	%	NOUN
aiua-5029	122	28	.	.	PUNCT
aiua-5029	123	1	the	the	DET
aiua-5029	123	2	3	3	NUM
aiua-5029	123	3	year	year	NOUN
aiua-5029	123	4	os	os	NOUN
aiua-5029	123	5	for	for	ADP
aiua-5029	123	6	arm	arm	NOUN
aiua-5029	123	7	b	b	PROPN
aiua-5029	123	8	patients	patient	NOUN
aiua-5029	123	9	who	who	PRON
aiua-5029	123	10	figure	figure	VERB
aiua-5029	123	11	1	1	NUM
aiua-5029	123	12	.	.	PUNCT
aiua-5029	124	1	the	the	DET
aiua-5029	124	2	3	3	NUM
aiua-5029	124	3	year	year	NOUN
aiua-5029	124	4	os	os	NOUN
aiua-5029	124	5	for	for	ADP
aiua-5029	124	6	the	the	DET
aiua-5029	124	7	study	study	NOUN
aiua-5029	124	8	groups	group	NOUN
aiua-5029	124	9	p	p	NOUN
aiua-5029	124	10	value	value	NOUN
aiua-5029	124	11	=	=	NOUN
aiua-5029	124	12	0.05	0.05	NUM
aiua-5029	124	13	,	,	PUNCT
aiua-5029	124	14	chi	chi	NOUN
aiua-5029	124	15	square	square	NOUN
aiua-5029	124	16	=	=	NOUN
aiua-5029	124	17	3.66	3.66	X
aiua-5029	124	18	.	.	PUNCT
aiua-5029	124	19	figure	figure	NOUN
aiua-5029	124	20	3	3	NUM
aiua-5029	124	21	.	.	PUNCT
aiua-5029	125	1	the	the	DET
aiua-5029	125	2	kaplan	kaplan	PROPN
aiua-5029	125	3	-	-	PUNCT
aiua-5029	125	4	meier	meier	PROPN
aiua-5029	125	5	survival	survival	PROPN
aiua-5029	125	6	curve	curve	NOUN
aiua-5029	125	7	for	for	ADP
aiua-5029	125	8	arm	arm	NOUN
aiua-5029	125	9	a	a	DET
aiua-5029	125	10	patients	patient	NOUN
aiua-5029	125	11	grouped	group	VERB
aiua-5029	125	12	by	by	ADP
aiua-5029	125	13	their	their	PRON
aiua-5029	125	14	pathological	pathological	ADJ
aiua-5029	125	15	response	response	NOUN
aiua-5029	125	16	to	to	ADP
aiua-5029	125	17	neoadjuvant	neoadjuvant	ADJ
aiua-5029	125	18	chemotherapy	chemotherapy	NOUN
aiua-5029	125	19	.	.	PUNCT
aiua-5029	126	1	p	p	NOUN
aiua-5029	126	2	value	value	NOUN
aiua-5029	126	3	=	=	NOUN
aiua-5029	126	4	0.3	0.3	NUM
aiua-5029	126	5	.	.	PUNCT
aiua-5029	127	1	figure	figure	NOUN
aiua-5029	127	2	2	2	NUM
aiua-5029	127	3	.	.	PUNCT
aiua-5029	128	1	the	the	DET
aiua-5029	128	2	3	3	NUM
aiua-5029	128	3	year	year	NOUN
aiua-5029	128	4	pfs	pf	NOUN
aiua-5029	128	5	for	for	ADP
aiua-5029	128	6	the	the	DET
aiua-5029	128	7	study	study	NOUN
aiua-5029	128	8	groups	group	NOUN
aiua-5029	128	9	p	p	NOUN
aiua-5029	128	10	value	value	NOUN
aiua-5029	128	11	=	=	NOUN
aiua-5029	128	12	0.02	0.02	NUM
aiua-5029	128	13	,	,	PUNCT
aiua-5029	128	14	chi	chi	NOUN
aiua-5029	128	15	square	square	NOUN
aiua-5029	128	16	=	=	NOUN
aiua-5029	128	17	4.88	4.88	NUM
aiua-5029	128	18	.	.	PUNCT
aiua-5029	129	1	arm	arm	VERB
aiua-5029	129	2	a	a	DET
aiua-5029	129	3	(	(	PUNCT
aiua-5029	129	4	%	%	NOUN
aiua-5029	129	5	)	)	PUNCT
aiua-5029	130	1	arm	arm	NOUN
aiua-5029	130	2	b	b	PROPN
aiua-5029	130	3	(	(	PUNCT
aiua-5029	130	4	%	%	NOUN
aiua-5029	130	5	)	)	PUNCT
aiua-5029	130	6	p	p	NOUN
aiua-5029	130	7	value	value	NOUN
aiua-5029	130	8	hazard	hazard	NOUN
aiua-5029	130	9	ratio	ratio	NOUN
aiua-5029	130	10	1	1	NUM
aiua-5029	130	11	.	.	PUNCT
aiua-5029	131	1	age	age	NOUN
aiua-5029	131	2	<	<	X
aiua-5029	131	3	60	60	NUM
aiua-5029	131	4	years	year	NOUN
aiua-5029	131	5	old	old	ADJ
aiua-5029	131	6	64	64	NUM
aiua-5029	131	7	54	54	NUM
aiua-5029	131	8	0.02	0.02	NUM
aiua-5029	131	9	1.8	1.8	NUM
aiua-5029	131	10	>	>	SYM
aiua-5029	131	11	60	60	NUM
aiua-5029	131	12	years	year	NOUN
aiua-5029	131	13	old	old	ADJ
aiua-5029	131	14	50	50	NUM
aiua-5029	131	15	17	17	NUM
aiua-5029	131	16	0.2	0.2	NUM
aiua-5029	131	17	1.1	1.1	NUM
aiua-5029	131	18	2	2	NUM
aiua-5029	131	19	.	.	PUNCT
aiua-5029	132	1	pathological	pathological	ADJ
aiua-5029	132	2	stage	stage	NOUN
aiua-5029	132	3	pt2	pt2	NOUN
aiua-5029	132	4	83	83	NUM
aiua-5029	132	5	75	75	NUM
aiua-5029	132	6	0.05	0.05	NUM
aiua-5029	132	7	1.6	1.6	NUM
aiua-5029	132	8	pt3	pt3	NOUN
aiua-5029	132	9	-	-	PUNCT
aiua-5029	132	10	t4a	t4a	PROPN
aiua-5029	132	11	54.5	54.5	NUM
aiua-5029	132	12	41	41	NUM
aiua-5029	132	13	0.08	0.08	NUM
aiua-5029	132	14	1.55	1.55	NUM
aiua-5029	132	15	3	3	NUM
aiua-5029	132	16	.	.	PUNCT
aiua-5029	132	17	tumor	tumor	NOUN
aiua-5029	132	18	size	size	NOUN
aiua-5029	132	19	<	<	X
aiua-5029	132	20	4	4	NUM
aiua-5029	132	21	cm	cm	NUM
aiua-5029	132	22	70	70	NUM
aiua-5029	132	23	61	61	NUM
aiua-5029	132	24	0.1	0.1	NUM
aiua-5029	132	25	2.0	2.0	NUM
aiua-5029	132	26	>	>	SYM
aiua-5029	132	27	4	4	NUM
aiua-5029	132	28	cm	cm	NOUN
aiua-5029	132	29	37.5	37.5	NUM
aiua-5029	132	30	33	33	NUM
aiua-5029	132	31	0.09	0.09	NUM
aiua-5029	132	32	1.2	1.2	NUM
aiua-5029	132	33	table	table	NOUN
aiua-5029	132	34	5	5	NUM
aiua-5029	132	35	.	.	PUNCT
aiua-5029	133	1	the	the	DET
aiua-5029	133	2	3	3	NUM
aiua-5029	133	3	year	year	NOUN
aiua-5029	133	4	os	os	NOUN
aiua-5029	133	5	for	for	ADP
aiua-5029	133	6	each	each	DET
aiua-5029	133	7	treatment	treatment	NOUN
aiua-5029	133	8	arm	arm	NOUN
aiua-5029	133	9	categorized	categorize	VERB
aiua-5029	133	10	by	by	ADP
aiua-5029	133	11	the	the	DET
aiua-5029	133	12	prognostic	prognostic	ADJ
aiua-5029	133	13	factors	factor	NOUN
aiua-5029	133	14	.	.	PUNCT
aiua-5029	134	1	osman_stesura	osman_stesura	NOUN
aiua-5029	134	2	seveso	seveso	VERB
aiua-5029	134	3	22/01/15	22/01/15	PROPN
aiua-5029	134	4	09:58	09:58	NUM
aiua-5029	134	5	pagina	pagina	NOUN
aiua-5029	134	6	281	281	NUM
aiua-5029	134	7	archivio	archivio	NOUN
aiua-5029	134	8	italiano	italiano	X
aiua-5029	134	9	di	di	X
aiua-5029	134	10	urologia	urologia	PROPN
aiua-5029	134	11	e	e	PROPN
aiua-5029	134	12	andrologia	andrologia	NOUN
aiua-5029	134	13	2014	2014	NUM
aiua-5029	134	14	;	;	PUNCT
aiua-5029	134	15	86	86	NUM
aiua-5029	134	16	,	,	PUNCT
aiua-5029	134	17	4	4	NUM
aiua-5029	134	18	m.a	m.a	NOUN
aiua-5029	134	19	osman	osman	PROPN
aiua-5029	134	20	,	,	PUNCT
aiua-5029	134	21	a.m.	a.m.	PROPN
aiua-5029	134	22	gabr	gabr	NOUN
aiua-5029	134	23	,	,	PUNCT
aiua-5029	134	24	m.s	m.s	PROPN
aiua-5029	134	25	.	.	PROPN
aiua-5029	134	26	elkady	elkady	PROPN
aiua-5029	134	27	282	282	NUM
aiua-5029	134	28	have	have	VERB
aiua-5029	134	29	tumors	tumor	NOUN
aiua-5029	134	30	<	<	X
aiua-5029	134	31	4	4	NUM
aiua-5029	134	32	cm	cm	NOUN
aiua-5029	134	33	was	be	AUX
aiua-5029	134	34	61	61	NUM
aiua-5029	134	35	%	%	NOUN
aiua-5029	134	36	,	,	PUNCT
aiua-5029	134	37	and	and	CCONJ
aiua-5029	134	38	for	for	ADP
aiua-5029	134	39	those	those	PRON
aiua-5029	134	40	>	>	SYM
aiua-5029	134	41	4	4	NUM
aiua-5029	134	42	cm	cm	NOUN
aiua-5029	134	43	was	be	AUX
aiua-5029	134	44	33	33	NUM
aiua-5029	134	45	%	%	NOUN
aiua-5029	134	46	(	(	PUNCT
aiua-5029	134	47	p	p	NOUN
aiua-5029	134	48	value	value	NOUN
aiua-5029	134	49	0.1	0.1	NUM
aiua-5029	134	50	,	,	PUNCT
aiua-5029	134	51	chi	chi	PROPN
aiua-5029	134	52	square	square	PROPN
aiua-5029	134	53	2.2	2.2	NUM
aiua-5029	134	54	)	)	PUNCT
aiua-5029	134	55	.	.	PUNCT
aiua-5029	135	1	for	for	ADP
aiua-5029	135	2	the	the	DET
aiua-5029	135	3	3	3	NUM
aiua-5029	135	4	year	year	NOUN
aiua-5029	135	5	follow	follow	NOUN
aiua-5029	135	6	-	-	PUNCT
aiua-5029	135	7	up	up	NOUN
aiua-5029	135	8	for	for	ADP
aiua-5029	135	9	arm	arm	NOUN
aiua-5029	135	10	a	a	DET
aiua-5029	135	11	patient	patient	NOUN
aiua-5029	135	12	,	,	PUNCT
aiua-5029	135	13	all	all	DET
aiua-5029	135	14	those	those	PRON
aiua-5029	135	15	who	who	PRON
aiua-5029	135	16	achieved	achieve	VERB
aiua-5029	135	17	pcr	pcr	PROPN
aiua-5029	135	18	were	be	AUX
aiua-5029	135	19	still	still	ADV
aiua-5029	135	20	alive	alive	ADJ
aiua-5029	135	21	(	(	PUNCT
aiua-5029	135	22	100	100	NUM
aiua-5029	135	23	%	%	NOUN
aiua-5029	135	24	)	)	PUNCT
aiua-5029	135	25	.	.	PUNCT
aiua-5029	136	1	of	of	ADP
aiua-5029	136	2	them	they	PRON
aiua-5029	136	3	,	,	PUNCT
aiua-5029	136	4	only	only	ADV
aiua-5029	136	5	1	1	NUM
aiua-5029	136	6	patient	patient	NOUN
aiua-5029	136	7	relapsed	relapse	VERB
aiua-5029	136	8	(	(	PUNCT
aiua-5029	136	9	10	10	NUM
aiua-5029	136	10	%	%	NOUN
aiua-5029	136	11	)	)	PUNCT
aiua-5029	137	1	after	after	ADP
aiua-5029	137	2	26	26	NUM
aiua-5029	137	3	months	month	NOUN
aiua-5029	137	4	of	of	ADP
aiua-5029	137	5	treatment	treatment	NOUN
aiua-5029	137	6	.	.	PUNCT
aiua-5029	138	1	for	for	ADP
aiua-5029	138	2	those	those	PRON
aiua-5029	138	3	who	who	PRON
aiua-5029	138	4	achieved	achieve	VERB
aiua-5029	138	5	ppr	ppr	NOUN
aiua-5029	138	6	,	,	PUNCT
aiua-5029	138	7	8	8	NUM
aiua-5029	138	8	patients	patient	NOUN
aiua-5029	138	9	were	be	AUX
aiua-5029	138	10	still	still	ADV
aiua-5029	138	11	alive	alive	ADJ
aiua-5029	138	12	(	(	PUNCT
aiua-5029	138	13	67	67	NUM
aiua-5029	138	14	%	%	NOUN
aiua-5029	138	15	)	)	PUNCT
aiua-5029	138	16	,	,	PUNCT
aiua-5029	138	17	and	and	CCONJ
aiua-5029	138	18	3	3	NUM
aiua-5029	138	19	died	die	VERB
aiua-5029	138	20	from	from	ADP
aiua-5029	138	21	cancer	cancer	NOUN
aiua-5029	138	22	recurrence	recurrence	NOUN
aiua-5029	138	23	.	.	PUNCT
aiua-5029	139	1	further	far	ADV
aiua-5029	139	2	,	,	PUNCT
aiua-5029	139	3	1	1	NUM
aiua-5029	139	4	patient	patient	NOUN
aiua-5029	139	5	recurred	recur	VERB
aiua-5029	139	6	,	,	PUNCT
aiua-5029	139	7	and	and	CCONJ
aiua-5029	139	8	was	be	AUX
aiua-5029	139	9	still	still	ADV
aiua-5029	139	10	alive	alive	ADJ
aiua-5029	139	11	.	.	PUNCT
aiua-5029	140	1	for	for	ADP
aiua-5029	140	2	those	those	PRON
aiua-5029	140	3	who	who	PRON
aiua-5029	140	4	achieved	achieve	VERB
aiua-5029	140	5	sd	sd	ADP
aiua-5029	140	6	pathologically	pathologically	ADV
aiua-5029	140	7	,	,	PUNCT
aiua-5029	140	8	all	all	PRON
aiua-5029	140	9	of	of	ADP
aiua-5029	140	10	them	they	PRON
aiua-5029	140	11	died	die	VERB
aiua-5029	140	12	.	.	PUNCT
aiua-5029	141	1	(	(	PUNCT
aiua-5029	141	2	p	p	NOUN
aiua-5029	141	3	value	value	NOUN
aiua-5029	141	4	0.0001	0.0001	NUM
aiua-5029	141	5	,	,	PUNCT
aiua-5029	141	6	chi	chi	PROPN
aiua-5029	141	7	square	square	PROPN
aiua-5029	141	8	23.3	23.3	NUM
aiua-5029	141	9	)	)	PUNCT
aiua-5029	141	10	(	(	PUNCT
aiua-5029	141	11	figure	figure	NOUN
aiua-5029	141	12	3	3	NUM
aiua-5029	141	13	)	)	PUNCT
aiua-5029	141	14	.	.	PUNCT
aiua-5029	142	1	toxicity	toxicity	NOUN
aiua-5029	142	2	profile	profile	PROPN
aiua-5029	142	3	chemotherapy	chemotherapy	NOUN
aiua-5029	142	4	side	side	NOUN
aiua-5029	142	5	effects	effect	NOUN
aiua-5029	142	6	:	:	PUNCT
aiua-5029	142	7	for	for	ADP
aiua-5029	142	8	arm	arm	NOUN
aiua-5029	142	9	a	a	PRON
aiua-5029	142	10	,	,	PUNCT
aiua-5029	142	11	among	among	ADP
aiua-5029	142	12	the	the	DET
aiua-5029	142	13	89	89	NUM
aiua-5029	142	14	chemotherapy	chemotherapy	NOUN
aiua-5029	142	15	cycles	cycle	NOUN
aiua-5029	142	16	given	give	VERB
aiua-5029	142	17	,	,	PUNCT
aiua-5029	142	18	dose	dose	NOUN
aiua-5029	142	19	reduction	reduction	NOUN
aiua-5029	142	20	was	be	AUX
aiua-5029	142	21	done	do	VERB
aiua-5029	142	22	in	in	ADP
aiua-5029	142	23	10	10	NUM
aiua-5029	142	24	%	%	NOUN
aiua-5029	142	25	of	of	ADP
aiua-5029	142	26	cycles	cycle	NOUN
aiua-5029	142	27	for	for	ADP
aiua-5029	142	28	leuconeutropenia	leuconeutropenia	NOUN
aiua-5029	142	29	.	.	PUNCT
aiua-5029	143	1	treatment	treatment	NOUN
aiua-5029	143	2	delay	delay	NOUN
aiua-5029	143	3	was	be	AUX
aiua-5029	143	4	in	in	ADP
aiua-5029	143	5	10	10	NUM
aiua-5029	143	6	%	%	NOUN
aiua-5029	143	7	of	of	ADP
aiua-5029	143	8	cycles	cycle	NOUN
aiua-5029	143	9	.	.	PUNCT
aiua-5029	144	1	the	the	DET
aiua-5029	144	2	mean	mean	ADJ
aiua-5029	144	3	delay	delay	NOUN
aiua-5029	144	4	time	time	NOUN
aiua-5029	144	5	was	be	AUX
aiua-5029	144	6	1	1	NUM
aiua-5029	144	7	week	week	NOUN
aiua-5029	144	8	(	(	PUNCT
aiua-5029	144	9	range	range	NOUN
aiua-5029	144	10	1	1	NUM
aiua-5029	144	11	-	-	SYM
aiua-5029	144	12	2	2	NUM
aiua-5029	144	13	weeks	week	NOUN
aiua-5029	144	14	)	)	PUNCT
aiua-5029	144	15	.	.	PUNCT
aiua-5029	145	1	cisplatin	cisplatin	NOUN
aiua-5029	145	2	was	be	AUX
aiua-5029	145	3	replaced	replace	VERB
aiua-5029	145	4	by	by	ADP
aiua-5029	145	5	carboplatin	carboplatin	NOUN
aiua-5029	145	6	in	in	ADP
aiua-5029	145	7	the	the	DET
aiua-5029	145	8	last	last	ADJ
aiua-5029	145	9	2	2	NUM
aiua-5029	145	10	cycles	cycle	NOUN
aiua-5029	145	11	for	for	ADP
aiua-5029	145	12	1	1	NUM
aiua-5029	145	13	patient	patient	NOUN
aiua-5029	145	14	for	for	ADP
aiua-5029	145	15	persistent	persistent	ADJ
aiua-5029	145	16	low	low	ADJ
aiua-5029	145	17	gfr	gfr	PROPN
aiua-5029	145	18	.	.	PUNCT
aiua-5029	146	1	treatment	treatment	NOUN
aiua-5029	146	2	was	be	AUX
aiua-5029	146	3	stopped	stop	VERB
aiua-5029	146	4	in	in	ADP
aiua-5029	146	5	the	the	DET
aiua-5029	146	6	last	last	ADJ
aiua-5029	146	7	cycle	cycle	NOUN
aiua-5029	146	8	in	in	ADP
aiua-5029	146	9	1	1	NUM
aiua-5029	146	10	patient	patient	NOUN
aiua-5029	146	11	for	for	ADP
aiua-5029	146	12	persistent	persistent	ADJ
aiua-5029	146	13	urinary	urinary	ADJ
aiua-5029	146	14	tract	tract	NOUN
aiua-5029	146	15	infection	infection	NOUN
aiua-5029	146	16	(	(	PUNCT
aiua-5029	146	17	uti	uti	PROPN
aiua-5029	146	18	)	)	PUNCT
aiua-5029	146	19	,	,	PUNCT
aiua-5029	146	20	and	and	CCONJ
aiua-5029	146	21	poor	poor	ADJ
aiua-5029	146	22	general	general	ADJ
aiua-5029	146	23	condition	condition	NOUN
aiua-5029	146	24	.	.	PUNCT
aiua-5029	147	1	no	no	DET
aiua-5029	147	2	deaths	death	NOUN
aiua-5029	147	3	occurred	occur	VERB
aiua-5029	147	4	related	relate	VERB
aiua-5029	147	5	to	to	ADP
aiua-5029	147	6	treatment	treatment	NOUN
aiua-5029	147	7	in	in	ADP
aiua-5029	147	8	each	each	DET
aiua-5029	147	9	group	group	NOUN
aiua-5029	147	10	(	(	PUNCT
aiua-5029	147	11	table	table	NOUN
aiua-5029	147	12	6	6	NUM
aiua-5029	147	13	-	-	SYM
aiua-5029	147	14	7	7	NUM
aiua-5029	147	15	)	)	PUNCT
aiua-5029	147	16	.	.	PUNCT
aiua-5029	148	1	table	table	NOUN
aiua-5029	148	2	6	6	NUM
aiua-5029	148	3	summarize	summarize	NOUN
aiua-5029	148	4	grade	grade	NOUN
aiua-5029	148	5	3	3	NUM
aiua-5029	148	6	-	-	SYM
aiua-5029	148	7	4	4	NUM
aiua-5029	148	8	side	side	NOUN
aiua-5029	148	9	effects	effect	NOUN
aiua-5029	148	10	,	,	PUNCT
aiua-5029	148	11	and	and	CCONJ
aiua-5029	148	12	their	their	PRON
aiua-5029	148	13	percentage	percentage	NOUN
aiua-5029	148	14	for	for	ADP
aiua-5029	148	15	arm	arm	NOUN
aiua-5029	148	16	a	a	DET
aiua-5029	148	17	group	group	NOUN
aiua-5029	148	18	.	.	PUNCT
aiua-5029	149	1	table	table	NOUN
aiua-5029	149	2	7	7	NUM
aiua-5029	149	3	showed	show	VERB
aiua-5029	149	4	the	the	DET
aiua-5029	149	5	early	early	ADJ
aiua-5029	149	6	surgical	surgical	ADJ
aiua-5029	149	7	complications	complication	NOUN
aiua-5029	149	8	in	in	ADP
aiua-5029	149	9	both	both	DET
aiua-5029	149	10	arms	arm	NOUN
aiua-5029	149	11	and	and	CCONJ
aiua-5029	149	12	their	their	PRON
aiua-5029	149	13	percentage	percentage	NOUN
aiua-5029	149	14	.	.	PUNCT
aiua-5029	150	1	all	all	DET
aiua-5029	150	2	patients	patient	NOUN
aiua-5029	150	3	who	who	PRON
aiua-5029	150	4	developed	develop	VERB
aiua-5029	150	5	early	early	ADJ
aiua-5029	150	6	surgical	surgical	ADJ
aiua-5029	150	7	complications	complication	NOUN
aiua-5029	150	8	recovered	recover	VERB
aiua-5029	150	9	smoothly	smoothly	ADV
aiua-5029	150	10	.	.	PUNCT
aiua-5029	151	1	late	late	ADJ
aiua-5029	151	2	toxicities	toxicity	NOUN
aiua-5029	151	3	during	during	ADP
aiua-5029	151	4	the	the	DET
aiua-5029	151	5	36	36	NUM
aiua-5029	151	6	months	month	NOUN
aiua-5029	151	7	follow	follow	VERB
aiua-5029	151	8	-	-	PUNCT
aiua-5029	151	9	up	up	NOUN
aiua-5029	151	10	period	period	NOUN
aiua-5029	151	11	,	,	PUNCT
aiua-5029	151	12	1	1	NUM
aiua-5029	151	13	patient	patient	NOUN
aiua-5029	151	14	from	from	ADP
aiua-5029	151	15	arm	arm	NOUN
aiua-5029	151	16	a	a	PRON
aiua-5029	151	17	died	die	VERB
aiua-5029	151	18	by	by	ADP
aiua-5029	151	19	congestive	congestive	ADJ
aiua-5029	151	20	cardiac	cardiac	ADJ
aiua-5029	151	21	failure	failure	NOUN
aiua-5029	151	22	at	at	ADP
aiua-5029	151	23	30	30	NUM
aiua-5029	151	24	months	month	NOUN
aiua-5029	151	25	.	.	PUNCT
aiua-5029	152	1	further	far	ADV
aiua-5029	152	2	,	,	PUNCT
aiua-5029	152	3	1	1	NUM
aiua-5029	152	4	patient	patient	NOUN
aiua-5029	152	5	developed	develop	VERB
aiua-5029	152	6	impaired	impaired	ADJ
aiua-5029	152	7	renal	renal	ADJ
aiua-5029	152	8	function	function	NOUN
aiua-5029	152	9	from	from	ADP
aiua-5029	152	10	repeated	repeat	VERB
aiua-5029	152	11	uti	uti	PROPN
aiua-5029	152	12	and	and	CCONJ
aiua-5029	152	13	he	he	PRON
aiua-5029	152	14	still	still	ADV
aiua-5029	152	15	alive	alive	ADJ
aiua-5029	152	16	and	and	CCONJ
aiua-5029	152	17	did	do	AUX
aiua-5029	152	18	not	not	PART
aiua-5029	152	19	require	require	VERB
aiua-5029	152	20	dialysis	dialysis	NOUN
aiua-5029	152	21	,	,	PUNCT
aiua-5029	152	22	yet	yet	ADV
aiua-5029	152	23	.	.	PUNCT
aiua-5029	153	1	for	for	ADP
aiua-5029	153	2	arm	arm	NOUN
aiua-5029	153	3	b	b	PROPN
aiua-5029	153	4	patients	patient	NOUN
aiua-5029	153	5	,	,	PUNCT
aiua-5029	153	6	2	2	NUM
aiua-5029	153	7	patients	patient	NOUN
aiua-5029	153	8	died	die	VERB
aiua-5029	153	9	from	from	ADP
aiua-5029	153	10	pulmonary	pulmonary	ADJ
aiua-5029	153	11	embolism	embolism	NOUN
aiua-5029	153	12	(	(	PUNCT
aiua-5029	153	13	18	18	NUM
aiua-5029	153	14	,	,	PUNCT
aiua-5029	153	15	27	27	NUM
aiua-5029	153	16	months	month	NOUN
aiua-5029	153	17	)	)	PUNCT
aiua-5029	153	18	.	.	PUNCT
aiua-5029	154	1	discussion	discussion	NOUN
aiua-5029	154	2	the	the	DET
aiua-5029	154	3	role	role	NOUN
aiua-5029	154	4	of	of	ADP
aiua-5029	154	5	neoadjuvant	neoadjuvant	ADJ
aiua-5029	154	6	chemotherapy	chemotherapy	NOUN
aiua-5029	154	7	in	in	ADP
aiua-5029	154	8	urinary	urinary	ADJ
aiua-5029	154	9	bladder	bladder	NOUN
aiua-5029	154	10	cancer	cancer	NOUN
aiua-5029	154	11	was	be	AUX
aiua-5029	154	12	strongly	strongly	ADV
aiua-5029	154	13	encouraged	encourage	VERB
aiua-5029	154	14	in	in	ADP
aiua-5029	154	15	stages	stage	NOUN
aiua-5029	154	16	pt2	pt2	ADJ
aiua-5029	154	17	-	-	ADJ
aiua-5029	154	18	t4a	t4a	ADJ
aiua-5029	154	19	bladder	bladder	NOUN
aiua-5029	154	20	cancer	cancer	NOUN
aiua-5029	154	21	,	,	PUNCT
aiua-5029	154	22	based	base	VERB
aiua-5029	154	23	on	on	ADP
aiua-5029	154	24	3	3	NUM
aiua-5029	154	25	important	important	ADJ
aiua-5029	154	26	trials	trial	NOUN
aiua-5029	154	27	,	,	PUNCT
aiua-5029	154	28	including	include	VERB
aiua-5029	154	29	that	that	PRON
aiua-5029	154	30	of	of	ADP
aiua-5029	154	31	griffiths	griffiths	PROPN
aiua-5029	154	32	et	et	PROPN
aiua-5029	154	33	al	al	PROPN
aiua-5029	154	34	.	.	PROPN
aiua-5029	154	35	,	,	PUNCT
aiua-5029	154	36	2011	2011	NUM
aiua-5029	154	37	,	,	PUNCT
aiua-5029	154	38	vale	vale	NOUN
aiua-5029	154	39	et	et	PROPN
aiua-5029	154	40	al	al	PROPN
aiua-5029	154	41	.	.	PROPN
aiua-5029	154	42	,	,	PUNCT
aiua-5029	154	43	2003	2003	NUM
aiua-5029	154	44	,	,	PUNCT
aiua-5029	154	45	and	and	CCONJ
aiua-5029	154	46	winquist	winquist	PROPN
aiua-5029	154	47	et	et	PROPN
aiua-5029	154	48	al	al	PROPN
aiua-5029	154	49	.	.	PROPN
aiua-5029	154	50	,	,	PUNCT
aiua-5029	154	51	2004	2004	NUM
aiua-5029	154	52	(	(	PUNCT
aiua-5029	154	53	4	4	NUM
aiua-5029	154	54	-	-	SYM
aiua-5029	154	55	6	6	NUM
aiua-5029	154	56	)	)	PUNCT
aiua-5029	154	57	.	.	PUNCT
aiua-5029	155	1	however	however	ADV
aiua-5029	155	2	,	,	PUNCT
aiua-5029	155	3	there	there	PRON
aiua-5029	155	4	are	be	VERB
aiua-5029	155	5	still	still	ADV
aiua-5029	155	6	controversies	controversy	NOUN
aiua-5029	155	7	about	about	ADP
aiua-5029	155	8	its	its	PRON
aiua-5029	155	9	impact	impact	NOUN
aiua-5029	155	10	on	on	ADP
aiua-5029	155	11	survival	survival	NOUN
aiua-5029	155	12	.	.	PUNCT
aiua-5029	156	1	griffiths	griffiths	PROPN
aiua-5029	156	2	et	et	PROPN
aiua-5029	156	3	al	al	PROPN
aiua-5029	156	4	.	.	PROPN
aiua-5029	156	5	,	,	PUNCT
aiua-5029	156	6	2011	2011	NUM
aiua-5029	156	7	(	(	PUNCT
aiua-5029	156	8	4	4	NUM
aiua-5029	156	9	)	)	PUNCT
aiua-5029	156	10	,	,	PUNCT
aiua-5029	156	11	reported	report	VERB
aiua-5029	156	12	that	that	SCONJ
aiua-5029	156	13	,	,	PUNCT
aiua-5029	156	14	neoadjuvant	neoadjuvant	ADJ
aiua-5029	156	15	chemotherapy	chemotherapy	NOUN
aiua-5029	156	16	(	(	PUNCT
aiua-5029	156	17	mvac	mvac	NOUN
aiua-5029	156	18	)	)	PUNCT
aiua-5029	156	19	slightly	slightly	ADV
aiua-5029	156	20	improved	improve	VERB
aiua-5029	156	21	survival	survival	NOUN
aiua-5029	156	22	by	by	ADP
aiua-5029	156	23	6	6	NUM
aiua-5029	156	24	%	%	NOUN
aiua-5029	156	25	over	over	ADP
aiua-5029	156	26	5	5	NUM
aiua-5029	156	27	years	year	NOUN
aiua-5029	156	28	.	.	PUNCT
aiua-5029	157	1	however	however	ADV
aiua-5029	157	2	,	,	PUNCT
aiua-5029	157	3	this	this	DET
aiua-5029	157	4	slight	slight	ADJ
aiua-5029	157	5	improvement	improvement	NOUN
aiua-5029	157	6	in	in	ADP
aiua-5029	157	7	survival	survival	NOUN
aiua-5029	157	8	can	can	AUX
aiua-5029	157	9	be	be	AUX
aiua-5029	157	10	attributed	attribute	VERB
aiua-5029	157	11	to	to	ADP
aiua-5029	157	12	their	their	PRON
aiua-5029	157	13	use	use	NOUN
aiua-5029	157	14	of	of	ADP
aiua-5029	157	15	mvac	mvac	NOUN
aiua-5029	157	16	regimen	regiman	NOUN
aiua-5029	157	17	,	,	PUNCT
aiua-5029	157	18	which	which	PRON
aiua-5029	157	19	was	be	AUX
aiua-5029	157	20	associated	associate	VERB
aiua-5029	157	21	with	with	ADP
aiua-5029	157	22	significant	significant	ADJ
aiua-5029	157	23	toxicity	toxicity	NOUN
aiua-5029	157	24	profile	profile	NOUN
aiua-5029	157	25	(	(	PUNCT
aiua-5029	157	26	9	9	NUM
aiua-5029	157	27	)	)	PUNCT
aiua-5029	157	28	.	.	PUNCT
aiua-5029	158	1	the	the	DET
aiua-5029	158	2	aim	aim	NOUN
aiua-5029	158	3	of	of	ADP
aiua-5029	158	4	neoadjuvant	neoadjuvant	ADJ
aiua-5029	158	5	chemotherapy	chemotherapy	NOUN
aiua-5029	158	6	is	be	AUX
aiua-5029	158	7	to	to	PART
aiua-5029	158	8	achieve	achieve	VERB
aiua-5029	158	9	tumor	tumor	NOUN
aiua-5029	158	10	downstaging	downstaging	NOUN
aiua-5029	158	11	,	,	PUNCT
aiua-5029	158	12	improved	improved	ADJ
aiua-5029	158	13	respectability	respectability	NOUN
aiua-5029	158	14	,	,	PUNCT
aiua-5029	158	15	and	and	CCONJ
aiua-5029	158	16	better	well	ADJ
aiua-5029	158	17	survival	survival	NOUN
aiua-5029	158	18	(	(	PUNCT
aiua-5029	158	19	10	10	NUM
aiua-5029	158	20	,	,	PUNCT
aiua-5029	158	21	11	11	NUM
aiua-5029	158	22	)	)	PUNCT
aiua-5029	158	23	.	.	PUNCT
aiua-5029	159	1	neoadjuvant	neoadjuvant	ADJ
aiua-5029	159	2	chemotherapy	chemotherapy	NOUN
aiua-5029	159	3	is	be	AUX
aiua-5029	159	4	considered	consider	VERB
aiua-5029	159	5	better	well	ADJ
aiua-5029	159	6	than	than	ADP
aiua-5029	159	7	adjuvant	adjuvant	ADJ
aiua-5029	159	8	chemotherapy	chemotherapy	NOUN
aiua-5029	159	9	in	in	ADP
aiua-5029	159	10	relation	relation	NOUN
aiua-5029	159	11	to	to	ADP
aiua-5029	159	12	its	its	PRON
aiua-5029	159	13	tolerability	tolerability	NOUN
aiua-5029	159	14	,	,	PUNCT
aiua-5029	159	15	and	and	CCONJ
aiua-5029	159	16	patients	patient	NOUN
aiua-5029	159	17	usually	usually	ADV
aiua-5029	159	18	receive	receive	VERB
aiua-5029	159	19	adequate	adequate	ADJ
aiua-5029	159	20	cycles	cycle	NOUN
aiua-5029	159	21	of	of	ADP
aiua-5029	159	22	neoadjuvant	neoadjuvant	ADJ
aiua-5029	159	23	chemotherapy	chemotherapy	NOUN
aiua-5029	159	24	with	with	ADP
aiua-5029	159	25	effective	effective	ADJ
aiua-5029	159	26	doses	dose	NOUN
aiua-5029	159	27	.	.	PUNCT
aiua-5029	160	1	it	it	PRON
aiua-5029	160	2	is	be	AUX
aiua-5029	160	3	still	still	ADV
aiua-5029	160	4	unclear	unclear	ADJ
aiua-5029	160	5	which	which	DET
aiua-5029	160	6	neoadjuvant	neoadjuvant	ADJ
aiua-5029	160	7	chemotherapy	chemotherapy	NOUN
aiua-5029	160	8	regimen	regiman	NOUN
aiua-5029	160	9	offers	offer	VERB
aiua-5029	160	10	the	the	DET
aiua-5029	160	11	best	good	ADJ
aiua-5029	160	12	results	result	NOUN
aiua-5029	160	13	.	.	PUNCT
aiua-5029	161	1	in	in	ADP
aiua-5029	161	2	patients	patient	NOUN
aiua-5029	161	3	with	with	ADP
aiua-5029	161	4	advanced	advanced	ADJ
aiua-5029	161	5	or	or	CCONJ
aiua-5029	161	6	metastatic	metastatic	ADJ
aiua-5029	161	7	tcc	tcc	PROPN
aiua-5029	161	8	the	the	DET
aiua-5029	161	9	combination	combination	NOUN
aiua-5029	161	10	of	of	ADP
aiua-5029	161	11	gemcitabine	gemcitabine	NOUN
aiua-5029	161	12	and	and	CCONJ
aiua-5029	161	13	cisplatin	cisplatin	NOUN
aiua-5029	161	14	achieved	achieve	VERB
aiua-5029	161	15	comparable	comparable	ADJ
aiua-5029	161	16	survival	survival	NOUN
aiua-5029	161	17	results	result	NOUN
aiua-5029	161	18	with	with	ADP
aiua-5029	161	19	mvac	mvac	NOUN
aiua-5029	161	20	,	,	PUNCT
aiua-5029	161	21	and	and	CCONJ
aiua-5029	161	22	was	be	AUX
aiua-5029	161	23	associated	associate	VERB
aiua-5029	161	24	with	with	ADP
aiua-5029	161	25	less	less	ADJ
aiua-5029	161	26	toxicity	toxicity	NOUN
aiua-5029	161	27	(	(	PUNCT
aiua-5029	161	28	10	10	NUM
aiua-5029	161	29	)	)	PUNCT
aiua-5029	161	30	.	.	PUNCT
aiua-5029	162	1	for	for	ADP
aiua-5029	162	2	the	the	DET
aiua-5029	162	3	current	current	ADJ
aiua-5029	162	4	study	study	NOUN
aiua-5029	162	5	,	,	PUNCT
aiua-5029	162	6	although	although	SCONJ
aiua-5029	162	7	,	,	PUNCT
aiua-5029	162	8	there	there	PRON
aiua-5029	162	9	was	be	VERB
aiua-5029	162	10	no	no	DET
aiua-5029	162	11	clear	clear	ADJ
aiua-5029	162	12	epidemiological	epidemiological	ADJ
aiua-5029	162	13	trials	trial	NOUN
aiua-5029	162	14	that	that	PRON
aiua-5029	162	15	reported	report	VERB
aiua-5029	162	16	definite	definite	ADJ
aiua-5029	162	17	disease	disease	NOUN
aiua-5029	162	18	characters	character	NOUN
aiua-5029	162	19	among	among	ADP
aiua-5029	162	20	the	the	DET
aiua-5029	162	21	egyptians	egyptians	PROPN
aiua-5029	162	22	,	,	PUNCT
aiua-5029	162	23	our	our	PRON
aiua-5029	162	24	patient	patient	NOUN
aiua-5029	162	25	cohort	cohort	NOUN
aiua-5029	162	26	,	,	PUNCT
aiua-5029	162	27	and	and	CCONJ
aiua-5029	162	28	distribution	distribution	NOUN
aiua-5029	162	29	were	be	AUX
aiua-5029	162	30	nearly	nearly	ADV
aiua-5029	162	31	equivalent	equivalent	ADJ
aiua-5029	162	32	to	to	ADP
aiua-5029	162	33	that	that	PRON
aiua-5029	162	34	of	of	ADP
aiua-5029	162	35	fedewa	fedewa	PROPN
aiua-5029	162	36	et	et	PROPN
aiua-5029	162	37	al	al	PROPN
aiua-5029	162	38	.	.	PROPN
aiua-5029	162	39	,	,	PUNCT
aiua-5029	162	40	2009	2009	NUM
aiua-5029	162	41	(	(	PUNCT
aiua-5029	162	42	1	1	NUM
aiua-5029	162	43	)	)	PUNCT
aiua-5029	162	44	,	,	PUNCT
aiua-5029	162	45	which	which	PRON
aiua-5029	162	46	showed	show	VERB
aiua-5029	162	47	the	the	DET
aiua-5029	162	48	incidence	incidence	NOUN
aiua-5029	162	49	of	of	ADP
aiua-5029	162	50	bladder	bladder	NOUN
aiua-5029	162	51	cancer	cancer	NOUN
aiua-5029	162	52	in	in	ADP
aiua-5029	162	53	the	the	DET
aiua-5029	162	54	nile	nile	PROPN
aiua-5029	162	55	delta	delta	PROPN
aiua-5029	162	56	region	region	PROPN
aiua-5029	162	57	of	of	ADP
aiua-5029	162	58	egypt	egypt	PROPN
aiua-5029	162	59	.	.	PUNCT
aiua-5029	163	1	further	far	ADV
aiua-5029	163	2	,	,	PUNCT
aiua-5029	163	3	our	our	PRON
aiua-5029	163	4	patients	patient	NOUN
aiua-5029	163	5	were	be	AUX
aiua-5029	163	6	properly	properly	ADV
aiua-5029	163	7	randomized	randomize	VERB
aiua-5029	163	8	with	with	ADP
aiua-5029	163	9	no	no	DET
aiua-5029	163	10	significant	significant	ADJ
aiua-5029	163	11	differences	difference	NOUN
aiua-5029	163	12	in	in	ADP
aiua-5029	163	13	patient	patient	ADJ
aiua-5029	163	14	characters	character	NOUN
aiua-5029	163	15	between	between	ADP
aiua-5029	163	16	the	the	DET
aiua-5029	163	17	2	2	NUM
aiua-5029	163	18	arms	arm	NOUN
aiua-5029	163	19	.	.	PUNCT
aiua-5029	164	1	there	there	PRON
aiua-5029	164	2	were	be	VERB
aiua-5029	164	3	non	non	ADJ
aiua-5029	164	4	-	-	ADJ
aiua-5029	164	5	statistically	statistically	ADV
aiua-5029	164	6	significant	significant	ADJ
aiua-5029	164	7	differences	difference	NOUN
aiua-5029	164	8	between	between	ADP
aiua-5029	164	9	the	the	DET
aiua-5029	164	10	2	2	NUM
aiua-5029	164	11	groups	group	NOUN
aiua-5029	164	12	in	in	ADP
aiua-5029	164	13	relation	relation	NOUN
aiua-5029	164	14	to	to	ADP
aiua-5029	164	15	age	age	NOUN
aiua-5029	164	16	,	,	PUNCT
aiua-5029	164	17	tumor	tumor	NOUN
aiua-5029	164	18	size	size	NOUN
aiua-5029	164	19	,	,	PUNCT
aiua-5029	164	20	and	and	CCONJ
aiua-5029	164	21	performance	performance	NOUN
aiua-5029	164	22	state	state	NOUN
aiua-5029	164	23	in	in	ADP
aiua-5029	164	24	favor	favor	NOUN
aiua-5029	164	25	of	of	ADP
aiua-5029	164	26	arm	arm	NOUN
aiua-5029	164	27	a.	a.	NOUN
aiua-5029	164	28	however	however	ADV
aiua-5029	164	29	,	,	PUNCT
aiua-5029	164	30	the	the	DET
aiua-5029	164	31	difference	difference	NOUN
aiua-5029	164	32	in	in	ADP
aiua-5029	164	33	age	age	NOUN
aiua-5029	164	34	was	be	AUX
aiua-5029	164	35	statistically	statistically	ADV
aiua-5029	164	36	significant	significant	ADJ
aiua-5029	164	37	for	for	ADP
aiua-5029	164	38	the	the	DET
aiua-5029	164	39	group	group	NOUN
aiua-5029	164	40	of	of	ADP
aiua-5029	164	41	patients	patient	NOUN
aiua-5029	164	42	>	>	X
aiua-5029	164	43	60	60	NUM
aiua-5029	164	44	years	year	NOUN
aiua-5029	164	45	.	.	PUNCT
aiua-5029	165	1	this	this	PRON
aiua-5029	165	2	was	be	AUX
aiua-5029	165	3	explained	explain	VERB
aiua-5029	165	4	by	by	ADP
aiua-5029	165	5	the	the	DET
aiua-5029	165	6	fact	fact	NOUN
aiua-5029	165	7	that	that	SCONJ
aiua-5029	165	8	the	the	DET
aiua-5029	165	9	investigators	investigator	NOUN
aiua-5029	165	10	tried	try	VERB
aiua-5029	165	11	to	to	PART
aiua-5029	165	12	avoid	avoid	VERB
aiua-5029	165	13	giving	give	VERB
aiua-5029	165	14	chemotherapy	chemotherapy	NOUN
aiua-5029	165	15	in	in	ADP
aiua-5029	165	16	older	old	ADJ
aiua-5029	165	17	ages	age	NOUN
aiua-5029	165	18	to	to	PART
aiua-5029	165	19	avoid	avoid	VERB
aiua-5029	165	20	its	its	PRON
aiua-5029	165	21	long	long	ADJ
aiua-5029	165	22	term	term	NOUN
aiua-5029	165	23	complications	complication	NOUN
aiua-5029	165	24	,	,	PUNCT
aiua-5029	165	25	as	as	ADV
aiua-5029	165	26	well	well	ADV
aiua-5029	165	27	as	as	ADP
aiua-5029	165	28	to	to	PART
aiua-5029	165	29	avoid	avoid	VERB
aiua-5029	165	30	delay	delay	NOUN
aiua-5029	165	31	in	in	ADP
aiua-5029	165	32	the	the	DET
aiua-5029	165	33	definitive	definitive	ADJ
aiua-5029	165	34	surgery	surgery	NOUN
aiua-5029	165	35	especially	especially	ADV
aiua-5029	165	36	with	with	ADP
aiua-5029	165	37	larger	large	ADJ
aiua-5029	165	38	tumor	tumor	NOUN
aiua-5029	165	39	sizes	size	NOUN
aiua-5029	165	40	in	in	ADP
aiua-5029	165	41	this	this	DET
aiua-5029	165	42	group	group	NOUN
aiua-5029	165	43	.	.	PUNCT
aiua-5029	166	1	in	in	ADP
aiua-5029	166	2	the	the	DET
aiua-5029	166	3	current	current	ADJ
aiua-5029	166	4	trial	trial	NOUN
aiua-5029	166	5	,	,	PUNCT
aiua-5029	166	6	the	the	DET
aiua-5029	166	7	primary	primary	ADJ
aiua-5029	166	8	end	end	NOUN
aiua-5029	166	9	point	point	NOUN
aiua-5029	166	10	was	be	AUX
aiua-5029	166	11	survival	survival	NOUN
aiua-5029	166	12	for	for	ADP
aiua-5029	166	13	neoadjuvant	neoadjuvant	ADJ
aiua-5029	166	14	chemotherapy	chemotherapy	NOUN
aiua-5029	166	15	as	as	SCONJ
aiua-5029	166	16	compared	compare	VERB
aiua-5029	166	17	with	with	ADP
aiua-5029	166	18	the	the	DET
aiua-5029	166	19	standard	standard	ADJ
aiua-5029	166	20	treatment	treatment	NOUN
aiua-5029	166	21	that	that	PRON
aiua-5029	166	22	is	be	AUX
aiua-5029	166	23	cystectomy	cystectomy	NOUN
aiua-5029	166	24	.	.	PUNCT
aiua-5029	167	1	we	we	PRON
aiua-5029	167	2	believed	believe	VERB
aiua-5029	167	3	that	that	SCONJ
aiua-5029	167	4	survival	survival	NOUN
aiua-5029	167	5	benefit	benefit	NOUN
aiua-5029	167	6	had	have	VERB
aiua-5029	167	7	to	to	PART
aiua-5029	167	8	be	be	AUX
aiua-5029	167	9	the	the	DET
aiua-5029	167	10	main	main	ADJ
aiua-5029	167	11	concern	concern	NOUN
aiua-5029	167	12	for	for	ADP
aiua-5029	167	13	trials	trial	NOUN
aiua-5029	167	14	like	like	ADP
aiua-5029	167	15	ours	ours	PRON
aiua-5029	167	16	that	that	PRON
aiua-5029	167	17	treated	treat	VERB
aiua-5029	167	18	cancers	cancer	NOUN
aiua-5029	167	19	with	with	ADP
aiua-5029	167	20	curative	curative	ADJ
aiua-5029	167	21	intent	intent	NOUN
aiua-5029	167	22	.	.	PUNCT
aiua-5029	168	1	however	however	ADV
aiua-5029	168	2	,	,	PUNCT
aiua-5029	168	3	the	the	DET
aiua-5029	168	4	follow	follow	VERB
aiua-5029	168	5	-	-	PUNCT
aiua-5029	168	6	up	up	NOUN
aiua-5029	168	7	period	period	NOUN
aiua-5029	168	8	was	be	AUX
aiua-5029	168	9	not	not	PART
aiua-5029	168	10	long	long	ADJ
aiua-5029	168	11	enough	enough	ADV
aiua-5029	168	12	to	to	PART
aiua-5029	168	13	show	show	VERB
aiua-5029	168	14	clear	clear	ADJ
aiua-5029	168	15	survival	survival	NOUN
aiua-5029	168	16	benefit	benefit	NOUN
aiua-5029	168	17	over	over	ADP
aiua-5029	168	18	a	a	DET
aiua-5029	168	19	long	long	ADJ
aiua-5029	168	20	period	period	NOUN
aiua-5029	168	21	of	of	ADP
aiua-5029	168	22	time	time	NOUN
aiua-5029	168	23	.	.	PUNCT
aiua-5029	169	1	the	the	DET
aiua-5029	169	2	researchers	researcher	NOUN
aiua-5029	169	3	of	of	ADP
aiua-5029	169	4	the	the	DET
aiua-5029	169	5	current	current	ADJ
aiua-5029	169	6	trial	trial	NOUN
aiua-5029	169	7	used	use	VERB
aiua-5029	169	8	to	to	PART
aiua-5029	169	9	define	define	VERB
aiua-5029	169	10	survival	survival	NOUN
aiua-5029	169	11	in	in	ADP
aiua-5029	169	12	side	side	ADJ
aiua-5029	169	13	effect	effect	NOUN
aiua-5029	169	14	arm	arm	VERB
aiua-5029	169	15	a	a	DET
aiua-5029	169	16	grade	grade	NOUN
aiua-5029	169	17	4	4	NUM
aiua-5029	169	18	(	(	PUNCT
aiua-5029	169	19	%	%	NOUN
aiua-5029	169	20	)	)	PUNCT
aiua-5029	169	21	grade	grade	NOUN
aiua-5029	169	22	3	3	NUM
aiua-5029	169	23	(	(	PUNCT
aiua-5029	169	24	%	%	NOUN
aiua-5029	169	25	)	)	PUNCT
aiua-5029	169	26	leuconeutropenia	leuconeutropenia	NOUN
aiua-5029	169	27	12.2	12.2	NUM
aiua-5029	169	28	2.2	2.2	NUM
aiua-5029	169	29	anemia	anemia	NOUN
aiua-5029	169	30	2.2	2.2	NUM
aiua-5029	169	31	--thrombocytopenia	--thrombocytopenia	SYM
aiua-5029	169	32	17.8	17.8	NUM
aiua-5029	169	33	--febrile	--febrile	PROPN
aiua-5029	169	34	neutropneia	neutropneia	NOUN
aiua-5029	169	35	2.2	2.2	NUM
aiua-5029	169	36	--nausea	--nausea	NUM
aiua-5029	169	37	,	,	PUNCT
aiua-5029	169	38	vomiting	vomit	VERB
aiua-5029	169	39	4.4	4.4	NUM
aiua-5029	169	40	---mucositis	---mucositis	SYM
aiua-5029	169	41	5.5	5.5	NUM
aiua-5029	169	42	--others	--other	NOUN
aiua-5029	169	43	(	(	PUNCT
aiua-5029	169	44	uti	uti	PROPN
aiua-5029	169	45	)	)	PUNCT
aiua-5029	169	46	7	7	NUM
aiua-5029	169	47	%	%	NOUN
aiua-5029	169	48	---table	---table	NUM
aiua-5029	169	49	6	6	NUM
aiua-5029	169	50	.	.	PUNCT
aiua-5029	170	1	grade	grade	NOUN
aiua-5029	170	2	3	3	NUM
aiua-5029	170	3	-	-	SYM
aiua-5029	170	4	4	4	NUM
aiua-5029	170	5	side	side	NOUN
aiua-5029	170	6	effects	effect	NOUN
aiua-5029	170	7	,	,	PUNCT
aiua-5029	170	8	and	and	CCONJ
aiua-5029	170	9	their	their	PRON
aiua-5029	170	10	percentage	percentage	NOUN
aiua-5029	170	11	for	for	ADP
aiua-5029	170	12	arm	arm	NOUN
aiua-5029	170	13	a	a	DET
aiua-5029	170	14	group	group	NOUN
aiua-5029	170	15	.	.	PUNCT
aiua-5029	171	1	side	side	ADJ
aiua-5029	171	2	effect	effect	NOUN
aiua-5029	171	3	arm	arm	VERB
aiua-5029	171	4	a	a	DET
aiua-5029	171	5	grade	grade	NOUN
aiua-5029	171	6	4	4	NUM
aiua-5029	171	7	(	(	PUNCT
aiua-5029	171	8	%	%	NOUN
aiua-5029	171	9	)	)	PUNCT
aiua-5029	171	10	grade	grade	NOUN
aiua-5029	171	11	3	3	NUM
aiua-5029	171	12	(	(	PUNCT
aiua-5029	171	13	%	%	NOUN
aiua-5029	171	14	)	)	PUNCT
aiua-5029	171	15	leuconeutropenia	leuconeutropenia	NOUN
aiua-5029	171	16	12.2	12.2	NUM
aiua-5029	171	17	2.2	2.2	NUM
aiua-5029	171	18	anemia	anemia	NOUN
aiua-5029	171	19	2.2	2.2	NUM
aiua-5029	171	20	--thrombocytopenia	--thrombocytopenia	SYM
aiua-5029	171	21	17.8	17.8	NUM
aiua-5029	171	22	--febrile	--febrile	PROPN
aiua-5029	171	23	neutropneia	neutropneia	NOUN
aiua-5029	171	24	2.2	2.2	NUM
aiua-5029	171	25	--nausea	--nausea	NUM
aiua-5029	171	26	,	,	PUNCT
aiua-5029	171	27	vomiting	vomit	VERB
aiua-5029	171	28	4.4	4.4	NUM
aiua-5029	171	29	---mucositis	---mucositis	SYM
aiua-5029	171	30	5.5	5.5	NUM
aiua-5029	171	31	--others	--other	NOUN
aiua-5029	171	32	(	(	PUNCT
aiua-5029	171	33	uti	uti	PROPN
aiua-5029	171	34	)	)	PUNCT
aiua-5029	171	35	7	7	NUM
aiua-5029	171	36	%	%	NOUN
aiua-5029	171	37	---table	---table	NUM
aiua-5029	171	38	7	7	NUM
aiua-5029	171	39	.	.	PUNCT
aiua-5029	172	1	the	the	DET
aiua-5029	172	2	early	early	ADJ
aiua-5029	172	3	surgical	surgical	ADJ
aiua-5029	172	4	complications	complication	NOUN
aiua-5029	172	5	in	in	ADP
aiua-5029	172	6	both	both	DET
aiua-5029	172	7	arms	arm	NOUN
aiua-5029	172	8	and	and	CCONJ
aiua-5029	172	9	their	their	PRON
aiua-5029	172	10	percentage	percentage	NOUN
aiua-5029	172	11	.	.	PUNCT
aiua-5029	173	1	osman_stesura	osman_stesura	NOUN
aiua-5029	173	2	seveso	seveso	VERB
aiua-5029	173	3	15/01/15	15/01/15	PROPN
aiua-5029	173	4	13:09	13:09	NUM
aiua-5029	173	5	pagina	pagina	NOUN
aiua-5029	173	6	282	282	NUM
aiua-5029	173	7	283archivio	283archivio	PROPN
aiua-5029	173	8	italiano	italiano	NOUN
aiua-5029	173	9	di	di	X
aiua-5029	173	10	urologia	urologia	PROPN
aiua-5029	173	11	e	e	PROPN
aiua-5029	173	12	andrologia	andrologia	NOUN
aiua-5029	173	13	2014	2014	NUM
aiua-5029	173	14	;	;	PUNCT
aiua-5029	173	15	86	86	NUM
aiua-5029	173	16	,	,	PUNCT
aiua-5029	173	17	4	4	NUM
aiua-5029	173	18	nact	nact	VERB
aiua-5029	173	19	versus	versus	ADP
aiua-5029	173	20	cystectomy	cystectomy	NOUN
aiua-5029	173	21	in	in	ADP
aiua-5029	173	22	bladder	bladder	NOUN
aiua-5029	173	23	cancer	cancer	NOUN
aiua-5029	173	24	relation	relation	NOUN
aiua-5029	173	25	to	to	ADP
aiua-5029	173	26	several	several	ADJ
aiua-5029	173	27	subgroup	subgroup	NOUN
aiua-5029	173	28	analysis	analysis	NOUN
aiua-5029	173	29	for	for	ADP
aiua-5029	173	30	better	well	ADJ
aiua-5029	173	31	evaluation	evaluation	NOUN
aiua-5029	173	32	,	,	PUNCT
aiua-5029	173	33	and	and	CCONJ
aiua-5029	173	34	to	to	PART
aiua-5029	173	35	define	define	VERB
aiua-5029	173	36	which	which	DET
aiua-5029	173	37	subgroup	subgroup	NOUN
aiua-5029	173	38	would	would	AUX
aiua-5029	173	39	benefit	benefit	VERB
aiua-5029	173	40	most	most	ADV
aiua-5029	173	41	from	from	ADP
aiua-5029	173	42	treatment	treatment	NOUN
aiua-5029	173	43	protocol	protocol	NOUN
aiua-5029	173	44	.	.	PUNCT
aiua-5029	174	1	further	far	ADV
aiua-5029	174	2	,	,	PUNCT
aiua-5029	174	3	the	the	DET
aiua-5029	174	4	researchers	researcher	NOUN
aiua-5029	174	5	planed	plane	VERB
aiua-5029	174	6	to	to	PART
aiua-5029	174	7	make	make	VERB
aiua-5029	174	8	an	an	DET
aiua-5029	174	9	updated	update	VERB
aiua-5029	174	10	report	report	NOUN
aiua-5029	174	11	for	for	ADP
aiua-5029	174	12	the	the	DET
aiua-5029	174	13	survival	survival	NOUN
aiua-5029	174	14	benefit	benefit	NOUN
aiua-5029	174	15	,	,	PUNCT
aiua-5029	174	16	and	and	CCONJ
aiua-5029	174	17	toxicity	toxicity	NOUN
aiua-5029	174	18	profile	profile	NOUN
aiua-5029	174	19	after	after	ADP
aiua-5029	174	20	5	5	NUM
aiua-5029	174	21	years	year	NOUN
aiua-5029	174	22	,	,	PUNCT
aiua-5029	174	23	and	and	CCONJ
aiua-5029	174	24	hopefully	hopefully	ADV
aiua-5029	174	25	after	after	ADP
aiua-5029	174	26	10	10	NUM
aiua-5029	174	27	years	year	NOUN
aiua-5029	174	28	follow	follow	VERB
aiua-5029	174	29	-	-	PUNCT
aiua-5029	174	30	up	up	ADP
aiua-5029	174	31	periods	period	NOUN
aiua-5029	174	32	.	.	PUNCT
aiua-5029	175	1	for	for	ADP
aiua-5029	175	2	the	the	DET
aiua-5029	175	3	diversion	diversion	NOUN
aiua-5029	175	4	procedures	procedure	NOUN
aiua-5029	175	5	,	,	PUNCT
aiua-5029	175	6	although	although	SCONJ
aiua-5029	175	7	orthotopic	orthotopic	ADJ
aiua-5029	175	8	diversion	diversion	NOUN
aiua-5029	175	9	was	be	AUX
aiua-5029	175	10	the	the	DET
aiua-5029	175	11	standard	standard	NOUN
aiua-5029	175	12	in	in	ADP
aiua-5029	175	13	our	our	PRON
aiua-5029	175	14	institutes	institute	NOUN
aiua-5029	175	15	,	,	PUNCT
aiua-5029	175	16	the	the	DET
aiua-5029	175	17	authors	author	NOUN
aiua-5029	175	18	tried	try	VERB
aiua-5029	175	19	to	to	PART
aiua-5029	175	20	avoid	avoid	VERB
aiua-5029	175	21	the	the	DET
aiua-5029	175	22	metabolic	metabolic	NOUN
aiua-5029	175	23	complications	complication	NOUN
aiua-5029	175	24	of	of	ADP
aiua-5029	175	25	orthotopic	orthotopic	ADJ
aiua-5029	175	26	diversion	diversion	NOUN
aiua-5029	175	27	especially	especially	ADV
aiua-5029	175	28	after	after	ADP
aiua-5029	175	29	neoadjuvant	neoadjuvant	ADJ
aiua-5029	175	30	cisplatin	cisplatin	NOUN
aiua-5029	175	31	containing	contain	VERB
aiua-5029	175	32	regimen	regiman	NOUN
aiua-5029	175	33	.	.	PUNCT
aiua-5029	176	1	the	the	DET
aiua-5029	176	2	current	current	ADJ
aiua-5029	176	3	study	study	NOUN
aiua-5029	176	4	clearly	clearly	ADV
aiua-5029	176	5	showed	show	VERB
aiua-5029	176	6	survival	survival	NOUN
aiua-5029	176	7	benefit	benefit	NOUN
aiua-5029	176	8	for	for	ADP
aiua-5029	176	9	neoadjuvant	neoadjuvant	ADJ
aiua-5029	176	10	cisplatin	cisplatin	NOUN
aiua-5029	176	11	and	and	CCONJ
aiua-5029	176	12	gemcitabine	gemcitabine	NOUN
aiua-5029	176	13	combination	combination	NOUN
aiua-5029	176	14	over	over	ADP
aiua-5029	176	15	radical	radical	ADJ
aiua-5029	176	16	cystectomy	cystectomy	NOUN
aiua-5029	176	17	.	.	PUNCT
aiua-5029	177	1	further	far	ADV
aiua-5029	177	2	,	,	PUNCT
aiua-5029	177	3	the	the	DET
aiua-5029	177	4	survival	survival	NOUN
aiua-5029	177	5	was	be	AUX
aiua-5029	177	6	better	well	ADJ
aiua-5029	177	7	for	for	ADP
aiua-5029	177	8	each	each	DET
aiua-5029	177	9	subgroup	subgroup	NOUN
aiua-5029	177	10	for	for	ADP
aiua-5029	177	11	arm	arm	NOUN
aiua-5029	177	12	a	a	PRON
aiua-5029	177	13	over	over	ADP
aiua-5029	177	14	arm	arm	NOUN
aiua-5029	177	15	b.	b.	PROPN
aiua-5029	178	1	the	the	DET
aiua-5029	178	2	current	current	ADJ
aiua-5029	178	3	study	study	NOUN
aiua-5029	178	4	showed	show	VERB
aiua-5029	178	5	better	well	ADJ
aiua-5029	178	6	surgical	surgical	ADJ
aiua-5029	178	7	resectability	resectability	NOUN
aiua-5029	178	8	for	for	ADP
aiua-5029	178	9	arm	arm	NOUN
aiua-5029	178	10	a	a	DET
aiua-5029	178	11	patients	patient	NOUN
aiua-5029	178	12	,	,	PUNCT
aiua-5029	178	13	when	when	SCONJ
aiua-5029	178	14	compared	compare	VERB
aiua-5029	178	15	with	with	ADP
aiua-5029	178	16	arm	arm	NOUN
aiua-5029	178	17	b	b	PROPN
aiua-5029	178	18	patients	patient	NOUN
aiua-5029	178	19	.	.	PUNCT
aiua-5029	179	1	arm	arm	VERB
aiua-5029	179	2	a	a	DET
aiua-5029	179	3	patients	patient	NOUN
aiua-5029	179	4	had	have	VERB
aiua-5029	179	5	higher	high	ADJ
aiua-5029	179	6	r0	r0	NOUN
aiua-5029	179	7	number	number	NOUN
aiua-5029	179	8	over	over	ADP
aiua-5029	179	9	arm	arm	PROPN
aiua-5029	179	10	b	b	PROPN
aiua-5029	179	11	(	(	PUNCT
aiua-5029	179	12	100	100	NUM
aiua-5029	179	13	%	%	NOUN
aiua-5029	179	14	vs	vs	ADP
aiua-5029	179	15	86	86	NUM
aiua-5029	179	16	%	%	NOUN
aiua-5029	179	17	respectively	respectively	ADV
aiua-5029	179	18	)	)	PUNCT
aiua-5029	179	19	.	.	PUNCT
aiua-5029	180	1	further	far	ADV
aiua-5029	180	2	,	,	PUNCT
aiua-5029	180	3	neoadjuvant	neoadjuvant	ADJ
aiua-5029	180	4	chemotherapy	chemotherapy	NOUN
aiua-5029	180	5	achieved	achieve	VERB
aiua-5029	180	6	tumor	tumor	NOUN
aiua-5029	180	7	downstaging	downstage	VERB
aiua-5029	180	8	in	in	ADP
aiua-5029	180	9	78	78	NUM
aiua-5029	180	10	%	%	NOUN
aiua-5029	180	11	of	of	ADP
aiua-5029	180	12	patients	patient	NOUN
aiua-5029	180	13	.	.	PUNCT
aiua-5029	181	1	for	for	ADP
aiua-5029	181	2	toxicity	toxicity	NOUN
aiua-5029	181	3	profile	profile	NOUN
aiua-5029	181	4	,	,	PUNCT
aiua-5029	181	5	neoadjuvant	neoadjuvant	ADJ
aiua-5029	181	6	chemotherapy	chemotherapy	NOUN
aiua-5029	181	7	was	be	AUX
aiua-5029	181	8	tolerated	tolerate	VERB
aiua-5029	181	9	well	well	ADV
aiua-5029	181	10	,	,	PUNCT
aiua-5029	181	11	and	and	CCONJ
aiua-5029	181	12	was	be	AUX
aiua-5029	181	13	associated	associate	VERB
aiua-5029	181	14	with	with	ADP
aiua-5029	181	15	mild	mild	ADJ
aiua-5029	181	16	grade	grade	NOUN
aiua-5029	181	17	3	3	NUM
aiua-5029	181	18	-	-	SYM
aiua-5029	181	19	4	4	NUM
aiua-5029	181	20	toxicities	toxicity	NOUN
aiua-5029	181	21	.	.	PUNCT
aiua-5029	182	1	surgery	surgery	NOUN
aiua-5029	182	2	after	after	SCONJ
aiua-5029	182	3	chemotherapy	chemotherapy	NOUN
aiua-5029	182	4	was	be	AUX
aiua-5029	182	5	associated	associate	VERB
aiua-5029	182	6	with	with	ADP
aiua-5029	182	7	very	very	ADV
aiua-5029	182	8	comparable	comparable	ADJ
aiua-5029	182	9	side	side	NOUN
aiua-5029	182	10	effects	effect	NOUN
aiua-5029	182	11	with	with	ADP
aiua-5029	182	12	that	that	PRON
aiua-5029	182	13	of	of	ADP
aiua-5029	182	14	arm	arm	PROPN
aiua-5029	182	15	b.	b.	PROPN
aiua-5029	182	16	bleeding	bleed	VERB
aiua-5029	182	17	complication	complication	NOUN
aiua-5029	182	18	were	be	AUX
aiua-5029	182	19	relatively	relatively	ADV
aiua-5029	182	20	higher	high	ADJ
aiua-5029	182	21	among	among	ADP
aiua-5029	182	22	the	the	DET
aiua-5029	182	23	group	group	NOUN
aiua-5029	182	24	who	who	PRON
aiua-5029	182	25	received	receive	VERB
aiua-5029	182	26	neoadjuvant	neoadjuvant	ADJ
aiua-5029	182	27	chemotherapy	chemotherapy	NOUN
aiua-5029	182	28	.	.	PUNCT
aiua-5029	183	1	for	for	ADP
aiua-5029	183	2	the	the	DET
aiua-5029	183	3	delayed	delay	VERB
aiua-5029	183	4	side	side	NOUN
aiua-5029	183	5	effects	effect	NOUN
aiua-5029	183	6	,	,	PUNCT
aiua-5029	183	7	the	the	DET
aiua-5029	183	8	incidence	incidence	NOUN
aiua-5029	183	9	of	of	ADP
aiua-5029	183	10	them	they	PRON
aiua-5029	183	11	was	be	AUX
aiua-5029	183	12	nearly	nearly	ADV
aiua-5029	183	13	equivalent	equivalent	ADJ
aiua-5029	183	14	between	between	ADP
aiua-5029	183	15	the	the	DET
aiua-5029	183	16	2	2	NUM
aiua-5029	183	17	treatment	treatment	NOUN
aiua-5029	183	18	groups	group	NOUN
aiua-5029	183	19	.	.	PUNCT
aiua-5029	184	1	further	far	ADV
aiua-5029	184	2	,	,	PUNCT
aiua-5029	184	3	reports	report	NOUN
aiua-5029	184	4	with	with	ADP
aiua-5029	184	5	relatively	relatively	ADV
aiua-5029	184	6	longer	long	ADJ
aiua-5029	184	7	follow	follow	VERB
aiua-5029	184	8	-	-	PUNCT
aiua-5029	184	9	up	up	ADP
aiua-5029	184	10	durations	duration	NOUN
aiua-5029	184	11	are	be	AUX
aiua-5029	184	12	needed	need	VERB
aiua-5029	184	13	before	before	ADP
aiua-5029	184	14	confirming	confirm	VERB
aiua-5029	184	15	that	that	DET
aiua-5029	184	16	point	point	NOUN
aiua-5029	184	17	.	.	PUNCT
aiua-5029	185	1	conclusion	conclusion	NOUN
aiua-5029	185	2	neoadjuvant	neoadjuvant	ADJ
aiua-5029	185	3	chemotherapy	chemotherapy	NOUN
aiua-5029	185	4	before	before	SCONJ
aiua-5029	185	5	cystectomy	cystectomy	NOUN
aiua-5029	185	6	achieved	achieve	VERB
aiua-5029	185	7	better	well	ADJ
aiua-5029	185	8	survival	survival	NOUN
aiua-5029	185	9	results	result	NOUN
aiua-5029	185	10	,	,	PUNCT
aiua-5029	185	11	surgical	surgical	ADJ
aiua-5029	185	12	respectability	respectability	NOUN
aiua-5029	185	13	,	,	PUNCT
aiua-5029	185	14	and	and	CCONJ
aiua-5029	185	15	nearly	nearly	ADV
aiua-5029	185	16	equivalent	equivalent	ADJ
aiua-5029	185	17	toxicities	toxicity	NOUN
aiua-5029	185	18	when	when	SCONJ
aiua-5029	185	19	compared	compare	VERB
aiua-5029	185	20	with	with	ADP
aiua-5029	185	21	radical	radical	ADJ
aiua-5029	185	22	cystectomy	cystectomy	NOUN
aiua-5029	185	23	in	in	ADP
aiua-5029	185	24	the	the	DET
aiua-5029	185	25	management	management	NOUN
aiua-5029	185	26	of	of	ADP
aiua-5029	185	27	stage	stage	NOUN
aiua-5029	185	28	ii	ii	PROPN
aiua-5029	185	29	,	,	PUNCT
aiua-5029	185	30	and	and	CCONJ
aiua-5029	185	31	iii	iii	NUM
aiua-5029	185	32	urothelial	urothelial	ADJ
aiua-5029	185	33	bladder	bladder	NOUN
aiua-5029	185	34	cancer	cancer	NOUN
aiua-5029	185	35	.	.	PUNCT
aiua-5029	186	1	references	reference	NOUN
aiua-5029	186	2	1	1	NUM
aiua-5029	186	3	.	.	PUNCT
aiua-5029	186	4	fedewa	fedewa	PROPN
aiua-5029	186	5	sa	sa	PROPN
aiua-5029	186	6	,	,	PUNCT
aiua-5029	186	7	soliman	soliman	NOUN
aiua-5029	186	8	as	as	ADP
aiua-5029	186	9	,	,	PUNCT
aiua-5029	186	10	ismail	ismail	PROPN
aiua-5029	186	11	k	k	PROPN
aiua-5029	186	12	,	,	PUNCT
aiua-5029	186	13	et	et	PROPN
aiua-5029	186	14	al	al	PROPN
aiua-5029	186	15	.	.	PUNCT
aiua-5029	187	1	incidence	incidence	NOUN
aiua-5029	187	2	analyses	analysis	NOUN
aiua-5029	187	3	of	of	ADP
aiua-5029	187	4	bladder	bladder	NOUN
aiua-5029	187	5	cancer	cancer	NOUN
aiua-5029	187	6	in	in	ADP
aiua-5029	187	7	the	the	DET
aiua-5029	187	8	nile	nile	PROPN
aiua-5029	187	9	delta	delta	PROPN
aiua-5029	187	10	region	region	PROPN
aiua-5029	187	11	of	of	ADP
aiua-5029	187	12	egypt	egypt	PROPN
aiua-5029	187	13	.	.	PUNCT
aiua-5029	188	1	cancer	cancer	NOUN
aiua-5029	188	2	epidemiol	epidemiol	PROPN
aiua-5029	188	3	.	.	PUNCT
aiua-5029	189	1	2009	2009	NUM
aiua-5029	189	2	;	;	PUNCT
aiua-5029	189	3	33:176	33:176	NUM
aiua-5029	189	4	-	-	SYM
aiua-5029	189	5	181	181	NUM
aiua-5029	189	6	.	.	NOUN
aiua-5029	190	1	2	2	NUM
aiua-5029	190	2	.	.	X
aiua-5029	190	3	edge	edge	PROPN
aiua-5029	190	4	sb	sb	PROPN
aiua-5029	190	5	,	,	PUNCT
aiua-5029	190	6	byrd	byrd	PROPN
aiua-5029	190	7	dr	dr	PROPN
aiua-5029	190	8	,	,	PUNCT
aiua-5029	190	9	compton	compton	PROPN
aiua-5029	190	10	cc	cc	PROPN
aiua-5029	190	11	,	,	PUNCT
aiua-5029	190	12	et	et	PROPN
aiua-5029	190	13	al	al	PROPN
aiua-5029	190	14	.	.	PUNCT
aiua-5029	191	1	eds	eds	PROPN
aiua-5029	191	2	.	.	PUNCT
aiua-5029	191	3	:	:	PUNCT
aiua-5029	192	1	ajcc	ajcc	PROPN
aiua-5029	192	2	cancer	cancer	NOUN
aiua-5029	192	3	staging	staging	NOUN
aiua-5029	192	4	manual	manual	NOUN
aiua-5029	192	5	.	.	PUNCT
aiua-5029	193	1	7th	7th	ADJ
aiua-5029	193	2	ed	ed	NOUN
aiua-5029	193	3	.	.	PUNCT
aiua-5029	194	1	urinary	urinary	ADJ
aiua-5029	194	2	bladder	bladder	NOUN
aiua-5029	194	3	.	.	PUNCT
aiua-5029	195	1	new	new	PROPN
aiua-5029	195	2	york	york	PROPN
aiua-5029	195	3	,	,	PUNCT
aiua-5029	195	4	ny	ny	PROPN
aiua-5029	195	5	:	:	PUNCT
aiua-5029	195	6	springer	springer	NOUN
aiua-5029	195	7	,	,	PUNCT
aiua-5029	195	8	2010	2010	NUM
aiua-5029	195	9	,	,	PUNCT
aiua-5029	195	10	pp	pp	ADP
aiua-5029	195	11	497	497	NUM
aiua-5029	195	12	-	-	SYM
aiua-5029	195	13	505	505	NUM
aiua-5029	195	14	.	.	PUNCT
aiua-5029	196	1	3	3	X
aiua-5029	196	2	.	.	X
aiua-5029	196	3	nccn	nccn	ADJ
aiua-5029	196	4	clinical	clinical	ADJ
aiua-5029	196	5	practice	practice	NOUN
aiua-5029	196	6	guidelines	guideline	NOUN
aiua-5029	196	7	in	in	ADP
aiua-5029	196	8	oncology	oncology	NOUN
aiua-5029	196	9	,	,	PUNCT
aiua-5029	196	10	bladder	bladder	NOUN
aiua-5029	196	11	cancer	cancer	NOUN
aiua-5029	196	12	,	,	PUNCT
aiua-5029	196	13	version	version	NOUN
aiua-5029	196	14	1	1	NUM
aiua-5029	196	15	,	,	PUNCT
aiua-5029	196	16	2014	2014	NUM
aiua-5029	196	17	,	,	PUNCT
aiua-5029	196	18	http://www.nccn.org/professionals/physician_gls/	http://www.nccn.org/professionals/physician_gls/	CCONJ
aiua-5029	196	19	f_guidelines	f_guideline	NOUN
aiua-5029	196	20	.	.	PUNCT
aiua-5029	197	1	asp#bladder	asp#bladder	NOUN
aiua-5029	197	2	.	.	PROPN
aiua-5029	198	1	4	4	NUM
aiua-5029	198	2	.	.	X
aiua-5029	198	3	griffiths	griffiths	PROPN
aiua-5029	198	4	g	g	PROPN
aiua-5029	198	5	,	,	PUNCT
aiua-5029	198	6	hall	hall	NOUN
aiua-5029	198	7	r	r	NOUN
aiua-5029	198	8	,	,	PUNCT
aiua-5029	198	9	sylvester	sylvester	NOUN
aiua-5029	198	10	r	r	NOUN
aiua-5029	198	11	,	,	PUNCT
aiua-5029	198	12	et	et	PROPN
aiua-5029	198	13	al	al	PROPN
aiua-5029	198	14	.	.	PUNCT
aiua-5029	198	15	international	international	ADJ
aiua-5029	198	16	phase	phase	NOUN
aiua-5029	198	17	iii	iii	NOUN
aiua-5029	198	18	trial	trial	NOUN
aiua-5029	198	19	assessing	assess	VERB
aiua-5029	198	20	neoadjuvant	neoadjuvant	ADJ
aiua-5029	198	21	cisplatin	cisplatin	NOUN
aiua-5029	198	22	,	,	PUNCT
aiua-5029	198	23	methotrexate	methotrexate	NOUN
aiua-5029	198	24	,	,	PUNCT
aiua-5029	198	25	and	and	CCONJ
aiua-5029	198	26	vinblastine	vinblastine	NOUN
aiua-5029	198	27	chemotherapy	chemotherapy	NOUN
aiua-5029	198	28	for	for	ADP
aiua-5029	198	29	muscle	muscle	NOUN
aiua-5029	198	30	-	-	PUNCT
aiua-5029	198	31	invasive	invasive	ADJ
aiua-5029	198	32	bladder	bladder	NOUN
aiua-5029	198	33	cancer	cancer	NOUN
aiua-5029	198	34	:	:	PUNCT
aiua-5029	198	35	long	long	ADJ
aiua-5029	198	36	-	-	PUNCT
aiua-5029	198	37	term	term	NOUN
aiua-5029	198	38	results	result	NOUN
aiua-5029	198	39	of	of	ADP
aiua-5029	198	40	the	the	DET
aiua-5029	198	41	ba06	ba06	PROPN
aiua-5029	198	42	30894	30894	NUM
aiua-5029	198	43	trial	trial	NOUN
aiua-5029	198	44	.	.	PUNCT
aiua-5029	199	1	j	j	PROPN
aiua-5029	199	2	clin	clin	PROPN
aiua-5029	199	3	oncol	oncol	PROPN
aiua-5029	199	4	.	.	PUNCT
aiua-5029	200	1	2011	2011	NUM
aiua-5029	200	2	;	;	PUNCT
aiua-5029	200	3	29:2171	29:2171	NUM
aiua-5029	200	4	-	-	SYM
aiua-5029	200	5	2177	2177	NUM
aiua-5029	200	6	.	.	PUNCT
aiua-5029	201	1	5	5	NUM
aiua-5029	201	2	.	.	X
aiua-5029	201	3	vale	vale	PROPN
aiua-5029	201	4	c	c	PROPN
aiua-5029	201	5	,	,	PUNCT
aiua-5029	201	6	advanced	advanced	ADJ
aiua-5029	201	7	bladder	bladder	NOUN
aiua-5029	201	8	cancer	cancer	NOUN
aiua-5029	201	9	meta	meta	ADJ
aiua-5029	201	10	-	-	PUNCT
aiua-5029	201	11	analysis	analysis	NOUN
aiua-5029	201	12	collaboration	collaboration	NOUN
aiua-5029	201	13	mrc	mrc	NOUN
aiua-5029	201	14	clinical	clinical	ADJ
aiua-5029	201	15	trials	trial	NOUN
aiua-5029	201	16	unit	unit	NOUN
aiua-5029	201	17	:	:	PUNCT
aiua-5029	201	18	neoadjuvant	neoadjuvant	ADJ
aiua-5029	201	19	chemotherapy	chemotherapy	NOUN
aiua-5029	201	20	in	in	ADP
aiua-5029	201	21	invasive	invasive	ADJ
aiua-5029	201	22	bladder	bladder	NOUN
aiua-5029	201	23	cancer	cancer	NOUN
aiua-5029	201	24	:	:	PUNCT
aiua-5029	201	25	a	a	DET
aiua-5029	201	26	systematic	systematic	ADJ
aiua-5029	201	27	review	review	NOUN
aiua-5029	201	28	and	and	CCONJ
aiua-5029	201	29	meta	meta	ADJ
aiua-5029	201	30	-	-	PUNCT
aiua-5029	201	31	analysis	analysis	NOUN
aiua-5029	201	32	.	.	PUNCT
aiua-5029	202	1	lancet	lancet	PROPN
aiua-5029	202	2	.	.	PUNCT
aiua-5029	203	1	2003	2003	NUM
aiua-5029	203	2	;	;	PUNCT
aiua-5029	203	3	361:1927	361:1927	NUM
aiua-5029	203	4	-	-	SYM
aiua-5029	203	5	1934	1934	NUM
aiua-5029	203	6	.	.	PUNCT
aiua-5029	204	1	6	6	NUM
aiua-5029	204	2	.	.	X
aiua-5029	204	3	winquist	winquist	PROPN
aiua-5029	204	4	e	e	PROPN
aiua-5029	204	5	,	,	PUNCT
aiua-5029	204	6	kirchner	kirchner	PROPN
aiua-5029	204	7	ts	ts	PROPN
aiua-5029	204	8	,	,	PUNCT
aiua-5029	204	9	segal	segal	PROPN
aiua-5029	204	10	r	r	PROPN
aiua-5029	204	11	,	,	PUNCT
aiua-5029	204	12	et	et	PROPN
aiua-5029	204	13	al	al	PROPN
aiua-5029	204	14	.	.	PROPN
aiua-5029	204	15	neoadjuvant	neoadjuvant	ADJ
aiua-5029	204	16	chemotherapy	chemotherapy	NOUN
aiua-5029	204	17	for	for	ADP
aiua-5029	204	18	transitional	transitional	ADJ
aiua-5029	204	19	cell	cell	NOUN
aiua-5029	204	20	carcinoma	carcinoma	NOUN
aiua-5029	204	21	of	of	ADP
aiua-5029	204	22	the	the	DET
aiua-5029	204	23	bladder	bladder	NOUN
aiua-5029	204	24	:	:	PUNCT
aiua-5029	204	25	a	a	DET
aiua-5029	204	26	systematic	systematic	ADJ
aiua-5029	204	27	review	review	NOUN
aiua-5029	204	28	and	and	CCONJ
aiua-5029	204	29	meta	meta	ADJ
aiua-5029	204	30	-	-	PUNCT
aiua-5029	204	31	analysis	analysis	NOUN
aiua-5029	204	32	.	.	PUNCT
aiua-5029	205	1	j	j	PROPN
aiua-5029	205	2	urol	urol	PROPN
aiua-5029	205	3	.	.	PUNCT
aiua-5029	205	4	2004	2004	NUM
aiua-5029	205	5	;	;	PUNCT
aiua-5029	206	1	171:561	171:561	NUM
aiua-5029	206	2	-	-	SYM
aiua-5029	206	3	569	569	NUM
aiua-5029	206	4	.	.	PUNCT
aiua-5029	206	5	7	7	X
aiua-5029	206	6	.	.	X
aiua-5029	206	7	bcca	bcca	NOUN
aiua-5029	206	8	protocol	protocol	NOUN
aiua-5029	206	9	summary	summary	NOUN
aiua-5029	206	10	for	for	ADP
aiua-5029	206	11	palliative	palliative	ADJ
aiua-5029	206	12	therapy	therapy	NOUN
aiua-5029	206	13	for	for	ADP
aiua-5029	206	14	urothelial	urothelial	ADJ
aiua-5029	206	15	carcinoma	carcinoma	NOUN
aiua-5029	206	16	using	use	VERB
aiua-5029	206	17	cisplatin	cisplatin	NOUN
aiua-5029	206	18	and	and	CCONJ
aiua-5029	206	19	gemcitabine	gemcitabine	NOUN
aiua-5029	206	20	.	.	PUNCT
aiua-5029	207	1	http://www.bccancer	http://www.bccancer	NOUN
aiua-5029	207	2	.	.	PUNCT
aiua-5029	208	1	b	b	PROPN
aiua-5029	208	2	c	c	NOUN
aiua-5029	208	3	.	.	PUNCT
aiua-5029	209	1	c	c	VERB
aiua-5029	209	2	a	a	PRON
aiua-5029	209	3	/	/	SYM
aiua-5029	209	4	n	n	CCONJ
aiua-5029	209	5	r	r	NOUN
aiua-5029	209	6	/	/	SYM
aiua-5029	209	7	r	r	NOUN
aiua-5029	209	8	d	d	NOUN
aiua-5029	209	9	o	o	NOUN
aiua-5029	209	10	n	n	X
aiua-5029	209	11	l	l	NOUN
aiua-5029	209	12	y	y	NOUN
aiua-5029	209	13	r	r	NOUN
aiua-5029	209	14	e	e	X
aiua-5029	209	15	s	s	X
aiua-5029	209	16	/	/	SYM
aiua-5029	209	17	a	a	DET
aiua-5029	209	18	2	2	NUM
aiua-5029	209	19	4	4	NUM
aiua-5029	209	20	5	5	NUM
aiua-5029	209	21	1	1	NUM
aiua-5029	209	22	2	2	NUM
aiua-5029	209	23	0	0	NUM
aiua-5029	209	24	5	5	NUM
aiua-5029	209	25	5	5	NUM
aiua-5029	209	26	c	c	NOUN
aiua-5029	209	27	1	1	NUM
aiua-5029	209	28	3	3	NUM
aiua-5029	209	29	4	4	NUM
aiua-5029	209	30	3	3	NUM
aiua-5029	209	31	3	3	NUM
aiua-5029	209	32	c	c	NOUN
aiua-5029	209	33	a	a	PRON
aiua-5029	209	34	a	a	NOUN
aiua-5029	209	35	d	d	X
aiua-5029	209	36	e	e	ADP
aiua-5029	209	37	2e0dc1519d71/67037	2e0dc1519d71/67037	NUM
aiua-5029	209	38	/guavpg_protocol_1nov2013	/guavpg_protocol_1nov2013	SYM
aiua-5029	209	39	.	.	PUNCT
aiua-5029	210	1	pdf	pdf	PROPN
aiua-5029	210	2	,	,	PUNCT
aiua-5029	210	3	2013	2013	NUM
aiua-5029	210	4	.	.	PUNCT
aiua-5029	211	1	8	8	NUM
aiua-5029	211	2	.	.	PUNCT
aiua-5029	211	3	common	common	ADJ
aiua-5029	211	4	toxicity	toxicity	NOUN
aiua-5029	211	5	criteria	criterion	NOUN
aiua-5029	211	6	(	(	PUNCT
aiua-5029	211	7	ctc	ctc	NOUN
aiua-5029	211	8	)	)	PUNCT
aiua-5029	211	9	version	version	NOUN
aiua-5029	211	10	2.0	2.0	NUM
aiua-5029	211	11	,	,	PUNCT
aiua-5029	211	12	http://www.eortc	http://www.eortc	PROPN
aiua-5029	211	13	.	.	PUNCT
aiua-5029	212	1	be	be	AUX
aiua-5029	212	2	/	/	SYM
aiua-5029	212	3	services	service	NOUN
aiua-5029	212	4	/	/	SYM
aiua-5029	212	5	doc	doc	PROPN
aiua-5029	212	6	/	/	SYM
aiua-5029	212	7	ctc	ctc	PROPN
aiua-5029	212	8	/	/	SYM
aiua-5029	212	9	ctcv20	ctcv20	PROPN
aiua-5029	213	1	4-30-992.pdfpublished	4-30-992.pdfpublishe	VERB
aiua-5029	213	2	april	april	PROPN
aiua-5029	213	3	30	30	NUM
aiua-5029	213	4	,	,	PUNCT
aiua-5029	213	5	1999	1999	NUM
aiua-5029	213	6	.	.	PUNCT
aiua-5029	214	1	9	9	X
aiua-5029	214	2	.	.	X
aiua-5029	214	3	calabrò	calabrò	PROPN
aiua-5029	214	4	f	f	PROPN
aiua-5029	214	5	,	,	PUNCT
aiua-5029	214	6	sternberg	sternberg	PROPN
aiua-5029	214	7	cn	cn	PROPN
aiua-5029	214	8	.	.	PROPN
aiua-5029	214	9	localized	localized	ADJ
aiua-5029	214	10	and	and	CCONJ
aiua-5029	214	11	locally	locally	ADV
aiua-5029	214	12	advanced	advanced	ADJ
aiua-5029	214	13	bladder	bladder	NOUN
aiua-5029	214	14	cancer	cancer	NOUN
aiua-5029	214	15	.	.	PUNCT
aiua-5029	215	1	curr	curr	PROPN
aiua-5029	215	2	treat	treat	PROPN
aiua-5029	215	3	options	option	NOUN
aiua-5029	215	4	oncol	oncol	ADJ
aiua-5029	215	5	.	.	PUNCT
aiua-5029	216	1	2002	2002	NUM
aiua-5029	216	2	;	;	PUNCT
aiua-5029	216	3	3:413	3:413	NUM
aiua-5029	216	4	-	-	SYM
aiua-5029	216	5	28	28	NUM
aiua-5029	216	6	.	.	PUNCT
aiua-5029	217	1	10	10	NUM
aiua-5029	217	2	.	.	PUNCT
aiua-5029	217	3	von	von	PROPN
aiua-5029	217	4	der	der	PROPN
aiua-5029	217	5	maase	maase	NOUN
aiua-5029	217	6	h	h	NOUN
aiua-5029	217	7	,	,	PUNCT
aiua-5029	217	8	sengelov	sengelov	PROPN
aiua-5029	217	9	l	l	PROPN
aiua-5029	217	10	,	,	PUNCT
aiua-5029	217	11	roberts	roberts	PROPN
aiua-5029	217	12	jt	jt	PROPN
aiua-5029	217	13	,	,	PUNCT
aiua-5029	217	14	et	et	PROPN
aiua-5029	217	15	al	al	PROPN
aiua-5029	217	16	.	.	PUNCT
aiua-5029	218	1	long	long	ADJ
aiua-5029	218	2	-	-	PUNCT
aiua-5029	218	3	term	term	NOUN
aiua-5029	218	4	survival	survival	NOUN
aiua-5029	218	5	results	result	NOUN
aiua-5029	218	6	of	of	ADP
aiua-5029	218	7	a	a	DET
aiua-5029	218	8	randomized	randomized	ADJ
aiua-5029	218	9	trial	trial	NOUN
aiua-5029	218	10	comparing	compare	VERB
aiua-5029	218	11	gemcitabine	gemcitabine	NOUN
aiua-5029	218	12	plus	plus	CCONJ
aiua-5029	218	13	cisplatin	cisplatin	NOUN
aiua-5029	218	14	,	,	PUNCT
aiua-5029	218	15	with	with	ADP
aiua-5029	218	16	methotrexate	methotrexate	NOUN
aiua-5029	218	17	,	,	PUNCT
aiua-5029	218	18	vinblastine	vinblastine	NOUN
aiua-5029	218	19	,	,	PUNCT
aiua-5029	218	20	doxorubicin	doxorubicin	PROPN
aiua-5029	218	21	plus	plus	CCONJ
aiua-5029	218	22	cisplatin	cisplatin	NOUN
aiua-5029	218	23	in	in	ADP
aiua-5029	218	24	patients	patient	NOUN
aiua-5029	218	25	with	with	ADP
aiua-5029	218	26	bladder	bladder	NOUN
aiua-5029	218	27	cancer	cancer	NOUN
aiua-5029	218	28	.	.	PUNCT
aiua-5029	219	1	j	j	PROPN
aiua-5029	219	2	clin	clin	PROPN
aiua-5029	219	3	oncol	oncol	PROPN
aiua-5029	219	4	.	.	PUNCT
aiua-5029	220	1	2005	2005	NUM
aiua-5029	220	2	;	;	PUNCT
aiua-5029	220	3	23:4602	23:4602	NUM
aiua-5029	220	4	-	-	SYM
aiua-5029	220	5	4605	4605	NUM
aiua-5029	220	6	.	.	PUNCT
aiua-5029	221	1	11	11	NUM
aiua-5029	221	2	.	.	PUNCT
aiua-5029	222	1	herr	herr	PROPN
aiua-5029	222	2	hw	hw	PROPN
aiua-5029	222	3	,	,	PUNCT
aiua-5029	222	4	dotan	dotan	PROPN
aiua-5029	222	5	z	z	PROPN
aiua-5029	222	6	,	,	PUNCT
aiua-5029	222	7	donat	donat	PROPN
aiua-5029	222	8	sm	sm	PROPN
aiua-5029	222	9	,	,	PUNCT
aiua-5029	222	10	bajorin	bajorin	NOUN
aiua-5029	222	11	df	df	PROPN
aiua-5029	222	12	.	.	PUNCT
aiua-5029	223	1	defining	define	VERB
aiua-5029	223	2	optimal	optimal	ADJ
aiua-5029	223	3	therapy	therapy	NOUN
aiua-5029	223	4	for	for	ADP
aiua-5029	223	5	muscle	muscle	NOUN
aiua-5029	223	6	invasive	invasive	ADJ
aiua-5029	223	7	bladder	bladder	NOUN
aiua-5029	223	8	cancer	cancer	NOUN
aiua-5029	223	9	.	.	PUNCT
aiua-5029	224	1	j	j	PROPN
aiua-5029	224	2	urol	urol	PROPN
aiua-5029	224	3	.	.	PUNCT
aiua-5029	224	4	2007	2007	NUM
aiua-5029	224	5	;	;	PUNCT
aiua-5029	224	6	177:437	177:437	NUM
aiua-5029	224	7	-	-	SYM
aiua-5029	224	8	443	443	NUM
aiua-5029	224	9	.	.	PUNCT
aiua-5029	225	1	correspondence	correspondence	NOUN
aiua-5029	225	2	mohammed	mohammed	PROPN
aiua-5029	225	3	a	a	DET
aiua-5029	225	4	osman	osman	PROPN
aiua-5029	225	5	,	,	PUNCT
aiua-5029	225	6	md	md	PROPN
aiua-5029	225	7	(	(	PUNCT
aiua-5029	225	8	corresponding	correspond	VERB
aiua-5029	225	9	author	author	NOUN
aiua-5029	225	10	)	)	PUNCT
aiua-5029	226	1	mmoneam@hotmail.com	mmoneam@hotmail.com	X
aiua-5029	226	2	oncology	oncology	NOUN
aiua-5029	226	3	consultant	consultant	NOUN
aiua-5029	226	4	,	,	PUNCT
aiua-5029	226	5	general	general	ADJ
aiua-5029	226	6	organization	organization	NOUN
aiua-5029	226	7	for	for	ADP
aiua-5029	226	8	teaching	teaching	NOUN
aiua-5029	226	9	hospitals	hospital	NOUN
aiua-5029	226	10	institutes	institutes	PROPN
aiua-5029	226	11	egypt	egypt	PROPN
aiua-5029	226	12	ayman	ayman	PROPN
aiua-5029	226	13	m	m	PROPN
aiua-5029	226	14	gabr	gabr	PROPN
aiua-5029	226	15	,	,	PUNCT
aiua-5029	226	16	md	md	PROPN
aiua-5029	226	17	keshta64@gmail.com	keshta64@gmail.com	PROPN
aiua-5029	226	18	urology	urology	NOUN
aiua-5029	226	19	consultant	consultant	NOUN
aiua-5029	226	20	,	,	PUNCT
aiua-5029	226	21	national	national	PROPN
aiua-5029	226	22	institute	institute	PROPN
aiua-5029	226	23	of	of	ADP
aiua-5029	226	24	urology	urology	PROPN
aiua-5029	226	25	&	&	CCONJ
aiua-5029	226	26	nephrology	nephrology	NOUN
aiua-5029	226	27	,	,	PUNCT
aiua-5029	226	28	egypt	egypt	PROPN
aiua-5029	226	29	mohammad	mohammad	PROPN
aiua-5029	226	30	s	s	PROPN
aiua-5029	226	31	elkady	elkady	PROPN
aiua-5029	226	32	,	,	PUNCT
aiua-5029	226	33	md	md	PROPN
aiua-5029	226	34	mselkady@hotmail.com	mselkady@hotmail.com	PROPN
aiua-5029	226	35	ass	ass	PROPN
aiua-5029	226	36	.	.	PUNCT
aiua-5029	227	1	professor	professor	NOUN
aiua-5029	227	2	oncology	oncology	NOUN
aiua-5029	227	3	,	,	PUNCT
aiua-5029	227	4	ain	ain	PROPN
aiua-5029	227	5	shams	shams	PROPN
aiua-5029	227	6	university	university	PROPN
aiua-5029	227	7	,	,	PUNCT
aiua-5029	227	8	egypt	egypt	PROPN
aiua-5029	227	9	osman_stesura	osman_stesura	PROPN
aiua-5029	227	10	seveso	seveso	VERB
aiua-5029	227	11	15/01/15	15/01/15	PROPN
aiua-5029	227	12	13:09	13:09	NUM
aiua-5029	227	13	pagina	pagina	NOUN
aiua-5029	227	14	283	283	NUM